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Abstract 
Precision healthcare, also known as personalised medicine, is based on our 
understanding of the fundamental building blocks of biological systems, with the 
ultimate aim to clinically identify the best therapeutic strategy for each 
individual. Genomics and sequencing technologies have brought this to the 
foreground by enabling an individual’s entire genome to be mapped for less than 
a thousand dollar in just one day. Recently, metabolomics, the quantitative 
measurement of small molecules, has emerged as a field to understand an 
individual’s molecular profile in terms of both genetics and environmental 
factors. This is crucial because a genome could only indicate an individual’s 
susceptibility to a particular disease, whereas a metabolome provides an 
immediate measurement of body function, enabling a means of diagnosis. 
However, the current approach of measurements depends on large-scale and 
expensive equipment such as mass spectroscopy and NMR instrumentation, which 
does not offer a single analytical platform to detect the entire metabolome.  
This thesis describes the development of an integrated CMOS sensor array 
technology as a single platform to quantify different metabolites using specific 
enzymes. The key stages in the work were: to construct instrumentation systems 
to perform enzyme assays on the CMOS sensor array; to establish techniques to 
package the CMOS sensor array for an aqueous environment; to implement and 
develop a room temperature Ta2O5 sputtering process on CMOS sensor array for 
hydrogen ion detection; to collaborate with a chemist and investigate an 
inorganic layer on top of the CMOS ISFET sensor to show an improvement of 
sensitivity towards potassium ion; to test several different enzyme assays 
electrochemically and optically and show the functionalities of the sensors; to 
devise microfluidic channels for segregation of the sensor array into different 
compartments and perform enzyme immobilisation techniques on CMOS chips; 
and integrate the packaged chip with microfluidic channels and enzyme 
immobilisation using 2D inkjet printer into a complete system that has the 
potential to be used as a multi-enzyme platform for detection of different 
metabolites. 
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Two CMOS sensor array chips (1) a 256×256-pixel ISFET array chip and (2) a 
16×16-pixel Multi-Corder chip were fully understood. Therefore, a high-speed 
instrumentation system was constructed for the ISFET array chip with a 
maximum readout speed of 500 frames per second, with 2D and 3D imaging 
capability, as well as single pixel analysis. Follow by that, a miniaturised 
measurement platform was implemented for the Multi-Corder chip that has 
three different sensor arrays, which are ISFET, PD and SPAD. All the sensor 
arrays can be operated independently or together (ionic sensor and one of the 
optical sensors). 
Several post-processing steps were investigated to allow suitable fabrication 
process on small 4×4 mm2 CMOS chips. Post-processing of the CMOS chips was 
first established using room temperature sputtering process for Ta2O5 layer, 
achieving Ta:O ratio of 1:1.77 and a surface roughness of 0.42 nm. This Ta2O5 
layer was then fabricated on top of CMOS ISFETs, which improves the ISFET pH 
sensitivity to 45 mV/pH, with an average drift of 6.5 ± 8.6 mV/hour from chip to 
chip and a working pH range of 2 to 12. Furthermore, a layer of POMs was drop 
casted on top of Ta2O5 ISFET to make ISFET sensitive to potassium ions. This was 
investigated in terms of potassium ions sensitivity, hydrogen ions sensitivity and 
sodium ions as interfering background ions. The POMs Ta2O5 ISFET was found to 
have a net potassium sensitivity of 75 mV/pK, with a linear range between pH 
1.5 to 3. Moreover, the POMs ISFET has -5 mV/pH in pH sensitivity, showing that 
it is selectivity towards potassium ions and not hydrogen ions. However, sodium 
ions were found to produce a large interference towards the pK sensitivity of 
POMs ISFET and reduced the pK sensitivity of POMs ISFET. Hence, further work is 
still required to modify POMs layer for better selectivity and sensitivity. Besides 
that, microfluidic channels were fabricated on top of the CMOS chips that could 
provide segregation for multiple enzyme assays on a single chip. In addition, a 
PDMS and a manual dam and fill method were developed to encapsulate the 
CMOS chips for wet biochemistry measurements.  
The CMOS sensor array was found to have the ensemble averaging capability to 
reduce noise as a function of √N, where N is the number of sensors used for 
averaging. Several enzyme assays that include: hexokinase, lactate 
dehydrogenase, urease and lipase were tested on the ISFET sensor array. 
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Moreover, using an optical sensor array, namely a PD on the Multi-Corder chip 
and using LED illumination, quantification of cholesterol levels in human blood 
serum was demonstrated. Enzyme kinetics calculations were performed for 
hexokinase and cholesterol oxidase assays and the results were comparable to 
that obtained from a bench top spectrophotometer. This shows the CMOS sensor 
array can be used as a low cost portable diagnostic device. 
Several enzyme immobilisation techniques were explored but were unsuccessful. 
Alginate enzyme gel immobilisation with a 2D inkjet printer was found to be the 
best candidate to bio-functionalise the CMOS sensor array. The packaged chip 
was integrated with microfluidic channels and alginate enzyme gel 
immobilisation into a complete system, in order to perform an enzyme assay 
with its control experiments simultaneously on a single chip. As a proof-of-
concept, this complete system has the potential to be used as a multiple 
metabolite quantification platform. 
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Chapter 1 : Introduction to the 
Research 
1.1 Introduction 
This chapter describes the motivation of the research in terms of applications 
and technology. The aim and objectives of the work are identified and an 
outline of the thesis is provided. 
1.2 Motivation 
Modern biomedical and life sciences are predicated on our understanding of the 
fundamental building blocks that underpin biological systems. This knowledge 
will lead us to personalised healthcare, whereby individualised therapy or drugs 
that are best suited for an individual can be selected based on their clinical 
profile. It all began with the coining of the phrase “genomics” in 1986 and the 
sequencing of the human genome soon after, which brought the practice of 
medicine to enter the era of understanding an individual’s genome to determine 
optimal healthcare [1, Ch. 1]. Therefore, a low cost, rapid and portable medical 
device for routine testing is required. This will allow physician to tailor 
diagnosis, prevention and treatment based on an individual’s genetic makeup. 
However, sequencing 3-billion base pairs of DNA found in the human genome is 
very time consuming and expensive, thus various technologies have been 
established to reduce the cost of sequencing with a goal of reaching $1,000 per 
genome [2]. 
Common practice of DNA sequencing is limited by imaging technology, 
electromagnetic intermediates such as X-rays or light and specialised reagents or 
preparations [3]. In order to overcome this limitation, a non-optical sequencing 
technology using integrated circuits has been pursued. The microelectronics 
industry is dominated by complementary metal oxide semiconductor (CMOS) 
technology with its scalability, mass-manufacturing and low cost production. 
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More importantly, CMOS has the ability to facilitate an array of sensors into a 
small space and incorporate high quality standard electronics into one single 
integrated platform. CMOS has brought success to modern computing, 
communication and sensing technology by creating ubiquitous computers, mobile 
phones and digital cameras. Recently, Ion Torrent (Thermo Fisher Scientific) has 
brought the price of genome sequencing to the foreground, by inventing a 
personal genome machine on CMOS technology – the world’s first optics free 
sequencing system [4]. 
Personalised medicine has been focussing on the understanding of an individual’s 
genetic makeup to provide precision healthcare. However, a genome could only 
indicate an individual’s susceptibility to a particular disease. Moreover, most 
diseases are very complex and involve the interaction between genetics and 
environmental factors [5]. Therefore, studying the molecular makeup of an 
individual is very important for the advancement of personalised medicine. 
Various other “omics” groups such as transcriptomics (RNA), proteomics 
(proteins) and metabolomics (metabolome) have been spawned after genomics 
to better understand an individual’s clinical profile. Metabolomics is particularly 
well suited for this approach since the metabolome is the ensemble of all the 
tiny molecules, or metabolites of life, which reflects an individual’s health at a 
given period of time in one’s lifespan that is affected by both genetics and 
lifestyle, hence allowing immediate diagnosis.  
To date, metabolome detection relies on expensive, large-scale equipment such 
as mass spectroscopy and nuclear magnetic resonance (NMR) instrumentation 
and the required special skillsets to operate them [6]. More importantly, this 
equipment does not provide a single platform to detect the entire metabolome. 
In the same way that pioneering research in sequencing technologies unravelled 
the personal genome and reduced the genome cost, thus the pursuit of a 
technology is required to give everyone near instant access to their own 
metabolome for the advancement of personalised medicine. 
In this study, an integrated CMOS sensor array technology is developed as a 
single platform to quantify different metabolites using specific enzymes. 
Furthermore, using this platform, in tandem with microfluidics to segregate the 
sensor array into different sections, together with different enzyme 
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functionalisation, allows detection of multiple metabolites simultaneously. 
Finally, this sensor array can be integrated into a portable device, leading to a 
handheld diagnostic tool as a personal metabolome machine, revolutionising 
healthcare provision worldwide.  
1.3 Aim and Objectives 
The research work presented in this thesis is part of The Multicorder project 
that has a larger vision of using microelectronics technology to create the 
world’s first broad spectrum sensor technology for diagnostics, chemical 
synthesis and biotechnology. The main objective of this project is to develop a 
personal metabolome machine for precision healthcare, which is the primary aim 
of this thesis. The Multicorder is supported by the UK Engineering and Physical 
Sciences Research Council, with Professor David Cumming as the head of 
project. The project co-investigators are the School of Chemistry, Institute of 
Infection, Immunity and Inflammation (Wellcome Trust Centre for Molecular 
Parasitology) and the University of Newcastle.  
Dr. Balazs Nemeth, previously a research assistant in the microsystem 
technology (MST) group designed the 256×256-pixel ISFET array chip. The second 
CMOS chip studied in this work is the 16×16-pixel Multi-Corder chip designed by 
Dr. Mohammed Al-Rawhani, who is a research associate in the MST group. 
Moreover, Christoph Busche, a research fellow in the School of Chemistry, was 
responsible for synthesising the polyoxometalates (POMs) and worked with 
myself and Dr. Srinivas Velugotla, a research associate in the MST group, to 
enhance the sensitivity of the ISFET towards potassium ions with POMs. 
Furthermore, Dr. Alasdair MacDonald, a research associate at Institute of 
Infection, Immunity and Inflammation, prepared all the required enzyme assays 
reagents to be performed on top of the CMOS sensor array. Therefore, it has to 
be pointed out that all the CMOS chips are designed and enzyme assays are 
prepared by the individuals mentioned above. In spite of that, the designs of the 
CMOS chips have to be well understood to construct a complete instrumentation 
system for two different CMOS chips and the preparation of the reagents had to 
be fully comprehended to be able to produce proper measurements on the CMOS 
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chips. All this work is included in the thesis to provide a better understanding of 
the thesis. 
My activity in this project consisted in measuring and analysing different enzyme 
assays on two different CMOS chips using ISFET and PD sensors. At the same 
time, integrating SU-8 microfluidic channels with alginate entrapment of enzyme 
that was printed by a 2D inkjet printer, to produce a multi-enzyme platform for 
simultaneous measurements of different metabolites. Furthermore, part of my 
time was also devoted to improving the performance of ISFET towards hydrogen 
ions and potassium ions, using Ta2O5 thin film and POMs inorganic layer 
respectively. The specific objectives of this research work are detailed as 
follows: 
 To understand the design of both chips, (1) 256×256-pixel ISFET array chip 
and (2) 16×16-pixel Multi-Corder chip and develop two separate 
instrumentation systems for both chips, in terms of hardware and 
software.  
 To develop a robust and stable packaging technique, in order to produce a 
waterproof CMOS chip that could perform chemical and biological 
experiments.  
 To develop a fabrication process of Ta2O5 film on top of CMOS ISFETs using 
room temperature sputtering process and characterise it for its sensing 
performance, which includes sensitivity towards hydrogen ion 
concentration, drift and robustness. 
 To comprehend all the enzyme assays reagents preparation by the 
biologist, in order to measure and analyse all the enzyme assays on top of 
the CMOS chips. At the same time, learn how to prepare enzyme assays in 
order to be become independent. 
 To fabricate and test the SU-8 microfluidic channels on the CMOS chips. 
 To develop an enzyme immobilisation technique using a 2D inkjet printer 
that is measureable using the CMOS chips.  
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 To integrate the SU-8 microfluidic channels with enzyme immobilisation 
using 2D inkjet printing to create a complete system, which has the 
potential to perform multiple enzyme assays for simultaneous detection 
of different metabolites. 
1.4 Thesis Outline 
The subsequent chapters of this thesis are divided into seven chapters and a 
brief description of each chapter is provided as follows: 
Chapter 2 is a review of the literature relevant to the development of a 
personal metabolome machine for precision healthcare using CMOS sensor array 
technology. 
Chapter 3 presents the fundamental theory of enzymes to quantify metabolites 
using enzyme kinetics and describes how these enzyme assays can be detected 
optically and electrochemically. Finally, the theory of pH measurement using a 
conventional glass electrode in the context of an ISFET is provided.  
Chapter 4 describes the two different chips, 256×256-pixel ISFET array chip and 
16×16-pixel Multi-Corder chip, focussing on the understanding of the designs of 
both chips, to construct two separate instrumentation platforms.  
Chapter 5 discusses the post-processing that is required to improve the 
sensitivity of the ISFET towards hydrogen ions and potassium ions. In addition, a 
discussion on the fabrication of microfluidic channels on CMOS chips for multiple 
metabolite detection. Finally, the packaging technique is described for chemical 
and biological experiments in aqueous solution.   
Chapter 6 provides details of the measurements of different metabolites using 
both chips, including results and discussion. 
Chapter 7 describes the enzyme functionalisation technique on CMOS chips and 
how to integrate it into a complete system together with microfluidics to 
perform multiple metabolites with specific enzymes, including results and 
discussion. 
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Chapter 8 summarises the conclusion of this research work and discusses 
potential future work.  
1.5 Summary 
The motivation of this project was provided by describing the limitations of 
current approaches and proposed a better technology to overcome them with 
the potential of achieving greater goals. Furthermore, the aim and objectives of 
the research work were identified and an outline of the thesis was provided. The 
next chapter will be a review of the literature relevant to this project. 
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Chapter 2 : Literature Review 
2.1 Introduction 
This chapter presents a review of the literature relevant to the development of 
a sensor system on chip, specifically focussing on the advancements towards 
personalised medicine via genomics and metabolomics. A brief history of 
personalised medicine is first given along with a chronological description of the 
technology and strategies employed in genomics and metabolomics. Next, the 
various methods employed in microarray technologies that are commonly used 
for genomics research that could apply to metabolomics are discussed. This 
chapter further discusses low cost CMOS technology for the adaption of various 
different chemical sensors that can be integrated on a single chip. Finally the 
ion sensitive field effect transistor (ISFET) is introduced and adapted to CMOS 
technology, which opened up to various biosensing applications. 
2.2 Personalised Medicine 
The wellbeing of human health has always been a driving force for scientists to 
strive for the development of a better healthcare. Most of the current strategies 
of illness treatment and drug development are based on the efficacy towards a 
large population of people. These methods provide the same treatment to all 
patients with the same diagnosis of a certain disease, a conventional concept of 
“one-drug-fits-all” [1, Ch. 1]. These methods of medical treatment are based on 
the hypothesis that all diseases affect each patient in the same way however the 
same medical treatment could lead to different responses for each patient. 
Although the genetic makeup of mankind is 99.1% identical, a small inter-
individual genetic variation of 0.9% accounts for the huge variability that exists 
in human beings [1, Ch. 1], [5].  
The medical community has long recognised each patient has unique inherent 
traits, which may be evidenced by the ubiquity of certain diseases within 
families or ethnicities, variations in response to treatment and different 
manifestations of a single pathology [5]. In spite of these observations, medical 
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practice still uses a standard treatment for a heterogeneous population. With 
the advancement of scientific knowledge over the years, medical practice has 
underwent a paradigm shift towards tailoring medical treatment to best suit an 
individual’s needs taking into consideration both genetic and environmental 
factors, which is known as personalised medicine [1, Ch. 1], [7]. Figure 2.1 
shows the difference between present conventional medicine and personalised 
medicine.  
 
Figure 2.1 – Difference between conventional medicine and personalised medicine. 
Reproduced from [8]. 
2.2.1 History of Personalised Medicine 
The term personalised medicine was first used as a title in a monograph in 1998 
and followed by subsequent publications in MEDLINE in 1999 [1, Ch. 1]. However, 
the first concept of individualised healthcare was actually dated back to 4000 BC 
and the ancient medical system of India known as Ayurveda, where therapy is 
customised to the individual’s constitution (Prakriti) [9]. In addition, traditional 
Chinese medicine [10] and traditional Korean medicine (Sasang typology) [11] 
also provide treatments according to the needs and personality of the patient. 
Each of these traditional medicines has their specific methods to classify an 
individual’s constitution. For example, Ayurvedic practices use the tridosha 
theory to identify principles of motion (vata), metabolism (pitta) and structure 
a) Medicine of the present: one 
treatment fits all 
b) Medicine of the future: more 
personalised diagnostics 
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(kapha) to classify individual Prakriti subtype [9]. These ancient healthcare 
systems survive to the present day and are still practiced. 
From the late 19th century onwards, it is the beginning of modern medicine with 
the use of scientific knowledge to better understand diseases and enable 
accurate classification of patients. A lot of advances occurred during this period, 
from which genetic medicine started with the observation by Garrod [12] in 1931 
that inter-individual variation to drugs is due to differences in each person’s 
genetic constitution. The completion of Human Genome Project [13] in 2000 has 
hugely impacted scientists understanding of individuals and also brought 
personalised medicine a step closer to reality. The primary advancement in 
genetics technologies that enabled significant progress within the field of 
personalised medicine are single nucleotide polymorphism (SNP) genotyping [14] 
and microarrays/biochips [1, Ch. 2], [15]. Figure 2.2 illustrates the definition of 
the SNP biomarker and an example of the usage of a microarray for 
deoxyribonucleic acid (DNA) sequencing.  
 
Figure 2.2 – The two most significant advancements for personalised medicine. Reproduced 
from [16], [17]. 
The discovery of SNP – the single-nucleotide (base) substitution in the (DNA) 
sequence of the general population (at least 1%) explains most of the inter-
individual genetic variability [5]. The ability to identify SNPs is very important as 
it helps to link an individual’s susceptibility to certain diseases and also response 
a) Four different versions of SNP b) DNA microarray testing process 
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to medications. Through a lot of clinical studies and trials, researchers have 
proven that SNPs can be used as invaluable markers for segregating individuals.  
The invention of the efficient and cost effective microarray biochip has 
revolutionised the field of personalised medicine, with the capability to store 
and rapidly analyse the entire human genome of a patient. Microarray 
technology allows researchers and clinicians to conduct SNP genotyping 
efficiently and rapidly, enabling early detection of disease and prediction of 
drug response [14]. Ultimately, this will offer the possibility of analysing the 
entire proteome or metabolome, leading to protein-based diagnostics and 
therapeutics which could potentially provide point-of-care (POC) diagnosis.  
2.2.2 Genomics 
DNA is the chemical compound that carries the genetic information of an 
organism [18, Ch. 1]. DNA is made up of four different chemical units, called 
nucleotide bases: adenine (A), guanine (G), cytosine (C) and thymine (T). It is 
the sequence or the order of these bases that determines the encoded 
information in the DNA. All the bases tend to form base pairs, A with T and C 
with G, and creates two long DNA strands that twist into a spiral called a double 
helix. The complete DNA sequence of all these nucleotides is the total genetic 
material of an organism, called its genome. A human genome is very complex 
and contains approximately 3-billion DNA base pairs [19]. It is located in every 
single cell nucleus of the human body as 23 pairs of chromosomes. In these 
chromosomes, there are units of DNA called genes that carry the information to 
produce proteins, which are the main macromolecules of an organism and are 
used to build body structures such as organs. Figure 2.3 illustrates a graphical 
explanation of a genome. Currently, the Human Genome Project holds an 
estimation of the total number of genes in the human genome to be around 
20,500 [20].  
In 1860, Gregor Mendel experimented with pea plants and developed the 
fundamental principles of genetics, which is the study of singles genes and their 
functions [21]. Genetic research has pushed scientists to investigate the 
molecular makeup of a gene until in 1953 Watson and Crick [22] solved the 
puzzle of the DNA molecule. In 1960, Brenner described the correlation between 
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DNA and proteins and led to the identification of the first gene-disease 
association known as Huntington’s disease [5], [23]. This is a genetic disease 
caused by alterations in a single gene. However, many common human diseases 
are caused by the interaction between genes and their environments, which is 
called multifactorial or complex diseases. In contrast to a single gene disorder, 
they are caused by the defects in multiple genes with the effect from the 
environment.  
 
Figure 2.3 – Graphical explanation of a genome, from the cellular level to the formation of 
complex proteins that could be used for organ construction. Reproduced from [24]. 
Therefore, determining the complete base sequence of a DNA segment is crucial 
to understand genes and their effects. This led to the development of Sanger 
Sequencing, first demonstrated by Frederick Sanger [25] in 1977, which has 
become the basis for modern sequencing techniques [26], [27]. In order to study 
large pieces of DNA such as a gene, scientists have to sequence small sections of 
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DNA and assemble them into a larger sequence. Overlapping segments of DNA 
sequences between these short segments have to be read multiple times to 
ensure fidelity. This led to the introduction of polymerase chain reaction (PCR), 
a commonly used method to amplify DNA rapidly, by Karry B. Mullis [28] in 1987. 
With the need to understand the entire human genome, various next generation 
sequencing technologies have been developed to allow high-throughput 
sequencing and reduce the costs. With the advancement in genome sequencing, 
SNPs are identified by scientists when DNA samples were sequenced from 
multiple people. SNPs are the best markers for explaining most of the inter-
individual variations in general population [29]. Large scale genotyping of SNPs 
at thousands of genes in a human genome can establish an individual’s 
susceptibility to a disease and drugs response. Genomics technology has formed 
the basis for personalised medicine.  
2.2.3 Metabolomics 
Genomics alone is inadequate to describe an individual’s susceptibility to a 
certain disease or response to a drug with absolute certainty. To better 
comprehend the reason genomics technology is insufficient to represent 
personalised medicine, it is crucial to define the principal terms: genotype and 
phenotype. Genotype is the complete genomic sequence of an individual, while 
phenotype is the individual observable differences that generates from the 
complex interaction between genotype and environment [5]. Figure 2.4 
illustrates that metabolomics have the closest link to an individual’s phenotype. 
These environmental causes include diet, lifestyle, nutrition, medications and 
age [30]. Similar with the discussion in genomics, almost all common diseases 
have a multifactorial pathogenesis, which have genetic and environmental 
causes. Therefore, genotypic makeup of an individual is not enough to paint a 
clear picture to one’s risk of developing a disease or response to drugs. 
Metabolomics is a study of the metabolome, which is the total collection of 
small molecules known as metabolites in a human cell, body fluids, tissue or 
organ involved in the primary and intermediary metabolism [1, Ch. 7]. 
Metabolome is affected by both genetic and environmental factors, where the 
quantifiable metabolites at a given time will provide the closest link between 
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genotype and phenotype. Hence, it is the biological end point that commences 
from DNA and provides useful information about an individual phenotype, while 
genomics is just a prediction of the potential cause for a phenotypic response. 
This could provide useful information for an individual’s physiological status at a 
given time in life and assist early identification of diseases. Similar to single 
gene detection, the detection of a single metabolite can only provide crude 
diagnosis to an individual’s health, thus metabolome detection is required to 
provide an overall understanding of the metabolism of an individual [31]. 
Metabolomics was first demonstrated in the late 1960s and it was not until 1971 
that it was described by Pauling et al. in his publication [30]. They investigated 
several metabolites in body fluids that reflect certain diseases. After 
approximately 20 years, metabolomics started to blossom in 1990 with the first 
publication on metabolome and the Human Metabolome Project provided the 
first draft of human metabolome by 2007 [32]. Currently, the Human 
Metabolome database holds data on over 40,000 metabolites [33]. 
 
Figure 2.4 – Flow chart of an individual’s phenotypic profile, from DNA to metabolites. 
Reproduced from [34]. 
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The common method to study metabolomics is by collecting samples of interest, 
such as blood plasma and cerebral spinal fluids, and using different analytical 
platforms for detection. Reviews have reported that there are several commonly 
used analytical platforms that are proven to identify metabolites: nuclear 
magnetic resonance (NMR) spectroscopy, gas chromatography mass spectroscopy 
(GC-MS), liquid chromatography mass spectroscopy (LC-MS) and liquid 
chromatography electrochemistry array (LCECA) [6], [35]. 
The choice of a metabolomic analytical instrument depends on their analytical 
goal [6], for instance: 
 NMR has been very successful in toxicology studies. 
 GC-MS is commonly used in lipidomics, mapping of lipid biochemical 
pathways. 
 LC-MS can analyse most biochemical compounds, hence it is normally used 
to map the largest possible biochemical profile. 
 LCECA is excellent at mapping neurotransmitter pathways and oxidative 
stress pathways. 
All analytical platforms have their own strengths and limitations, as described in 
Table 2.1. Currently there is no single analytical platform that has the capability 
to detect the complete metabolome in one sample [6].  Moreover, all the 
analytical platforms are expensive and require special skillsets to operate them 
and understand the data. Metabolomics markers could provide early diagnosis of 
diseases and bring personalised medicine to the bedside of patients. With 
expensive and huge analytical platforms, POC diagnosis is not possible. 
Therefore, like genomics, metabolomics analytical platforms should be reduced 
in cost to the clinical medical range, and ideally there should be a single 
technology to detect whole human metabolome. Such a tool would revolutionise 
personalised medicine. 
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Table 2.1 – Comparison of different analytical platforms for metabolomics [6] 
Analytical 
Platforms 
Advantages Disadvantages 
NMR  Structural analysis 
 High-sample-throughput  
 Universal detection 
 Excellent quantitative 
precision 
 Non-destructive processing 
 Expensive (over one 
million dollars) 
 Poor sensitivity 
GC-MS  Structural analysis. 
 High-sample-throughput 
 Reasonable quantitative 
precision 
 Better sensitivity than NMR 
 Only study molecules that 
can be readily volatilised. 
 Expensive (100 – 300 
thousand dollars) 
 Destructive processing 
LC-MS  Can detect most 
compounds with different 
configurations 
 Inconsistent quantitative 
precision 
 Expensive (100 thousand 
to one million dollars) 
 Destructive processing 
LCECA  Extremely sensitive, better 
than GC-MS 
 Lower cost (slightly below 
100 thousand dollars) 
 Detects only 
electrochemical active 
compounds 
 Lack of structural analysis 
 Low-sample-throughput 
 
2.3 Microarray Technologies 
Microarrays are multiplexing technologies that enable simultaneous assessments 
of multiple variables using a tiny amount of sample with one single experiment. 
A microarray contains microspots of probing molecules immobilised onto a solid 
surface in rows and columns. These microspots are exposed to corresponding 
target molecules for detection in a sample. Various detection methods can be 
used to readout the signal from the microarray, such as fluorescence, mass 
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spectrometry, electrochemistry, chemiluminescence, colorimetric or 
radioactivity [36].  
The first implementation of microarray technology was in a multi-analyte 
immunoassay by Roger Ekins [37] in 1989. They demonstrated that microspot 
capture probes could be used to detect analyte concentration with high 
sensitivity and accuracy. However, microarray technology was not in demand 
during that period. Interest in microarray technology burgeoned with the advent 
of genome sequencing requiring simultaneous multi-gene analysis. Together with 
the high-throughput oligonucleotide synthesis using PCR amplification, 
microarray technology has created an array of oligonucleotide probes to 
sequence DNA samples via hybridisation. The ‘DNA chip’ became one of the 
greatest achievements in genomics. DNA is a uniform and stable molecule and its 
primary sequence binds with specific target DNA with good specificity using the 
complementary base-pair principle [38]. Hence, prediction of the DNA sequence 
of a target molecule can be easily determined. However, microarray 
technologies for complex molecules such as enzymes are not well established. 
Unlike DNA, enzymes are much more complex molecules. The primary amino 
acid sequence of an enzyme does not determine the affinity towards the target 
molecule. It also depends on the molecular structure of the enzyme and also a 
numerable of ways to interact with target molecules. Besides that, enzymes are 
not only specific to one target molecule but several of them. Enzymes will be 
discussed in more detail in Chapter 3. The following sections delineate the 
contemporary techniques to microarray technologies that are commonly used in 
creating planar DNA microarrays, which could be adopted for enzyme 
microarrays for metabolites detection on a CMOS platform, with the focus on 
printed microarrays.  
2.3.1 Printed Microarrays 
Printed microarrays were the first microarrays to be used in research 
laboratories. These microarrays have a lower density compared to in situ-
synthesised microarrays and high-density bead arrays [39]. In printed microarray 
technology, the probe spots are normally deposited onto a solid surface using 
non-contact or contact printing. Non-contact printing uses technology such as 
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inkjet printing, where the print head disperses the solution with a gap above the 
surface, while in contact printing, the print head contacts the surface to deliver 
the solution. Figure 2.5 shows the difference between contact and non-contact 
printing. These microarrays are inexpensive and rather simple to make. In 
addition, they are very versatile in which they can be used to print different 
kinds of biological samples. However, cross-contamination is a very critical issue 
for printed microarrays – it is imperative to maintain the integrity of the 
biological sample being printed.  
 
 
Figure 2.5 – Working mechanism of different printing techniques. Reproduced from [40].  
Printed DNA microarrays normally use double-stranded DNA from a known 
genome sequence (denature to form single-stranded DNA after immobilisation) 
or chemically synthesised oligonucleotide. The desired DNA is first printed on 
the surface and it is then followed by the immobilisation of the DNA. The 
double-stranded DNA immobilisation can be done via electrostatic interaction 
between the negatively charges DNA and the positively charged coated surface, 
or via UV-cross-linked covalent bonds between thymidine bases in the DNA and 
the amine groups on the surface. On the other hand for oligonucleotide 
attachment on the surface, it is normally coupled on aldehyde treated surface. 
In 2000, MacBeath et al. [41] demonstrated the first protein microarray using 
specific enzymes to detect small molecules. They used a high-precision contact-
a) Contact mechanical microspotting 
b) Non-contact inkjet printing 
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printing robot to produce such a microarray. The enzymes solutions were printed 
in phosphate-buffered saline with 40% glycerol to prevent evaporation. Similar to 
the coupling of oligonucleotide to the surface, they used an aldehyde treated 
solid surface to react with amine groups in enzymes immobilised on the surface. 
Using this method, enzymes could be attached on the surface in a variety of 
orientations without impeding the ability of the enzymes to interact with small 
molecules. Bovine serum albumin (BSA) was also used to quench all the 
unreacted aldehyde surfaces to prevent unspecific binding. 
The most recent invention, by Lee et al. [42] in 2004, is called the metabolic 
enzyme microarray (MetaChip). They developed an enzymatic microarray using a 
printing technique and also the immobilisation of enzymes on the surface using 
alginate gels [43, Ch. 14]. They used a solid surface coated with 
methyltrimethoxysilane (MTMOS) to produce hemispherical spots on the surface. 
The compounds required for enzyme reaction, barium chloride and poly-L-lysine 
(BaCl2-PLL) solutions, were printed onto the MTMOS coated solid surface. They 
were left to dry for some time and alginate solutions containing specific enzyme 
were printed straight on top of the compound spots, causing almost 
instantaneous gelation of the alginate matrix to form enzyme microarrays. 
Figure 2.6 shows the process of alginate gel enzyme formation and also a 
micrograph of the gel microspot.  
 
Figure 2.6 – Schematic and microscopic photograph of the gel microscpots on MetaChip 
[42]. 
a) MetaChip process b) Microscopic photograph of gel 
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2.3.2 In Situ-Synthesised Microarrays  
In situ-synthesised microarrays are extremely high-density microarrays that were 
first developed and patented by Affymetrix and are now known as GeneChips 
[39]. Affymetrix GeneChip oligonucleotide microarrays are fabricated using 
photolithography technology used in the semiconductor industry and synthesised 
onto a quartz surface. The quartz surface is modified with a photochemical 
resist, and then it is followed by UV light exposure using a photolithographic 
mask on a specific area. On the unprotected regions of the surface, a specific 
nucleotide is added to grow the oligonucleotide. The process of cycling mask, UV 
light exposure, and the addition of A, C, T or G to grow the oligonucleotide 
creates GeneChip, shown in Figure 2.7.  
 
Figure 2.7 – Chemical synthesis cycle for GeneChip microarray using photolithography [39]. 
A later invention from Roche NimbleGen oligonucleotide microarrays used a 
digital mask to replace the photolithographic mask. This technology uses 
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programmable micromirrors for the UV light to create a pattern for the 
nucleotide addition. Further improvements by Agilent Technologies eliminated 
the need for photolithographic or digital mask. Their technology uses inkjet 
printing, adopted from printed microarrays, to deposit the 4 different nucleotide 
bases and stack them into oligonucleotide synthesised on a glass slide, as shown 
in Figure 2.8.  
 
Figure 2.8 – Agilent oligonucleotide microarray using non-contact inkjet printing [39]. 
In 2001, He et al. [44] adopted in situ-synthesised DNA microarray to form an 
enzyme (luciferase) microarray [45], termed PISA (protein in situ array), shown 
in Figure 2.9. The enzyme is synthesised from a specific DNA sequence and 
tagged with a DNA sequence. Then, the enzyme is attached onto the surface 
with another DNA tag sequence that is complementary to the one on the 
enzyme. However, these microarrays are expensive to customise for different 
enzymes and involve a lot of complex chemical synthesis.  
a) Inkjet printing of four 
different bases 
b) Repeat base by base to reach 
required oligonucleotide length 
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Figure 2.9 – The PISA procedure for protein microarray formation [45]. 
2.3.3 High-Density Bead Arrays 
Bead arrays are highly packed microarray first developed by Illumina and named 
BeadArrays [39], shown in Figure 2.10. Unlike printed and in situ-synthesised 
microarrays described above, which immobilise probing molecules (DNA) directly 
onto a solid surface, bead arrays use different type of beads to attach the 
probing molecules. Illumina BeadArrays use fibre-optics bundles (an array of 
light-conducting fibres) or a well in silicon to accommodate the probing beads. 
To fabricate the well in the fibre core, a chemical etching technique is used. To 
form the silicon well, micro-electro-mechanical-systems technology is employed. 
In contrast to the known location on the surface using printed or in situ-
synthesised microarrays, beads with different covalently bonded probing 
molecules are randomly arranged into each of the microwells. Hence, a 
technique to identify the location is important. Typically for DNA bead 
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microarrays, the location is identified with fluorescently labelled 
complementary base pairs through hybridisation. Each bead has a unique capture 
oligonucleotide to serve as an identifier, which is specifically avoided the human 
DNA sequence. Bead arrays have been successfully applied to semiconductor 
integrated circuits for genome sequencing by Life Technologies (now Thermo 
Fisher Scientific), called Ion Torrent [4]. They have demonstrated 1.2 million 
microwells of bead arrays for large scale and low cost genome sequencing. The 
technology will be further explained in Section 2.4.3.  
 
Figure 2.10 – Illumina BeadArray using fibre optics bundles (left) or silicon wafer (right) [39]. 
2.3.4 Electronic Microarrays 
All the microarray technologies that are described above rely on the passive 
attachment of probing molecules onto the surface. Electronic microarrays 
provide an active attachment of probing molecules to a specific location using 
electric fields. Nanogen’s “NanoChip” was the first electronic approach to 
create a DNA microarray [39]. It only has 400 spots of probing molecules. It uses 
a positive current to activate several specific sites on the microarray and allows 
formation of a binding agent on the surface. Negatively charged DNA probes are 
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attracted to the site and create a bond with the binding agent. The greatest 
advantage of this microarray is the ability to combine it with semiconductor 
technology to address the probing molecules locations. This would enable 
semiconductor technology to create a complete system for immobilisation of 
probing molecules to sensor system. However, electronic microarrays do not 
provide a high-throughput analysis for large scale genome sequencing compared 
to other microarray technologies. The Nanogen microarray technology was 
discontinued in 2007 due to lack of demand.  
2.4 Sensor System on Chip 
In the wake of the Human Genome Project that revolutionised healthcare, the 
cost of genome sequencing has been substantially reduced, with the goal of 
reaching the $1,000 genome [2]. With the demand of increasing number of 
genomes being sequenced per year, in order to transition sequencing 
instruments from small-scale biomedical research efforts to diagnostic in clinical 
laboratories, with the aim of one day reaching the hands of a physician, a 
repeatable large scale manufacturing process is needed.  
In parallel to the development of personalised medicine, the electronics industry 
is also advancing, especially low cost, large scale and high quality manufacturing 
techniques for integrated circuits. The present dominant manufacturing 
technique is called complementary metal oxide semiconductor (CMOS) 
technology. CMOS has revolutionised modern computing, with the invention of 
digital logic chips such as microprocessors and memory. This can be seen from 
the transformation of the computer from as big as a room to current portable 
computing devices. A more recent advancement of CMOS has led to the 
commercialisation of digital camera and mobile phone communications using 
mixed digital-analogue signal chips. Mixed signal chips have enabled the 
possibility of creating a complete sensor system on chip. Using the analogue 
signal, electronic readout (voltage or current) from the sensor can be obtained, 
while the digital signal allows data processing and off-chip transmission. The 
advent of the digital camera has had an enormous impact on sensing technology. 
This can be observed in the evolution of the photography industry, with the 
displacement of chemical film technology to CMOS image sensor array chips. This 
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technological advancement has shown that it is important to embody a 
measuring device with a CMOS chip as a core component to enable large scale, 
high quality and low cost manufacturing. This will provide the necessary 
platform for both genomics and metabolomics development.  
2.4.1 CMOS Technology 
With the desire to miniaturise electronic systems, it was essential to replace the 
bulky, expensive and unreliable vacuum valve with a solid-state device [46]. The 
transistor, invented by Shockley, Bardeen and Brattain at Bell Laboratories [47], 
was the key technological breakthrough. For a decade, transistors were made 
individually from silicon and then assembled together to create electronic 
circuits. In 1976, Kilby [48] realised that this was a laborious and inefficient 
approach and prototyped the first integrated circuit on a single piece of silicon. 
The invention of the metal oxide semiconductor field effect transistor (MOSFET) 
enabled the first demonstration of a logic gate, presented by Wanlass and co-
workers [49]. Their logic gate was built with two different transistors, nMOS and 
pMOS, using n-type and p-type dopants respectively; hence the name 
complementary metal oxide semiconductor (CMOS). 
The CMOS process begins with a silicon wafer where it can be doped with an n-
type impurity, doped with p-type impurity or left undoped, creating different 
types of silicon substrate. CMOS processes can be classified into an n-well 
process, p-well process or twin-well process. Figure 2.11 illustrates the common 
n-well CMOS process. An n-well in p-type substrate is required to create a pMOS 
transistor. To form an n-well on a p-type silicon substrate donor atoms such as 
phosphorus are implanted into the silicon substrate. Prior to ion implantation of 
phosphorus to form the n-well, the silicon substrate is coated with a layer of 
silicon dioxide for masking and an opening over the desired area is made for the 
n-well formation. A thin layer of silicon dioxide is then thermally grown on top 
of the silicon substrate, creating the gate oxide. With the same mask, a thin 
layer of silicon nitride is deposited to define the active region for each transistor 
(Figure 2.11a). When transistors are next to each other, they inadvertently will 
have leakage current in between them. To eliminate this, a thick field oxide is 
formed in the shallow trenches between the transistors, in a process called 
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shallow trench isolation. For even better transistor isolation, deep trench 
isolation can be formed as well. The silicon nitride on top of each active region 
is etched away and polycrystalline silicon (polysilicon) is deposited on the same 
location, creating the gates for each transistor (Figure 2.11b). After the 
formation of transistor gates, the source and drain regions are defined. For an 
nMOS transistor the source and drain regions are doped with donor atoms such as 
arsenic or phosphorus to form heavily doped n+ diffusion regions. On the other 
hand for a pMOS transistor, the source and drain regions are doped with 
acceptor atoms such as boron to form heavily doped p+ diffusion regions (Figure 
2.11c). A thick silicon dioxide layer is deposited on top of the substrate and 
etched away at designated areas of the gate, source and drain, to deposit 
aluminium metal on top of them and introduce interconnects between devices 
(Figure 2.11d). Modern CMOS processes have multiple metal layers to create 
interconnects, with silicon dioxide layers in between each metal layer for 
isolation. After top metal layer is realised, a thick silicon dioxide layer is 
deposited as passivation to provide electrical, mechanical or chemical 
protection to the internal circuitry. A thin layer of silicon nitride is deposited on 
top of this for extra protection to liquids. Finally, the dielectric on top of the 
bond pads is etched away to enable wire bonding and allow connection to 
external circuitry.  
 
Figure 2.11 – Cross-section through an n-well CMOS process at various stages. 
a) Gate oxide b) Polysilicon gate 
c) Source and drain d) Metallisation 
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2.4.2 CMOS based Chemical Sensor System 
With the rapid advancement of CMOS technology, various attempts have been 
made to fabricate chemical sensors on a silicon substrate [50]. Micro-electro-
mechanical-systems (MEMS) have enabled the two-dimensional CMOS based 
chemical sensor integrated system to be extended to three dimensions by using 
micromachining techniques. Either bulk or surface micromachining is used. Bulk 
micromachining uses wet or dry etching to remove bulk silicon and create a 
sensing structure underneath the bulk silicon [51]. Surface micromachining keeps 
the silicon intact and uses a sacrificial layer that can be easily etched away to 
create three-dimensional sensing structures [52]. 
CMOS technology provides a platform for sensor integration with various 
attributes such as device miniaturisation capability, low power consumption, 
rapid response, high yield and low cost manufacturing [50]. As a consequence, 
various sensors with different physical characteristics have been implemented 
using CMOS technology.  
 Chemomechanical sensors respond to the mass of species collected on 
the sensing layer. The mass can be detected through the deflection of a 
micromechanical structure or the frequency of a resonating structure or a 
travelling acoustic wave.  
 Thermal sensors detect the change in temperature using a thermocouple 
as a sensing material. It can be measured either through the resistance of 
the thermocouple or the voltage difference of two different 
thermocouples.  
 Optical sensors use silicon-based photodiodes or other semiconductor 
materials to detect the change in light intensity.  
 Electrochemical sensors measure the voltage, current or resistance due 
to charge transfer from a chemical reaction.  
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The idea of building a complete computer using one single chip is called system-
on-chip. This idea has inspired CMOS based sensors and readout circuitry to be 
integrated in one single chip rather than using printed circuit board.  
One of the early works of a sensor system on chip was demonstrated by Yeow et 
al. [53] in 1997. The sensor system on chip consisted of a 15 × 16 array of pH-
ISFET with integrated readout circuitry. However, this was not fully compatible 
to a standard CMOS process since four new masks and four extra processing steps 
were required to complete the device. A far more superior sensor system on chip 
was reported by Hagleitner et al. [54] in 2001. The sensor system had 
demonstrated the capability of a CMOS smart gas sensor using three different 
transducers: mass-sensitive cantilever, calorimetric sensor and temperature 
sensor, together with integrated readout and signal conditioning circuits.  An 
analogue-to-digital converter (ADC) was incorporated to improve signal-to-noise 
ratio in order for a robust digital signal to send off-chip. The complete sensor 
system was fabricated using an unaltered CMOS process with a few 
micromachining steps for the cantilever and calorimetric sensor. Figure 2.12a 
illustrates the device. 
 
Figure 2.12 – Microphotograph of two sensor systems on CMOS chips. 
In 2005, Hammond et al. [55] demonstrated that the system-on-chip could be 
developed into a capsule-based device using an ion sensitive field effect 
transistor for in vivo diagnostic applications. Figure 2.12b shows the device. An 
on-chip programmable microcontroller unit (MCU) was designed to control the 
whole system for collecting and processing pH data, which can be stored in 
static memory (SRAM) or transmitted to the outside world using an off-chip radio 
transmitter. The whole system was fabricated using an unmodified CMOS 
b) pH sensor [55] a) Gas sensor [54] 
28 
 
process. A more recent system-on-chip approach in the biomedical field was 
presented by Huang et al. [56] for monitoring real-time multiple physiological 
parameters for the human body. The sensor system consisted of four different 
types of sensors: MEMS with modified hydrogel, nanowire, ISFET and bipolar 
junction transistor, to detect glucose, protein, pH and temperature respectively. 
The complete system had a digital processor to control almost all the functions 
including signal processing and additional circuitry including an ADC, signal 
amplification and a wireless transmitter to send to the outside world. This smart 
system was also self-powering with on-chip circuitry to receive two different off-
chip harvesting energy capabilities: solar cell and RF coil. Figure 2.13 illustrates 
the overall system architecture. 
 
Figure 2.13 – Microphotograph and overall system architecture of the most recent multiple 
sensor systems on a CMOS chip [56]. 
2.5 The Ion Sensitive Field Effect Transistors 
The largest and oldest group of chemical sensors are electrochemical sensors, 
many of which are commercially available. Similar to the transistor replacing the 
vacuum valve, a solid-state device was required to replace the glass electrode as 
an electrochemical sensor. As a consequence, the ion sensitive field effect 
transistor (ISFET) was introduced by Bergveld [57] in 1970 as the first 
miniaturised silicon-based chemical sensor. The operation and physical 
characteristics of the ISFET are almost similar to the conventional MOSFET with 
the exception that the metal gate electrode is removed, exposing the gate oxide 
(Figure 2.14).  
a) Chip microphotograph b) Cross-section view of sensors 
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Bergveld initially carried out a simple experiment with an ISFET by applying a 
constant voltage across the source and drain, and exposing the native silicon 
dioxide (SiO2) to an aqueous solution. In order for him to carry out ISFET 
experiments with aqueous solution, it is important that all the electrical 
contacts to source, drain and substrate are well insulated with epoxy resin. He 
found that the drain current of the device varied with the molarity of sodium 
chloride (NaCl) in the solution, with constant pH. Not long after, Bergveld 
reported that SiO2, the ion sensing membrane, is sensitive to the molarity of 
both sodium (Na+) ions and hydrogen (H+) ions, but with different sensitivity 
[58]. In his publication, Bergveld also demonstrated the measurement of 
extracellular ion pulses with a guinea pig taenia coli, using an ISFET. Ever since 
its introduction, the ISFET has captured the interest of researchers towards 
various applications. 
 
Figure 2.14 – Cross-section of an ISFET with silicon nitride as the sensing layer.  
2.5.1 Fabrication Materials 
The capability of ISFET to detect different ions species is dependent on the gate 
dielectric material. Moreover, this material acts as a protection for the ISFET’s 
channel from aqueous solution. Therefore, it is very important to explore a good 
sensing dielectric material for ISFET. A few years after the first introduction of 
the ISFET, Matsuo and Wise [59] made an improvement of the measurement 
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configuration by using silicon nitride (Si3N4) as the ion sensing layer as it 
provided better stability as the gate dielectric. The device had two dielectric 
layers on top of the gate, which were thermally grown SiO2 at the bottom and 
Si3N4 on top which was in direct contact with the aqueous solution. The ISFET 
was located at the tip of a probe structure with SiO2 covering the whole device 
to insulate the underlying circuitry and the SiO2 was selectively removed over 
the sensor area creating a cavity. In addition, the device was immersed in the 
solution together with a reference electrode to control the drain current. The 
results from the experiments had shown pH sensitivity that was similar to a 
conventional glass electrode but with slight sensitivity towards Na+ and 
potassium (K+) ions. Hence, this has fuelled the research towards using the ISFET 
as a miniaturised pH meter.  
Table 2.2 – Chemical characteristics of various sensing layers on the gate of an ISFET [60] 
Characteristics SiO2 Si3N4 Al2O3 Ta2O5 
pH range tested 4 – 10 1 – 13 1 – 13 1 – 13 
pH sensitivity (mV/pH) 25 - 35 (pH > 7) 
37 – 48 (pH < 7) 
46 – 56 53 – 57 56 – 57 
Sensitivity (mV/pX) 
Na+ 
K+ 
 
30 – 50 
20 - 30 
 
5 – 20 
5 - 25 
 
2 
2 
 
< 1 
< 1 
Response time 
(95%) (s) 
(98%) (min) 
 
1 
Undefinable 
 
< 0.1 
4 – 10 
 
< 0.1 
2 
 
< 0.1 
1 
Long term drift (mV/h, 
pH 7 ) 
Unstable 1.0 0.1 – 0.2 0.1 – 0.2 
Hysteresis Unstable 3.0 0.8 0.2 
 
Si3N4 fulfils the requirements as an ISFET gate oxide being waterproof, 
chemically inert and an excellent barrier for ion migration. However, the pH 
sensitivity of Si3N4 degrades with the increment of oxygen content in the film. As 
a consequence, this motivated Matsuo and Esashi [60] in 1981 to investigate 
several different kinds of dielectric material as ISFET sensing layer. These 
materials were SiO2, Si3N4, aluminium oxide (Al2O3) and tantalum pentoxide 
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(Ta2O5). Their findings of these gate oxide materials are summarised in Table 
2.2. In their investigation, they found that SiO2 was the poorest material to be 
used as pH sensing layer, with a sensitivity of 25 – 48 mV/pH and nonlinear 
dependence to pH. Si3N4 gave an improvement in pH sensitivity, with a 
sensitivity of 46 – 56 mV/pH and a near linear response to pH. Due to the 
decrement of pH sensitivity with oxygen content in Si3N4, Al2O3 and Ta2O5 were 
studied as gate oxide sensing layers. Al2O3 showed a sensitivity of 53 – 57 mV/pH 
while Ta2O5 showed a sensitivity of 56 – 57 mV/pH, with both materials 
displaying a near linear response to pH. In addition, both Al2O3 and Ta2O5 have 
shown almost zero sensitivity towards Na+ and K+ ions. Hence, these two 
materials are very selective to H+ ions and are excellent for pH sensing. 
Table 2.3 – Different uncommon sensing layer that have been studied in the literature 
Materials pH range Sensitivity 
(mV/pH) 
Reference 
Zirconium dioxide (ZrO2) 1 - 10 56 [61] 
Tin dioxide (SnO2) 2 – 10 58 [62] 
Silicon oxynitride (SiOxNy) 2 – 8.3 57 – 57.8 [63] 
Iridium oxide (IrO2) 1.5 - 12 51.1 – 51.7 [64]  
Indium nitride (InN) 2 - 12 58.3 [65] 
Indium tin oxide (ITO) 2 - 12 58 [66] 
Praseodymium titanium oxide 
(PrTiO3) 
2 - 12 53.2 - 56.8 [67] 
Ruthenium dioxide (RuO2) 2 - 10 59.15 [68] 
Holmium oxide (Ho2O3) 1 - 13 57 [69] 
Erbium (III) oxide (Er2O3) 1 - 13 57.58 [70] 
Borazon (BN) 1.8 – 10 50 – 59 [71] 
Platinum (Pt) 1 - 5 25.1 [72] 
Titanium nitride (TiN) 1.68 – 10.01 59 [73] 
 
Various other materials have also been investigated for use as pH-ISFET 
dielectric sensing layers in order to increase the pH sensitivity e.g. zirconium 
dioxide (ZrO2), tin dioxide (SnO2), silicon oxynitride (SiOxNy), iridium oxide 
(IrO2), indium nitride (InN), indium tin oxide (ITO), praseodymium titanium oxide 
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(PrTiO3), ruthenium dioxide (RuO2), holmium oxide (Ho2O3), erbium (III) oxide 
(Er2O3) and borazon (BN). Some efforts have also been made to reduce the 
response time to ionic solution and improve long term stability with materials 
such as platinum (Pt), titanium nitride (TiN) and iridium oxide (IrO2). The pH 
sensitivities for all the materials are presented in Table 2.3. Despite intense 
efforts at finding a material with high pH sensitivity, Si3N4 still remains the 
favourite choice among researchers since it is the default passivation layer for 
standard CMOS process. Besides that, various other materials have also been 
investigated to target different ionic species such as membranes containing 
valinomycin for K+ ions [74], crown ethers for Na+ ions [75] and tetracyano-
quinodimethanecopper (TCNQ) for copper (Cu2+) ions [76]. 
2.5.2 CMOS Integration 
After Bergveld’s description of using a solid-state device as a biosensor or 
chemical sensor, it has become a topic of interest to incorporate the device with 
integrated circuit technology into one single chip. CMOS technology is a standard 
process, which has been widely used for integrated circuit fabrication. Hence a 
great amount of interest is concentrated on utilising this technology to develop 
CMOS based ISFETs. However, the development of ISFET does not require 
polysilicon gate which acts like a mask to define self-aligned source and drain 
regions. Besides that, ISFET requires a chemical sensitive dielectric sensing layer 
which has to be deposited at a higher temperature than conventional metal 
layers. Consequently, the initial fabrication of CMOS based ISFET has been 
focussed on modifying or extending the standard CMOS process. 
The early attempt from Bousse et al. [77] was concentrated on modifying the 
existing CMOS process to fabricate the ISFET. The standard n-well CMOS process 
was used and the processing steps remained the same throughout until the 
metallisation stage for interconnects. Tungsten silicide was used as the 
interconnect material instead of aluminium due to its resistance to high 
temperature in later processing steps. Silicon dioxide was deposited onto the 
metal interconnect and polysilicon which then followed by photolithography step 
to define the area above the polysilicon. The SiO2 was etched away while 
retaining the polysilicon as a floating conductor in the insulator. The remaining 
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polysilicon did not affect the capacitance of the gate and had no negative effect 
to the ISFET sensitivity, while protecting the silicon substrate from ambient 
light. Si3N4 was deposited with low-pressure chemical vapour deposition (LPCVD) 
at 785oC across the whole surface and the opening window above the gate. The 
high temperature was not an issue as tungsten silicide has a high resistance 
towards high temperature. Therefore, the initial development of CMOS based 
ISFET required quite a lot of changes to the standard process. 
Later, Wong and White [78] fabricated an ISFET using a standard CMOS process 
without any modification until just before the contact windows were to be 
opened. The polysilicon and the gate oxide were wet etched away and left with 
the bare silicon. After that, a thin oxide layer was regrown above the silicon and 
a chemically sensitive dielectric layer, Si3N4 and Ta2O5 deposited on top, one 
after another, using LPCVD and RF magnetron sputtering respectively. The 
standard CMOS process followed with the opening of contact windows and 
deposition of aluminium.  
 
Figure 2.15 – Cross-section through an ISFET fabricated in an unmodified standard CMOS 
process.  
Both processes had shown that a modified CMOS process was required to 
fabricate a CMOS based ISFET. This was the case until Bausells et al. [79] 
34 
 
demonstrated the capability of fabricating an ISFET with an unmodified two-
metal CMOS process, shown in Figure 2.15. The device used silicon oxynitride 
(default passivation layer from foundry) as the ion sensing layer and also had an 
electrically-floating gate structure with polysilicon connected to two metal 
layers, similar to the structure proposed by Bousse and co-workers. The device 
had shown a sensitivity of 47 mV/pH. Using an unmodified commercial CMOS 
process to integrate the ISFET has simplified the circuit design and allowed the 
ability to use the tools and libraries provided by the foundry. This has led to the 
implementation of arrays of ISFET sensors with integrated readout circuits by 
Milgrew et al. [80] and Balazs et al. [81], [82], creating an ion imaging camera, 
illustrated in Figure 2.16.  
 
Figure 2.16 – Arrays of ISFET sensors using an unmodified CMOS process as an ion camera 
[82]. 
2.5.3 Applications for ISFET Biosensors 
The first demonstration by Bergveld that the ISFET could be used for 
extracellular detection led to the use of CMOS array ISFETs to monitor ion fluxes 
from both natural and artificial systems. However, ISFET capability is far more 
powerful and not just limited to extracellular imaging. A decade after the 
discovery of ISFET, Caras and Janata reported the first use of ISFET to detect 
penicillin directly via modification with an enzyme. This has created a basis for 
the ISFET to be used as a biosensor and numerous efforts have been made to 
incorporate different bio-recognition materials such as DNA and enzymes on 
ISFETs for biological detection, which could revolutionise the field of 
personalised medicine. 
a) Chip microphotograph b) pH fluctuation on chip 
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With the discovery of SNP genotyping, various attempts have been made to use 
the ISFET as a DNA sensing platform, which are normally performed with 
fluorescent nucleotides and detection following hybridisation, using optical 
imaging technology. The ISFET as a pH sensor normally measures the equilibrium 
of H+ and OH- ions in a solution that corresponds to the electrochemical double 
layer formed on top of gate insulator, which in turn affects the interface 
potential on the gate insulator. A detailed theoretical explanation is given in 
Chapter 3.  Therefore, Estrela et al. [83] proposed that any immobilised bio-
molecular interaction on top of the gate and electrolyte interface could change 
the potential across the double layer, which then modulates the potential 
applied to the gate of a field effect transistor. In their work, they immobilised 
single-stranded DNA on the surface of a metal, on top of an ISFET, and then the 
interaction of the complementary DNA gave a shift in voltage. They were able to 
detect a voltage shift with a DNA strand that had a mismatch of 3 nucleotide 
bases. This has presented a possibility of SNP detection. In 2006, Purushothaman 
et al. [84] demonstrated a much more sensitive procedure for single nucleotide 
mismatch detection using an ISFET. They immobilised single-stranded DNA on 
the sensing layer of the ISFET, then DNA polymerase and complementary 
nucleotides were added to give a potential shift. The incorporation of a 
nucleotide onto the single-stranded DNA would produce a proton, which acts as 
a marker. This technique was introduced by Sakurai and Husimi [85] in 1992 and 
showed the DNA polymerase incorporation reaction and subsequent hydrogen ion 
released could be sensed by an ISFET. However, this was only done in bulk 
reaction where all the nucleotides were incorporated completely to produce a 
potential change. 
By using multiple ISFETs integrated in a CMOS process on a single chip and the 
capability of measuring SNP, in 2011 Ion Torrent (Thermo Fisher Scientific) [4] 
introduced the world’s first non-optical genome sequencing, ion chip (Figure 
2.17). Using the high-density bead array technology described earlier (Section 
2.2.3), the ion chip has a microwell on top of each ISFET sensor, shown in Figure 
2.17c and Figure 2.17d. It is formed by etching a dielectric layer on top of the 
sensor all the way down to the top metal layer. To increase the sensitivity of ion 
chip, a metal layer is deposited on top of the top metal layer and also the side 
walls of the microwell. Then, a layer of Ta2O5 is deposited everywhere to 
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provide a sensitivity of 58 mV/pH. Hence, the loss of hydrogen ions to the non-
sensitive side wall would be prevented. The microwell is big enough to 
accommodate one magnetic bead that has hundreds or thousands of the same 
short DNA fragments together with DNA polymerase, to amplify the signal. They 
have demonstrated the genome sequencing of bacterial and human genome of 
G. Moore. This has brought the possibility of reaching the desirable $1,000 
genome and provided one of the key ingredient, genomics, to realise 
personalised medicine. 
 
Figure 2.17– Ion Torrent genome sequencing chip, packaging, well cross-section and 
working mechanism [4]. 
As previously discussed, the current methods for studying the metabolome rely 
on huge and expensive machinery, and more importantly there is no single 
apparatus or device that can detect the entire metabolome. Since the first use 
of an ISFET modified with an enzyme on top, called ENFET, for penicillin 
detection [86], a lot of effort has been made to use the enzyme ISFET for 
metabolite detection e.g. glucose [87], urea [88], creatinine [89], heparin [90], 
a) Chip microphotograph b) Full packaged chip with fluidics 
c) 3D cross-section of well d) Sensor, well and chip operating system 
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acetylcholine [91], glutamate [92] and etc. In 1986, Hanazato et al. [93] 
demonstrated the first multi-enzyme ISFET using the enzymes glucose oxidase 
and urease for the detection of their corresponding metabolites, glucose and 
urea, respectively. As the discovery of ions chips brought genome sequencing to 
the foreground, the vision of this work is to integrate ISFET and other chemical 
sensors using CMOS technology to create a low cost multi-enzyme platform for 
metabolome detection.  
2.6 Summary 
In this chapter, personalised medicine was defined and a brief history outlined. 
The microarray technologies and SNPs genotyping from genomics that made 
personalised medicine a reality were introduced. The technological 
advancements in genomics which has formed a basis for personalised medicine 
were detailed. The limitations of using genomics for personalised medicine were 
described and act as motivation for studying metabolomics. Microarray 
technologies were described in detail, with an emphasis on how to adapt these 
technologies from genomics to metabolomics. Since the current instrumentations 
for metabolome detection are expensive, huge and require multiple tools, CMOS 
technology was introduced as the most established low cost and large scale 
manufacturing alternative. Also, further advancements in CMOS technology and 
MEMS were highlighted to show that various chemical sensors can be realised and 
integrated into one single CMOS chip. CMOS presents itself as the low cost single 
platform that could be implemented for metabolome detection. The ISFET was 
then described, along with details on how to integrate the sensor with CMOS 
technology. The development of CMOS based ISFET sensor array as a biosensor 
was provided, which led to the invention of the personal genome machine by Ion 
Torrent. The next chapter will present the theory of enzymes and ISFET. 
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Chapter 3 : Theory 
3.1 Introduction 
The previous chapter reviewed the background literature relevant to the 
development of an integrated CMOS sensor array technology, in order to advance 
personalised medicine specifically focussing on genomics and metabolomics. This 
chapter introduces enzymes and their fundamental theory to quantify 
metabolites using enzyme kinetics, and describes the different methods used for 
enzyme assays in this work. The chapter later presents the fundamental theory 
of pH measurement that initially required a conventional glass electrode and the 
need of a solid-state device, which sparked the development of the first 
miniaturised solid-state chemical sensor, the ISFET. The operating principle of 
ISFET is also explained, together with the mechanism known as the “site-binding 
model” to determine the pH response of the ISFET sensing material. In addition, 
the relationship between absorbance and concentration of absorbing substance 
in an aqueous solution is explained by Beer-Lambert Law. 
3.2 Enzymes 
All life-forms, from viruses to human beings, depend on a set of chemical 
reactions to sustain life, which is maintained by biological catalysts called 
enzymes [94, Ch. 1]. These chemical reactions involve building, breaking or 
modifying chemical compounds and enzymes are used to accelerate the rate of 
these reactions. Besides their ability to speed up chemical reactions, enzymes 
also possess a unique characteristic called specificity, where they are able to 
recognise specific chemical compounds or substrates to act on and ignore 
everything else. As described in Figure 3.1, these enzymatic processes actually 
act like a “lock and key” mechanism, where enzymes are biologically shaped as 
locks (active-sites) and only the correct keys (substrates) can trigger the 
chemical reaction [95, Ch. 7]. In addition, enzymes are not consumed in the 
reaction and can be used again after the chemical reaction. Figure 3.2 shows a 
pectinase enzyme in the process of catalysing a specific substrate. 
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Figure 3.1 – The lock-and-key model for an enzyme reaction.  
Since the discovery of enzymes, a lot of industries have been increasingly 
exploiting their potential in food [96], beverages [97] and detergents [98]. Due 
to enzymes’ highly selective nature, they are also used in medical diagnostics as 
biomarkers to detect specific substrates [99], [100]. In an enzyme-catalysed 
reaction, the amount of substrate converted to product can be measured using 
different analytical methods such as spectrophotometry, electrochemistry, 
chemiluminescence or fluorescence [101, Ch. 1]. Hence, various diagnostic tools 
have been developed with specific enzyme to quantify metabolite from different 
biological analytes such as blood serums, urine, tears and sweat [102], [103, Ch. 
2]. 
 
Figure 3.2 – A pectinase enzyme in the act of catalysis, where the substrate pectate (yellow) 
is diffusing into the active-site of the enzyme [104]. 
3.2.1 Enzyme Kinetics 
To use enzyme as a biological sensor for detecting metabolite, the fundamental 
mechanism of enzymatic reaction has to be understood. In all types of chemical 
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reactions, both non-catalysed and catalysed, kinetic studies are used to 
understand them. In measuring the amount of substrate corresponding to the 
product of an enzyme-catalysed reaction, the most common question is the 
influence of time on both substrate and product. In every chemical reaction, the 
conversion of substrate to product undergoes a few states where some bonds are 
broken or formed, and the highest energy in between this transformation is 
called transition state. It is the limiting factor for a chemical reaction. Figure 
3.3 illustrates the free energy of the substrate, transition state and product in a 
so called reaction coordinate diagram. The energy difference between the 
substrate and product shows which direction of the reaction is more 
thermodynamically favourable, and does not tell the reaction rate. The free 
energy between the substrate and transition state is called free energy of 
activation (∆Gact), where the lower it is the faster the chemical reaction. In 
order to lower the activation energy and speed up reaction, enzyme acts as a 
catalyst to stabilise the transition state or find a lower energy pathway.  
Figure 3.3 presents the coordinate diagram for both enzyme-catalysed and non-
catalysed chemical reactions. An enzyme-catalysed reaction is a multi-step 
progression that involves several intermediates. At this point, it is important to 
differentiate between an intermediate and a transition state. An intermediate is 
a stable/semi-stable chemical species formed during a reaction, known as a 
local energy minimum, whereas a transition state known as a local energy 
maximum. For an enzyme to stabilise the transition state, the substrate and 
enzyme would come together and form a reversible enzyme-substrate complex, 
ES. This will lead to the formation of a stabilised enzyme-transition state 
complex (ES‡). During the transformation of substrate (ground state) to the 
transition state structure, the enzyme would provide functional groups in the 
active-site for necessary interactions to stabilise the transition state structure 
and bind it tighter than to the substrate [105, Ch. 3]. The more stable the ES 
complex, the lower the free energy for activation and increase of the reaction 
speed. Finally the formation of an enzyme-product complex, which can then be 
dissociate to product molecules and free enzyme for catalysis again. The 
enzymatic reaction is given below: 
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 𝐸 + 𝑆 ⇌ 𝐸 ∙ 𝑆 ⇌ 𝐸 ∙ 𝑃 ⇌ 𝐸 + 𝑃 3.1 
 
Figure 3.3 – Free energy profile of uncatalysed (red) and enzyme-catalysed reaction (purple) 
[105, Ch. 3]. 
As discussed above, an enzyme can accelerate a chemical reaction by lowering 
the activation energy. However, all enzymes have different catalytic power 
called the turnover number. It is defined as the maximum number of substrate 
molecules converted to product by one enzyme molecule per second, under 
conditions at which the concentration of all substrates is saturating. Hence, all 
enzymes will have different rate/velocity conversion of substrate to product.  
In any chemical reaction, the rate/velocity of the chemical reaction is described 
by the rate constant k: 
 
𝐴
𝑘
→ 𝐵 𝐴 + 𝐵
𝑘
→ 𝐶 + 𝐷 3.2 
42 
 
In a non-catalysed chemical reaction, the reaction rate is proportional to single 
substrate, two substrates or independent of substrate concentration 
respectively, as described: 
 First order Second order Zero order  
 ν = 𝑘 × [𝐴] ν = 𝑘 × [𝐴] × [𝐵] ν = 𝑘 3.3 
where the rate constant k has a unit of s-1 and 𝜈 is change of substrate 
concentration with time in second. 
However an enzyme-catalysed chemical reaction is more complex; simple 
equations like those above are not adequate to fully described enzyme kinetics. 
In 1913, Michaelis and Menten [106] provided the mathematical model for the 
analysis of enzyme reactions mechanisms [107, Ch. 2], [108, Ch. 2]. There are a 
few assumptions in Michaelis-Menten kinetics [109, Ch. 4]: 
 There is only one substrate change in the chemical reaction. 
 The substrate concentration is a lot higher than enzyme concentration. 
 The initial reaction rate is taken into account, where the product 
concentration is still very low. 
 The course of chemical reaction observation is very short, where the change 
in substrate and product concentration is very little. 
With these assumptions, not all enzyme reactions follow Michaelis-Menten model 
but it is a useful model to describe a wide range of enzymes [105, Ch. 3].  
As described in Equation 3.1, there are three steps in an enzymatic reaction. At 
low product concentration in the initial state of the reaction, the reverse 
reactions of 𝐸. 𝑆 ⇌ 𝐸. 𝑃 ⇌ 𝐸 + 𝑃 are neglected and yield: 
 
𝐸 + 𝑆
𝑘1
⇌
𝑘−1
𝐸 ∙ 𝑆
𝑘𝑐𝑎𝑡
→   𝐸 + 𝑃 3.4 
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Hence, Equation 3.4 gives the velocity of product formation, which can also be 
defined as the rate of the overall reaction: 
 ν = 𝑘𝑐𝑎𝑡 × [𝐸 ∙ 𝑆] 3.5 
When the substrate concentration is a lot higher than enzyme concentration, the 
upper limit of 𝜈 will be achieved. Therefore, all enzyme molecules are present 
as ES complexes and Equation 3.5 can be redefined as: 
 ν𝑚𝑎𝑥 = 𝑘𝑐𝑎𝑡 × [𝐸𝑇] 3.6 
where 𝜈max is the maximal reaction rate, kcat is the enzyme turnover number and 
[ET] is the total enzyme concentration. 
Besides the rate of product formation from Equation 3.4, the rate of formation 
of ES complex has to be defined as well. The ES complex could undergo 
decomposition into free enzyme and substrate with an equilibrium constant, 
known as the “true” dissociation constant: 
 
𝐾𝑆 =
[𝐸] × [𝑆]
[𝐸 ∙ 𝑆]
=
𝑘−1
𝑘1
 3.7 
Most of the enzyme reactions occur when the ES complex concentration remains 
constant, known as steady state approximations. This was proposed by Briggs 
and Haldane [110] in 1925 to provide a more general description of the 
Michaelis-Menten approach. With the rate of formation of ES complex is to be 
equal to the sum of the rate of breakdown to free enzyme and substrate, and 
the rate of catalysis into product: 
 𝑘1 × [𝐸] × [𝑆]⏟        
𝑅𝑎𝑡𝑒 𝑜𝑓 𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 
𝑜𝑓 𝐸∙𝑆
= 𝑘−1 × [𝐸 ∙ 𝑆]⏟        
𝑅𝑎𝑡𝑒 𝑜𝑓 𝑑𝑖𝑠𝑠𝑜𝑐𝑖𝑎𝑡𝑖𝑜𝑛 
𝑜𝑓 𝐸∙𝑆 𝑡𝑜 𝐸+𝑆
+ 𝑘𝑐𝑎𝑡 × [𝐸 ∙ 𝑆]⏟        
𝑅𝑎𝑡𝑒 𝑜𝑓 𝑝𝑟𝑜𝑑𝑢𝑐𝑡
𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛
 
3.8 
This gives: 
 𝑘1 × [𝐸] × [𝑆] = (𝑘−1 + 𝑘𝑐𝑎𝑡) × [𝐸 ∙ 𝑆] 3.9 
and, 
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 [𝐸] × [𝑆]
[𝐸 ∙ 𝑆]
=
𝑘−1 + 𝑘𝑐𝑎𝑡
𝑘1
= 𝐾𝑚 3.10 
 
[𝐸 ∙ 𝑆] = [𝐸] ×
[𝑆]
𝐾𝑚
 3.11 
Equation 3.10 gives the definition of the Michaelis-Menten constant, with the 
unit of mol l-1 or M. Km is similar to the dissociation constant and normally used 
as a relative measure of substrate binding affinity. With rearrangement of 
Equation 3.10 to 3.11, it has become clear that when the substrate 
concentration [S] is equal to Km, the free enzyme and ES complex matched up. 
This means that Km is the substrate concentration at which the enzyme is half 
saturated with its substrate. From Equation 3.5, the reaction rate is proportional 
to the ES complex concentration. Hence, Km also stands for the substrate 
concentration when the rate of reaction is at half maximal.  
At the initial states of the reaction there is no other intermediates build-up, only 
ES complexes. Therefore, it can be assumed that the total amount of enzyme is: 
 [𝐸𝑇] = [𝐸] + [𝐸 ∙ 𝑆] 3.12 
From Equation 3.8, it can be further described as follows: 
 𝑘1[𝐸𝑇][𝑆] − 𝑘1[𝐸 ∙ 𝑆][𝑆] = 𝑘−1[𝐸 ∙ 𝑆] + 𝑘𝑐𝑎𝑡[𝐸 ∙ 𝑆] 3.13 
 
[𝐸 ∙ 𝑆] =
𝑘1[𝐸𝑇][𝑆]
𝑘1[𝑆] + 𝑘𝑐𝑎𝑡 + 𝑘−1
 3.14 
To obtain the Michaelis-Menten equation, Equation 3.5 is combined with 3.14 to 
become: 
 
ν =
𝑘𝑐𝑎𝑡𝑘1[𝐸𝑇][𝑆]
𝑘1[𝑆] + 𝑘𝑐𝑎𝑡 + 𝑘−1
=
𝑘𝑐𝑎𝑡[𝐸𝑇][𝑆]
𝑘−1 + 𝑘𝑐𝑎𝑡
𝑘1
+ [𝑆]
=
𝑘𝑐𝑎𝑡[𝐸𝑇][𝑆]
𝐾𝑚 + [𝑆]
 3.15 
Hence, the final Michaelis-Menten equation is given as: 
45 
 
 
ν = ν𝑚𝑎𝑥
[𝑆]
𝐾𝑚 + [𝑆]
 3.16 
As shown in Figure 3.4, this equation can be represented graphically and can 
also be altered slightly to represent a Lineweaver-Burk plot, in order to 
determine 𝜈max and Km.  
 
Figure 3.4 – Graphical representation of the relationship between reaction rate (𝜈) and 
substrate concentration ([S]) in a typical enzymatic reaction [109, Ch. 4]. 
From the Michaelis-Menten equation measuring the reaction rate can be used to 
determine a range of different substrate concentrations. At zero substrate 
concentration, the velocity of the reaction is zero. When the substrate 
concentration doubles, the velocity doubles in proportion to the substrate 
concentration. When substrate concentration reaches Km, the velocity is at half 
of the maximal velocity. At a high substrate concentration, where almost all the 
enzyme can find the substrate and react, the velocity will approach 𝜈max. 
3.2.2 Enzyme Assays 
Enzyme kinetics offers a wealth of information regarding enzyme-catalysed 
chemical reactions, providing the determination of Km and kcat from the initial 
velocity with different substrate concentration. In order to determine the 
substrate concentration, there are several different enzyme assays to measure 
these reactions. The following discussions will describe the types of enzyme 
assays that are used in this work.  
a) Typical enzymatic reaction plot b) Lineweaver-Burk plot 
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3.2.2.1 Direct Assay 
In an enzyme-catalysed reaction, any property change such as pH or absorbance 
on the substrates or products can be measured directly using detection 
techniques such as electrochemistry or spectrophotometry [101, Ch. 1]. Direct 
assay is always the most preferable method of measuring enzymatic reactions. 
The reasons are the simplicity of progression curve observation through time to 
minimise source of errors and allow a better interpretation of the initial rate of 
the reaction. The most common method is using a spectrophotometric assay 
where the light absorbance properties that occur from substrate depletion or 
product formation are measured. Besides that, a lot of enzyme reactions 
produce or consume hydrogen ions in their reaction pathway. Hence, this will 
induce a pH change in an unbuffered or weakly buffered enzyme solution, that 
can be measured directly using a glass or ion sensitive electrode, with a 
restriction that it does not exceed the pH range of tolerance for an enzyme 
activity.  
3.2.2.2 Indirect Coupled Assay 
However, not all enzymatic reactions produce detectable signal for convenient 
measurement. In these cases, an indirect approach has to be implemented 
where an additional chemical reaction has to be added to produce a 
measureable signal. The most commonly used indirect assay is a coupled assay 
[101, Ch. 1]. It involves pairing up other enzymatic reactions to yield a chemical 
compound that is conveniently detectable. Normally, the product of the enzyme 
reaction of interest is the substrate of the subsequent enzyme reactions. 
Coupled assays usually utilise the reduction of NADP+ to NADPH that could be 
readily measured as light adsorption with spectrophotometry or production of 
hydrogen ion with a pH sensitive electrode.  Figure 3.5 shows a simple example 
of a coupled assay to monitor the hexokinase reaction using the reduction of 
NADP+. This reaction can be summarised as follows: 
 𝐴
𝜈1
→𝐵
𝜈2
→ 𝐶 3.17 
where A is substrate of interest, 𝜈1 is the velocity for the enzyme of interest, B 
is the product of first reaction and also substrate for the coupling enzyme, 𝜈2 is 
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the velocity for the coupling enzyme and C is the product from the coupling 
enzyme that can be measured easily.  
 
Figure 3.5 – A coupled assay for hexokinase enzyme reaction [101, Ch. 1].  
Due to coupled assays using more enzyme reactions for measurement, they 
present some potential problems. To produce a meaningful study of 𝜈1, it is 
important to make sure that the coupling enzyme does not become rate limiting 
(𝜈1 << 𝜈2), where the conversion of B to C is almost instantaneous. The velocity 
of 𝜈2 is dependent on the concentration of B. Hence, in the initial state of the 
measurement, there is a lag phase where 𝜈2 is only a fraction of its maximum 
velocity until it reaches the velocity of the enzyme of interest or faster. This will 
impede the correct measurement of the initial velocity if the lag phase is too 
long, where the catalysing enzyme starts to slow down before the coupling 
enzyme reaches its steady state velocity. The following equation shows the time 
required for [B] to reach steady state level [B]ss: 
 
𝑡99% =
𝜙𝐾𝑚2
𝜈1
 3.18 
where 𝜙 is the ratio of 𝜈1/𝜈max2. Therefore, to minimise the lag phase, the Km 
value of the coupling enzyme has to be low to be efficient at low substrate 
concentrations. As described previously in enzyme kinetics, 𝜈max2 is affected by 
the concentration of the enzyme. Increasing the concentration of the coupling 
enzyme can decrease the lag phase as well. 
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3.3 Measurement of pH 
The measurement of hydrogen ions (H+) concentration in an aqueous solution is 
introduced by Sørensen in 1909, which is known as pH [95, Ch. 23]. Hence, this 
concept gives the degree of acidity or alkalinity of a solution. The meaning of pH 
stands for “power of hydrogen” and it is defined as: 
 
𝑝𝐻 = − log[𝐻+] = log
1
[𝐻+]
 3.19 
where [H+] is the concentration of hydrogen ions/protons, with a unit of Molar 
(M). 
3.3.1 Interface Charge Transfer  
When measuring pH in an aqueous solution, an electrode is required to perform 
the measurement, which creates an electrolyte-electrode junction. Hence, it is 
important to understand the junction between them. When two chemical phases 
come together, for instance liquid-liquid or liquid-solid, there will be charge 
transfer across the interface creating a potential difference. At this boundary, 
electron transfer and a redistribution of charge species in the electrolyte 
creating an electrical double layer [111, Ch. 25] (discuss in detail in section 3.5) 
occurs, until the electrochemical potential of the charge carriers in both phases 
are in balance. Hence, it is vital to understand the interface charge transfer 
across different chemical environments.  
The kinetics of the electronic charge transfer across an interface between two 
chemical phases can be described by the Butler-Volmer equation [112, Ch. 3]. 
Imagine the interface between a solid (𝛽-phase) and a solution (𝛼-phase). The 
net charge for a single ion species, p, that flows in between these two 
phases, 𝑖𝑝, is described as the difference of ion fluxes going outward from a solid 
(𝑖𝑝⃑⃑  ⃑) and going into a solid (𝑖𝑝⃐⃑⃑⃑). Therefore, the net charge across the interface is, 
𝑖𝑝 = 𝑖𝑝⃑⃑  ⃑ − 𝑖𝑝⃐⃑⃑⃑  and is given in general by the Butler-Volmer equation: 
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𝑖𝑝 = 𝑧𝑝𝐹𝑘𝑝⃑⃑⃑⃑ [𝑋𝑝]𝛽𝑒𝑥𝑝 (
𝑧𝑝𝐹Ϛ∆𝜙
𝑅𝑇
) − 𝑧𝑝𝐹𝑘𝑝⃐⃑ ⃑⃑⃑[𝑋𝑝]𝛼𝑒𝑥𝑝 (
−𝑧𝑝𝐹(1 − Ϛ)∆𝜙
𝑅𝑇
) 3.20 
where  𝑖𝑝 is described by the potential difference between the solid phase and 
solution phase (∆𝜙 = 𝜙𝛽−𝜙𝛼) and also the concentration of the ion species, p, in 
solid phase [𝑋𝑝]𝛽 and solution phase [𝑋𝑝]𝛼. The term 𝑘𝑝
⃑⃑⃑⃑  and 𝑘𝑝⃐⃑ ⃑⃑⃑ are the 
heterogeneous rate constants of the forward and reverse flow of the ion fluxes 
across the interface. The component zp is the formal charge of p and Ϛ is the 
symmetry coefficient between the forward and reverse ion fluxes across the 
interface, which is in the range of 0 to 1 but is normally 0.5 [113]. T, F and R are 
the absolute temperature, Faraday constant and universal gas constant 
respectively. However, the general Butler-Volmer equation is not limited to 
describe the charge transfer across solid and liquid but it can be used for the 
interface between any chemical phases. Equation 3.20 has formed a foundation 
for describing a potential difference across an arbitrary interface between two 
distinct phases. 
Normally, a chemical phase interface involves more than one ion species. Hence, 
the total charge across the interface is 𝑖𝑡𝑜𝑡 = ∑ 𝑖𝑝
𝑚
𝑝=1  and governed by a single 
interfacial potential. However, in most cases, such as for an ion-selective 
electrode, it can be approximated that the interface potential is dominated by 
one single forward and reverse ion species, which is the fastest exchanging ions 
across the interface. Figure 3.6 describes the 𝑖 ∆𝜙⁄  curves with respect to the 
most dominant ion species. Besides that, Figure 3.6 also shows the itot in dotted 
line. Also, the ∆𝜙 value when itot = 0 is the open-circuit potential (OCP) 
difference. Since there is only one ion species, OCP is also the equilibrium 
potential, ∆𝜙𝑝(𝑒𝑞) with the forward and reverse ion fluxes are equal (𝑖𝑝⃑⃑  ⃑ = 𝑖𝑝⃐⃑⃑⃑). 
Therefore itot = ip, then Equation 3.20 can be solved for ∆𝜙, which will lead to 
the Nernst equation: 
 
∆𝜙 =
𝑅𝑇
𝑧𝑝𝐹
ln
𝑘𝑝⃐⃑ ⃑⃑⃑
𝑘𝑝⃑⃑⃑⃑ 
+
𝑅𝑇
𝑧𝑝𝐹
ln
[𝑋𝑝]𝛼
[𝑋𝑝]𝛽
= 𝜙𝑘 +
𝑅𝑇
𝑧𝑝𝐹
ln
[𝑋𝑝]𝛼
[𝑋𝑝]𝛽
 3.21 
50 
 
For the condition where the concentration of the ion species in the solid phase 
remains constant, due to large capacity of ions, then the term [𝑋𝑝]𝛽 can be 
included into 𝜙𝑘 to form a simplified version of the equation: 
 
∆𝜙 = 𝜙𝑘
′ +
𝑅𝑇
𝑧𝑝𝐹
ln[𝑋𝑝]𝛼 = 𝜙𝑘
′ + 2.303
𝑅𝑇
𝑧𝑝𝐹
log[𝑋𝑝]𝛼 3.22 
From this equation, ∆𝜙 against log[𝑋𝑝]𝛼 is a linear plot with a slope of 
59.2 mV/decade for univalent ions (zp = 1) at a temperature of 25
oC. This is ideal 
response for an interface and also referred to the Nernstian response [112, Ch. 
3]. For an electrochemical electrode that is selective to a single ion species, it is 
desirable to achieve such a response or at least as close to Nernstian.  
 
Figure 3.6 – Graph of the forward and reverse ion-exchange currents for the condition 
where the transport is dominated by a single ion species across the interface [113].  
3.3.2 Glass Electrode 
The most well recognised electrode/electrolyte interface is between glass and 
electrolyte interface. Hence in early twentieth century, the glass electrode was 
widely used for pH measurement [112, Ch. 2]. To use glass electrode for 
measurement, it is immersed into the test solution and the potential of the 
electrode is measured with respect to a reference electrode, for instance a 
saturated calomel electrode (SCE). The electrochemical cell of the system is 
described as [112, Ch. 2]: 
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𝐻𝑔|𝐻𝑔2𝐶𝑙2|𝐾𝐶𝑙(𝑠𝑎𝑙𝑡)⏟              
𝑆𝐶𝐸
|𝑇𝑒𝑠𝑡 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛| 𝐺𝑙𝑎𝑠𝑠 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒|𝐻𝐶𝑙(0.1 𝑀)|𝐴𝑔𝐶𝑙|𝐴𝑔⏞              
𝐼𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
⏟                        
𝐺𝑙𝑎𝑠𝑠 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒
 
where | represents the boundary with interface potential between two chemical 
phases. 
From the electrochemical cell above, the properties of the test solution is 
governed by two interfaces which could influence the overall potential 
difference. The first one is the liquid junction between the test solution and the 
SCE, where the liquid junction is porous and allows ions to pass through easily. 
Thus, the potential at this interface is very minute and constant, which can be 
neglected. The second interface is between the test solution and the glass 
membrane. All other interfaces in the cell are constant composition, thus the 
interface between the glass membrane and test solution is the only variable that 
could affect the overall cell potential difference. If the glass electrode is only 
selective to an ion species p, following Equation 3.22, the cell potential E can be 
described as:  
 
𝐸 = 𝐸0⏞
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
+
𝑅𝑇
𝑧𝑝𝐹
ln[𝑋𝑝]𝑆𝑂𝐿 = 𝐸0
⏞
𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
+ 2.303
𝑅𝑇
𝑧𝑝𝐹
log[𝑋𝑝]𝑆𝑂𝐿 
3.23 
where E0 is the sum of all the potential differences at all the interfaces, 
including the interface between the test solution and SCE, which is all constant. 
E0 can be measured with a known concentration of [𝑋𝑝]𝑆𝑂𝐿 during calibration 
steps.   
3.4 Ion Sensitive Field Effect Transistors 
As described in Section 3.3, a glass electrode is an ideal sensor for detecting 
ionic concentration by measuring the interface potential. However, a glass 
electrode is not suitable for large scale integration with CMOS technology 
(described in Section 2.3.1), thus a solid-state device as a chemical sensor to 
measure interface potential is required. This has led to the implementation of 
the first miniaturised chemical sensor in 1970, known as the ISFET (described in 
Section 2.5). To understand the operating principle of an ISFET sensor, it is best 
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explained with the working mechanism of a MOSFET. Take an n-channel MOSFET, 
when a positive voltage is applied at the polysilicon (gate terminal) the 
electrons in the p-type silicon substrate are attracted towards the gate and 
accumulate underneath the gate oxide. When sufficient positive voltage is 
applied, known as the threshold voltage, the local change of the silicon 
substrate just beneath gate oxide will be inverted, from p-type to n-type 
material. Hence, this will create an n-type channel across the source and drain, 
which allows free electrons to move between them. To allow the formation of 
channel underneath the gate oxide, the surface potential has to be altered from 
its original negative value (𝜙𝑠 = 𝜙𝐹), through zero (𝜙𝑠 = 0) to a positive value 
(𝜙𝑠 = −𝜙𝐹), where 𝜙𝐹 is the Fermi potential. The lowest required positive 
voltage to apply, the threshold voltage, in order to achieve a condition termed 
as “strong” inversion [114, Ch. 6], is given as: 
 
𝑉𝑇 = 𝑉𝐹𝐵 −
𝑄𝐵
𝐶𝑂𝑋
+ 2𝜙𝐹 3.24 
where VFB is the flatband voltage, QB is the depletion charge in the silicon 
substrate and COX is the capacitance of the gate oxide. The flatband voltage can 
be further described as: 
 
𝑉𝐹𝐵 =
ɸ𝑀 − ɸ𝑆
𝑞
−
𝑄𝑆𝑆 + 𝑄𝑂𝑋
𝐶𝑂𝑋
 3.25 
where (ɸ𝑀 − ɸ𝑆) is the work function between the gate metal (polysilicon) and 
the semiconductor (silicon substrate), q is the electron charge, QSS is the surface 
charge density at the silicon surface and QOX is the total fixed oxide charge. 
From Equation 3.24 and 3.25, it can be seen that the threshold voltage is 
affected by materials properties such as work function of the interface 
materials, the charge accumulation and also the material of the gate oxide that 
changes the gate oxide capacitance.  
After understanding the fundamental working principle of a MOSFET, now 
consider a MOSFET with its gate metal removed, and replaced with a reference 
electrode that is immersed into an electrolyte. By doing this, the gate oxide will 
be in direct contact with the electrolyte. The gate voltage is the applied 
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potential at the reference electrode, which is normally a grounded reference 
electrode and remains constant. The modification of a MOSFET to an ISFET is 
shown in Figure 3.7. From Equation 3.25, this can be modified to describe the 
flatband voltage of an ISFET, which is dependent on the potential of the 
reference electrode (EREF) and also the potential at the gate oxide/electrolyte 
interface (∆𝜙 + 𝜒𝑆𝑂𝐿). The term 𝜒𝑆𝑂𝐿 is the dipole potential of the electrolyte 
and is a constant, while ∆𝜙 is dependent on the concentration of the ion species 
in the electrolyte at the interface. Due to the replacement of the metal gate 
with the reference electrode, the associated work function ɸ𝑀 is included in the 
term EREF. Hence, the change is VFB will affect the threshold voltage and the 
equation for VFB is given as:  
 
𝑉𝐹𝐵 = 𝐸𝑅𝐸𝐹 − ∆𝜙 + 𝜒𝑆𝑂𝐿 −
ɸ𝑆
𝑞
−
𝑄𝑆𝑆 + 𝑄𝑂𝑋
𝐶𝑂𝑋
 3.26 
 
Figure 3.7 – Schematic view and physical structure of a MOSFET and an ISFET. 
From Equation 3.26, it is clear that the only variable in the equation is the 
term ∆𝜙, where it changes according to the ionic concentration of the 
electrolyte. Therefore the ISFET is an ideal solid-state device that could replace 
glass electrode as an ionic sensor, for convenient implementation with CMOS 
technology. However, the ISFET sensing capability was found to have sub-
Nernstian or non-linear characteristics that is not ideal for a transducer. This is 
due to the electrochemical interactions between the gate oxide and electrolyte. 
Therefore, it is vital to understand these electrochemical interactions to achieve 
a Nernstian response for the ISFET. 
a) MOSFET b) ISFET 
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3.5 Electrolyte-Insulator-Semiconductor 
Interface 
As discussed in Section 3.3.1, when two chemical phases come in contact with 
each other, a redistribution of charge and potential occurs at the interface, 
reaching an electrochemical equilibrium. At this equilibrium, charge carriers of 
both phases accumulated at the interface, creating an electrical double layer, 
develop an electrochemical potential by establishing an electric field across the 
interface. Previously the electrochemical reaction on the electrode is not 
considered. With the increasing usage of semiconductor electrode as chemical 
device (listed in Section 2.3.2), thus it is very important to understand the 
electrochemical properties of the electrolyte-insulator-semiconductor (EIS) 
interface. 
As shown in Figure 3.8, the EIS interface consists of three layers and is analysed 
using a model proposed by Grahame [115]. The concept of the formation of an 
electrical double layer when an electrode is immersed into an electrolyte was 
first described by Helmhotz in the late 19th century. Consider an insulator-
semiconductor electrode in contact with electrolyte. The solvent molecules in 
the electrolyte will adsorb onto the surface of the insulator electrostatically, 
creating a hydration sheath on the surface. At this monolayer, specific ion 
adsorption at the surface will occur within the hydration sheath as well. These 
unhydrated ions are absorbed onto the surface chemically and the electrostatic 
forces from the semiconductor have no effect on them. This locus of the 
electrical centres of the adsorbed ions is called inner Helmholtz plane (IHP) and 
the total charge density determined by these ions is termed 𝜎0. The next layer 
after the hydration sheath is populated by the hydrated ions. This is due to 
hydrated ions could not move to the surface as close as adsorbed ions, thus the 
locus of the closest approach of these hydrated ions is called outer Helmholtz 
plane (OHP). The interaction of these hydrated ions with the surface is purely 
electrostatic and has no effect on the chemical properties. According to the 
Helmholtz-Perin model [111, Ch. 25], the charge distribution on the surface 
forms a molecular capacitor, between the charge from the IHP and the opposing 
charge from the OHP. It is expressed as: 
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𝐶𝐻 =
𝜀0𝜀𝑟𝐴
𝑑
 3.27 
where 𝜀0 and 𝜀𝑟 are the permittivity of free space and the electrolyte 
respectively, A is the total surface area of IHP and OHP, d is the distance 
between them.  
 
Figure 3.8 – The model of the electrical double layer for the EIS interface [115]. 
Stern later grouped IHP and OHP together as the Stern layer, which is also called 
the immobile layer [112, Ch. 13]. The OHP is the frontier between Stern layer 
and the third layer of the diffuse charge region, called Gouy-Chapman layer. 
This diffuse layer extends from OHP into the bulk electrolyte.  
When an electrolyte and insulator come in contact, the insulator surface will be 
hydrolysed to form surface groups, which may have different states: positively 
charged, negatively charged or neutral. The charged states depend on the pH of 
the electrolyte. If the surface charge is zero with a certain pH value, it is 
defined as the pH of the point of zero charge “pH(pzc)”. The positive (H+) and 
negative (OH-) ions from the electrolyte determine the surface charge on the 
insulator, thus they are called potential-determining ions. Hence, the charge 
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distribution and potential gradient of the EIS interface is dependent on the 
surface if it acquires negative charge or positive charge, as shown in Figure 3.9a 
and Figure 3.9b respectively.  
 
Figure 3.9 – Sketches of the charges and potentials distribution in the EIS interface [116]. 
The charge density 𝜎0 in the IHP is due to the ion adsorption on the surface and 
the excess charge density from Gouy-Chapman layer is 𝜎𝐷, so the total charge 
density in the electrolyte is 𝜎0 + 𝜎𝐷. The charge density in the solid phase 
(insulator-semiconductor) is in the semiconductor region 𝜎𝑆. By applying the 
concept of charge neutrality: 
 𝜎0 + 𝜎𝐷 + 𝜎𝑆 = 0 3.28 
The potential across the EIS interface has to be in continuity, hence: 
 𝐸𝑅𝐸𝐹 + (𝜙𝐷 − 𝐸𝑅𝐸𝐹) + (𝜙0 − 𝜙𝐷) + (𝜙𝑆 − 𝜙0) − 𝜙𝑆 = 0 3.29 
and, 
b) pH < pH(pzc) a) pH > pH(pzc) 
57 
 
 (𝜙0 − 𝜙𝑆) = −
𝜎𝑆
𝐶𝑂𝑋
 3.30 
 (𝜙0 − 𝜙𝐷) = −
𝜎𝐷
𝐶𝐻
 3.31 
 
𝜙𝐷 − 𝐸𝑅𝐸𝐹 = −
2𝑘𝑇
𝑞
sinh−1 (
𝜎𝐷
√8𝜀𝑘𝑇𝑐
) 3.32 
where k is the Boltzmann’s constant, 𝜀 is the electrolyte permittivity and c is the 
ionic concentration in the electrolyte. Equation 3.32 is the Gouy-Chapman model 
[112, Ch. 13] for the diffuse layer and by combining Equation 3.29 to 3.32, this 
will yield: 
 
𝐸𝑅𝐸𝐹 + [−
2𝑘𝑇
𝑞
sinh−1 (
𝜎𝐷
√8𝜀𝑘𝑇𝑐
) −
𝜎𝐷
𝐶𝐻
]
⏟                    
𝜙𝐸𝐼=−∆𝜙
+ [
𝜎𝑆
𝐶𝑂𝑋
− 𝜙𝑆]
⏟      
𝜙𝐼𝑆
= 0 
3.33 
The term EREF is the external applied potential from a reference electrode in the 
electrolyte and 𝜙𝐸𝐼 and 𝜙𝐼𝑆 are the interface potentials at the electrolyte-
insulator and insulator-semiconductor junction, respectively. This equation 
provides the relationship between interface potential difference ∆𝜙 and the 
charge density across the EIS interface.  
3.6 Site Binding Model 
As mentioned before, when an electrolyte and an insulator comes into contact, 
this can affect the insulator interface potential (Section 3.5) and modulate the 
ISFET’s threshold voltage (Section 3.4). From Section 3.5, we also know that the 
insulator interface potential is affected by electrostatic potentials in the 
electrolyte and charge formation due to chemical reactions at the surface. 
Unlike electrostatic forces that are long ranged, these chemical reactions can 
only occur within the OHP. Only hydrogen and hydroxyl ions are small enough to 
penetrate the OHP to enable chemical reactions at the surface. Normally the 
surface would contain a large number of active-sites, which are amphoteric, 
basic and acidic. Amphoteric sites mean that they can act as proton donor or 
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receptor, while basic and acidic sites can only be proton acceptor and proton 
receptor respectively.  
For an ideal unblocked interface between an electrolyte and an insulator, 
various ion species can exchange freely between the two phases (Section 3.3.1). 
Such condition can be achieved if the insulator is doped with impurity atoms to 
facilitate the ion exchange. On the contrary, a completely blocked interface will 
have no reactions between the insulator and electrolyte. The charge and 
potential distribution in such an EIS system will be purely electrostatic 
interaction. Moreover, the insulator has no specificity towards any ion species, 
thus the interface potential will be governed by the total ionic concentration of 
the electrolyte. In the general case, insulator exhibits neither ion exchange 
events nor is it completely inert. Therefore to better describe the interaction at 
a general oxide-electrolyte interface, Yates et al. [117] developed the site 
binding model in 1974. By adopting this model, the relationship of interface 
potential and pH, thus pH sensitivity, can be described.  
The typical insulator materials used for ISFETs are oxides, such as SiO2, Al2O3 and 
Ta2O5, where B will be used to represent Si, Al or Ta. When these oxides come in 
contact with an electrolyte, it will hydrolyse to form surface BOH groups, as 
shown in Figure 3.10. All of these oxides only have amphoteric sites, meaning 
they may be positively, negatively or neutral charged. The acidic and basic 
character of the neutral site BOH is described by the following reaction with two 
equilibrium constants KA1 and KA2 [118]: 
 
𝐵𝑂𝐻2
+ ⇌ 𝐵𝑂𝐻 +𝐻+ 𝐾𝐴1 =
[𝐵𝑂𝐻][𝐻+]𝑆
[𝐵𝑂𝐻2
+]
 3.34 
 
𝐵𝑂𝐻 ⇌ 𝐵𝑂− + 𝐻+ 𝐾𝐴2 =
[𝐵𝑂−][𝐻+]𝑆
[𝐵𝑂𝐻]
 3.35 
where [𝐻+]𝑆 indicates a surface concentration of H
+ ions, which can be related 
to the bulk H+ ion concentration by Boltzmann statistics, under the condition of 
thermal mixing [117]: 
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Figure 3.10 – Representation of surface sites and reactions for an oxide (BOH). 
 
[𝐻+]𝑆 = [𝐻
+]𝑒𝑥𝑝 (−
𝑞∆𝜙
𝑘𝑇
) 3.36 
The density of active-sites on the surface NA and charge density per unit area 𝜎0𝐴 
are: 
 𝑁𝐴 = [𝐵𝑂𝐻2
+] + [𝐵𝑂𝐻] + [𝐵𝑂−] 3.37 
 𝜎0𝐴 = 𝑞([𝐵𝑂𝐻2
+] − [𝐵𝑂−]) 3.38 
By multiplying Equation 3.34 and 3.35, and replacing [𝐻+]𝑆 using Equation 3.36 
gives: 
 
[𝐻+] = √𝐾𝐴1𝐾𝐴2𝑒𝑥𝑝 (
𝑞∆𝜙
𝑘𝑇
)√
[𝐵𝑂𝐻2
+]
[𝐵𝑂−]
 3.39 
When ∆𝜙 = 0 and 𝜎0𝐴 = 0 (i.e. [𝐵𝑂𝐻2
+] = [𝐵𝑂−]), Equation 3.39 will be reduced 
to [𝐻+] = √𝐾𝐴1𝐾𝐴2. This is the amount of hydrogen ion concentration required in 
the solution to reach an electrically neutral insulator surface, which is known as 
the point of zero charge (pzc). The pH index for pzc is denoted as pH(pzc)A and 
Equation 3.39 can be expressed as: 
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2.303(𝑝𝐻(𝑝𝑧𝑐)𝐴 − 𝑝𝐻) = (
𝑞∆𝜙
𝑘𝑇
) + ln𝐹𝐴 3.40 
This equation gives the relationship between charge, potential and pH, with a 
function: 
 
𝐹𝐴 = √[𝐵𝑂𝐻2
+] [𝐵𝑂−]⁄  3.41 
This function plays a vital role in the electrochemical response of the insulator’s 
surface. In order to solve this function, the normalised net charge on the surface  
𝜒𝐴 is defined as: 
 
𝜒𝐴 =
𝜎0𝐴
𝑞𝑁𝐴
=
[𝐵𝑂𝐻2
+] − [𝐵𝑂−]
[𝐵𝑂𝐻2
+] + [𝐵𝑂𝐻] + [𝐵𝑂−]
 3.42 
𝜒𝐴 can be expressed as a function of FA, when Equation 3.42 is divided through 
by [BO-]: 
 
𝜒𝐴 =
𝐹𝐴
2 − 1
𝐹𝐴
2 + 𝐹𝐴√𝐾𝐴1 𝐾𝐴2⁄ + 1
 3.43 
This equation can be inverted by defining and substituting  𝛿 = 2√𝐾𝐴2 𝐾𝐴1⁄  and 
then taking the positive root of Equation 3.44 to give FA(𝜒𝐴): 
 
𝐹𝐴
2(𝜒𝐴 − 1) + 𝐹𝐴
2𝜒𝐴
𝛿
+ 𝜒𝐴 + 1 = 0 3.44 
 
𝐹𝐴 =
𝜒𝐴 𝛿⁄ + √(𝜒𝐴 𝛿⁄ )2(1 − 𝛿2) + 1
1 − 𝜒𝐴
 3.45 
Using Equation 3.40 and 3.45, we can see that the pH of a solution is a function 
of both ∆𝜙 and 𝜎0𝐴, and a direct relationship of ∆𝜙 and 𝜎0𝐴 can be found using 
Equation 3.33, which can be expressed as: 
 
∆𝜙 =
2𝑘𝑇
𝑞
sinh−1 (
𝜎𝐷
√8𝜀𝑘𝑇𝑐
) −
𝜎𝐷
𝐶𝐻
 3.46 
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Using charge neutrality through the EIS system: 
 𝜎𝐷 + 𝜎0𝐴 = ∆𝜎 = −𝜎𝑆 3.47 
By assuming ∆𝜎𝑆 = 0, which will give 𝜎𝐷 = −𝜎0𝐴 [119], we could now use a 
parametric method to solve for ∆𝜙 𝑝𝐻⁄ . ∆𝜙 can be obtained from Equation 3.46 
and 𝐹𝐴 can be found using Equation 3.45, thus the pH of a solution can be 
obtained using these two parameters to solve Equation 3.40. Therefore, this 
procedure is used to generate  ∆𝜙 𝑝𝐻⁄  curves (pH sensitivity) for an insulator 
with single active-site in a straightforward manner.  
3.7 Measurement of Light Absorbance 
As mentioned previously, the concentration of metabolites in an enzyme assay is 
measured using light adsorption from spectrophotometer. For each wavelength 
of light passing through a solution that contains specific absorbing species, the 
intensity of the light, I is measured and this is neglecting the reflection of light 
off the vial that contains the solution. The Beer-Lambert Law [120] was 
discovered in the 19th century, which is used to relate the attenuation of a 
travelling beam of light through a sample, to the length of the path of the beam 
in the sample and to the concentration of the attenuating species in the sample. 
This simple event is presented in Figure 3.11. 
 
Figure 3.11 – Diagram of light absorbed by a sample solution with certain vial width.  
The amount of light that is absorbed after passing through the solution is given 
as: 
 
𝐴 = log10
𝐼0
𝐼
 3.48 
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The absorbance, A is proportional to the concentration of the absorbing species 
in the sample, c and to the length of the light path in the sample, d. Hence, 
absorbance is given as: 
 𝐴 = 𝑘𝑐𝑑 3.49 
where k is the molar absorptivity constant of the adsorbing species.  
From Equation 3.48 and 3.49, it forms the common form of the Beer-Lambert 
Law, written as: 
 
𝐴 = log10
𝐼0
𝐼
= 𝑘𝑐𝑑 3.50 
This formula gives a direct relationship between the absorbance and the 
concentration of the absorbing substance in the solution for an enzyme assay, 
which directly relates to the concentration of metabolites. 
3.8 Summary 
In this chapter, two unique abilities of enzymes were introduced; as a catalyst 
for increasing reaction rate and the “lock and key” specificity for specific 
substrate binding. This makes enzymes very useful for the application in 
metabolites quantification. Enzyme kinetics has also been presented to show 
how useful kinetic information can be obtained to understand metabolites 
quantification. Furthermore, two different enzymes assays, which are used in 
this work, have been introduced. These enzyme assays can be detected using 
spectrophotometric light absorbance and electrochemical pH sensing on CMOS 
ISFETs. Later in the chapter, the working mechanism of the ISFET was explained 
together with the insulator-electrolyte interface that demonstrates the theory 
behind the pH response of different insulator materials. Last but not least, the 
relationship of the absorbance and the absorbing substance in an aqueous 
solution was explained by Beer-Lambert Law, which relates to the concentration 
of metabolites in an enzyme assay. In the next chapter, the CMOS sensor array 
and sensor systems used in this work to demonstrate the enzyme assays will be 
discussed.  
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Chapter 4 : Sensors and Sensor 
Systems  
4.1 Introduction 
The previous chapter introduced the fundamental theory of enzyme kinetics and 
the description of enzyme assays that can be studied via hydrogen ion 
concentration or light absorbance changes. In addition, Chapter 3 also included 
an explanation on the working principles of ISFETs and the mathematical 
derivations of ISFETs’ pH response. This chapter concentrates on the design 
descriptions of the CMOS sensor array chips and how to integrate into hardware 
and software system. The discussion for this chapter is separated into two 
distinct platforms: 256×256-pixel ISFET array chip and 16×16-pixel Multi-Corder 
chip. The ISFET array chip was designed by a former member of the Microsystem 
Technology (MST) group named Balazs Nemeth. The Multi-Corder chip was 
designed by Mohammed Al-Rawhani. He combined the circuitry of the ISFET 
(Balazs Nemeth), photodiode (Luiz Gouveia) and single photon avalanche diode 
(Mohammed Al-Rawhani) into one single chip. The chapter also emphasises the 
miniaturisation process from an expensive and bulky PXI platform to a low cost 
and small-scale ARM mbed platform measurement tool. This suited the idea of 
bringing the personal metabolome machine to the hands of a physician or 
patient as POC diagnostics.  
4.2 256×256-Pixel ISFET Array Platform 
The ability of using ISFET array CMOS chips for various applications, such as ionic 
imaging of fluids dynamics [121] and artificial [122] or natural systems [123] ion 
imaging, were demonstrated by the MST group at the University of Glasgow. This 
technology has been successfully implemented in genome sequencing as 
mentioned in Section 2.4.3, thus our vision is to further expand this technology 
for metabolome detection. The following sections will describe all the 
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components of the ISFET array chip (65,536 ISFET sensors) designed by our group 
along with the hardware and software system used for reading out the signals. 
4.2.1 Foundry Technology 
 
Figure 4.1 – Cross-sectional view of the 4 metal layer-0.35 μm AMS CMOS process [124]. 
The fabrication of the chip was outsourced to austriamicrosystems AG (AMS). 
They offer CMOS processes for ASIC (application-specific integrated circuit) 
systems and provide design kits to create integrated circuits [125]. The foundry 
technology is provided through the Europractice IC service [126]. This service is 
provided by IMEC and Fraunhofer which offer small volume and low cost ASIC 
prototyping through multi-project wafers. This service combines multiple designs 
from different customers on to a single wafer to reduce the cost of each ASIC 
design to approximately 5–10% of the full wafer cost. After the fabrication of the 
chips, Europractice also arranges the wafers to be diced, wire bonded and 
packaged into a standard chip carrier. However, in our case the CMOS chips have 
to be further post-processed to improve device sensitivity (a detailed discussion 
will be provided in Chapter 5), thus bare chips were requested and delivered to 
the University of Glasgow. The technology chosen for this project was the 
‘C35B4’ 0.35 μm CMOS process which consists of four metal layers and an 
operating voltage of 3.3 V. This technology was selected in this work to design a 
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working ISFET array chip. The wafer cross-section of the C35B4 technology is 
shown in Figure 4.1. 
4.2.2 ISFET Array Chip 
The ISFET array is composed of multiple single ISFET sensor pixels in a 
configuration of 256 rows and 256 columns, providing a total number of 65,536 
ISFET sensors. The circuit diagram and layout representation of a single ISFET 
pixel is shown in Figure 4.2. Each pixel circuit consists of four transistors (P1, 
P2, P3 and N1) as shown in Figure 4.2a. P2 is an ISFET pMOS transistor that is 
configured as a voltage-follower and used to measure the concentration of 
hydrogen ions in an aqueous solution. P1 is an in-pixel current source that acts 
as a load transistor, P3 and N1 form the transmission gate circuit used for 
individual pixel selection. In Figure 4.2b, it can be seen that the gate of the 
ISFET transistor is connected via POLY 1 to a central point of the pixel. Then it is 
connected to the top patterned Metal4 layer using intermediate vias and metal 
layers, creating a floating gate structure as an ISFET sensor (described in Section 
2.4.2). The passivation layer on top of Metal4 acts as a sensing layer to detect 
hydrogen ion concentration. This detection is measured by the gate potential 
changes of P2. The transmission gate circuit is in between the source-follower 
circuit and the analogue output channel of the pixel, preventing from any charge 
sharing between pixels in the same output channel. The transmission gate circuit 
also known as a switch, is comprised of two complementary transistors that 
require opposite digital signals to open or close the switch. The digital signals 
are inputted from external digital pads to the gate of the complementary pMOS 
and nMOS transistors via Vcol̅̅ ̅̅ ̅ and Vcol respectively.  
Each individual pixel has a physical size of 10.2×10.2 μm2 with 1 μm distance in 
between each adjacent pixel (11.2 μm pixel pitch size). The complete 256×256-
pixel array occupies a total area of approximately 2.87×2.87 mm2 in the middle 
of the chip and the total area of the chip is 4.6×4.7 mm2. Figure 4.3a illustrates 
the optical micrograph of a 3×3-pixel array highlighting the dimensions of a 
single pixel. Figure 4.3b shows the whole chip including the 256×256-pixel ISFET 
array, the readout electronics (multiplexing systems and column decoders) and 
the input/output (I/O) pads. 
66 
 
 
Figure 4.2 – A single pixel of the ISFET array chip. 
 
Figure 4.3 – Optical micrograph of the ISFET array chip. 
4.2.3 On-Chip Readout System 
The ISFET sensor array is divided symmetrically into two halves; each half 
contains a pixel array of 256 rows and 128 columns. Figure 4.4 shows the 
symmetry of the 256×256-pixel array readout architecture, containing two 
identical row multiplexing systems and column decoders for both sides of the 
array. The bond pads are divided into two sides, each side contains individual 
a) 3×3-pixel array 
 
b) Whole chip 
b) Layout 
 
a) Schematic 
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bond pads for each readout channel (32 channels per side), external digital 
addresses for the row multiplexers and column decoders, and global power 
supplies (VDD and GND). All the digital addresses are inputted from an external 
source to the chip. To avoid confusion, all the external digital addresses for both 
sides of the array are obtained from the same source. A 7-bit column decoder is 
used to readout 128 pixels from one half of the array. The same digital addresses 
are used to read the remaining 128 pixels from the other half of the array. These 
digital addresses activate individual transmission gates for every pixel in the 
selected columns, where each pixel is selected by an individual digital word 
(e.g. 0000001). Both decoders are configured to operate in opposite phases, thus 
the array is read from the centre columns to the opposite sides of the array. The 
row multiplexing system at each side of the array contains seven pieces of 32/64 
line selector blocks. Each block contains 32 single-pole-double-throw switches to 
enable the appropriate 32 channels selection (e.g. <0...31> or <32...63> lines) 
from 256 rows. The operating system of a single line selector block is shown in 
Figure 4.5. These blocks are configured in a 4-2-1 manner to function as a one 
from eight multiplexer. Blocks of 32 analogue signals are then readout 
sequentially from both sides of the array simultaneously. 
 
Figure 4.4 – A schematic diagram of the addressing architecture of the 256×256-pixel ISFET 
sensor array chip. 
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Figure 4.5 – Operation of the switches in the one from eight multiplexer selecting 32 rows of 
analogue output signals.  
4.2.4 Off-Chip Instrumentation and Measurement System 
In order to operate the ISFET sensor array chip, a high-speed instrumentation 
and measurement system was constructed to obtain the pixel output voltages 
and to provide digital addresses to the chip. The output voltages represent the 
local hydrogen ion concentration changes as explained in Section 3.4. The 
measurement tool designed for metabolites detection has a maximum speed 
capability of 2 μs/pixel, reading 64 analogue signals every 2 μs. Therefore, the 
maximum acquisition rate of the measurement unit can be translated into 2.048 
ms/frame (reading all 65,536 pixels), which is equivalent to approximately 
500 fps.  
Figure 4.6 illustrates the operational flow of the instrumentation and 
measurement system. The system consists of a desktop computer, four PXI-
Express-6538 X series acquisition cards placed in a PXI-Express-1073 chassis 
(National Instruments), a custom printed circuit board (Newbury Electronics) and 
a packaged ISFET array chip (the packaging process will be explained in Chapter 
5). The chip was bonded to provide access to all the internal connections. In 
addition, a voltage source was connected to an Ag/AgCl quasi-reference 
electrode [127], which was immersed into the aqueous solution that was 
contained in the packaged chip. To form the Ag/AgCl quasi-reference electrode, 
an Ag wire was first immersed into 0.1 M KCl solution together with another 
inert electrode such as platinum and then biased to 1.3 V using a potentiostat 
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for 2 minutes. The purpose of the reference electrode is to set a reference 
potential to the floating gates of all the ISFET sensors in the array. 
 
Figure 4.6 – The system-level description of the instrumentation system for 256×256-pixel 
ISFET array chip. 
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The PXI-Express chassis was connected to the desktop computer via a PCI-
Express-8361 card, which was inserted in one of the PCI-Express slots in the 
computer. On the printed circuit board (PCB), a PGA ZIF 15×15 socket was used 
to house the packaged chip. The PCB was used to connect all the 64 analogue 
outputs from the chip to the 64 analogue inputs for each of the four PXI-Express 
acquisition cards (16 inputs per card). In addition, the PCB was used to connect 
the 10 digital outputs from one of the PXI-Express cards to all the respective 
digital inputs to the chip. However, all the digital outputs from the acquisition 
card have a voltage range of 0 – 5 V, which is not compatible to the operating 
voltage of the chip. Hence, two MAX 3001E voltage level shifters were used to 
lower the voltage of the digital outputs from the acquisition card to the 
electronics maximum output range of 0 – 3.3 V.  The PCB also connected the 
gate of all the in-pixel load transistors (P1 in Figure 4.2a) to a 1 V voltage 
source. 
The whole operation of the instrumentation and measurement system was 
controlled by the software package LabVIEW from National Instruments (NI). It 
was programmed to read all the 64 analogue outputs from the chip and send the 
10-bit digital addresses to activate the pixels in the chip. Hence, it is very vital 
to synchronise the digital addressing and analogue data logging of the chip, in 
order to obtain the correct pixel voltage reading as a function of time. The PXI-
Express reference clock in the chassis was used to synchronise both the analogue 
signals and digital addressing. This reference clock links all the four acquisition 
cards together. In order to make perfect sure that the correct pixel 
measurement was obtained, the analogue data was read at half the period of 
the sampling rate. A picture of the complete instrumentation and measurement 
system is shown in Figure 4.7. 
The analogue input resolution of the acquisition cards is 16 bits for a single pixel 
voltage which means a frame will have 131.072 kB of data, thus the maximum 
transfer data rate from the chip to the computer is 64 MB/s. This is a significant 
amount of data that is difficult for a multi-tasking operating system such as 
Microsoft Windows to handle efficiently. Moreover, high-priority processes such 
as anti-virus or firewall could halt the measuring system, preventing a 
continuous process of sending digital addresses and receiving analogue signals. 
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To ensure high speed and continuous data transfer, the direct memory access 
(DMA) and data logging features of the PXI-Express-6358 X series acquisition 
cards were used in conjunction with a solid-state drive (SSD) of the PC. A total 
number of 1024 digital words made from 10-bit digital addresses were sent to 
the memory of the computer to extract a whole frame. The sending of digital 
addresses was also programmed to regenerate from memory after each frame to 
obtain continuous sampling. For high speed acquisition of analogue voltages, the 
data was transferred directly to the SSD as an NI standard TDMS file. Using this 
strategy, the system operated independently from the central processing unit 
and operating system of the computer, thus giving continuous addressing without 
interruptions and large volumes of data transfer. 
 
Figure 4.7 – Photograph of the instrumentation system for 256×256-pixel ISFET array 
platform. 
4.2.5 Data Analysis 
The raw data measurement from the acquisition system had to be extracted and 
analysed for the detection of hydrogen ion concentration in the aqueous solution 
on top of the chip. Figure 4.8 illustrates the data analysis procedure to visualise 
the hydrogen ion concentration. In order to do this, LabVIEW was again used to 
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arrange all the data into frames of 65,536 pixels. A reference frame was chosen 
manually prior to any chemical reaction. All the subsequent frames were then 
subtracted from the reference frame to take a differential measurement until 
the end of the desired length of the experiment. The results of each frame were 
then plotted to the appropriate LabVIEW graph to show 2D or 3D image 
representation, as well as the data analysis of individual pixels as a function of 
time. Furthermore, the average of all the pixels and the standard deviation 
between pixels can be obtained using the numerical operations in LabVIEW.  
 
Figure 4.8 – Description of the data analysis from the chip. 
4.3 16×16-Pixel Multi-Corder Array Platform 
With the progression of the work, the 256×256-pixel ISFET array chip was found 
to lack certain characteristic required for metabolome detection such as 
measuring multiple metabolites. In order to achieve this, microfluidics (will be 
discussed in Chapter 5 and 7) were required to be post-processed on top of the 
chip, consequently increasing the fabrication complexity (will be explained in 
Section 4.3.2). Therefore, a new chip, 16×16-pixel Multi-Corder chip was 
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designed and fabricated to allow the addition of microfluidics on top of the chip 
with fewer complications. Furthermore, with the ability to measure enzyme 
assays by spectrophotometric means (see Section 3.2.2), the Multi-Corder chip 
was designed to include two different optical sensors into every pixel along with 
the ISFET circuitry. These two optical sensors are photodiode (PD) and single 
photo avalanche diode (SPAD). Hence, the Multi-Corder chip provided an 
improvement from the original ISFET array chip (single sensor) to a multiple 
modality platform for metabolome sensing using optical and ionic sensors. The 
following sections will describe the components of the Multi-Corder chip (256 
pixels of three different sensors) as well as the new acquisition system to 
readout the signals from every sensor. 
4.3.1 Foundry Technology 
 
Figure 4.9 – Cross-sectional view of ISFET, PD and SPAD structures fabricated in H35B4 
technology. 
Similar to the 256×256-pixel ISFET array chip, the fabrication of the Multi-Corder 
chip was also outsourced to AMS. However, the CMOS process selected for the 
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16×16-pixel Multi-Corder chip was slightly different, which was the 0.35 μm high 
voltage (50 V) CMOS process with four metal layers (H35B4 technology). The 
reason behind the selection of a high voltage process was due to the 
requirements of SPADs to work at a high breakdown voltage. The CMOS H35B4 
technology has a deep n-well that allows the SPADs to operate at a high 
breakdown voltage [128]. Figure 4.9 illustrates the cross-section of a cluster of 
ISFET, PD and SPAD using H35B4 technology. 
4.3.2 Sensor Array Chip 
The Multi-Corder array is composed of multiple single pixels containing a cluster 
of three different sensors, where an ISFET is integrated with a PD and a SPAD 
along with its corresponding sensing circuits. The three sensors with their 
sensing circuits are arranged in the order of 16 rows and 16 columns to provide a 
total number of 256 pixels. The ISFET pixel circuit is the same as the one 
previously explained in Section 4.2.2. The first optical sensor in the chip is a PD, 
its pixel circuit diagram and readout waveforms are shown in Figure 4.10. A PD is 
a p-n junction photosensitive detector and conventionally a single pixel of a 
CMOS PD imager incorporates a PD with three nMOS transistors to readout the 
photocurrent [129]. As can be seen in Figure 4.10a, the detected light generates 
a current, iph, that will discharge at Vd, node. The discharged voltage, Vd, is 
supplied to the gate of transistor M2 which is configured as a source-follower. As 
shown in the timing diagram of Figure 4.10b, each measurement cycle begins 
with t = t0 when Vrst = VDD. From t0 to t1, the PD is reset by transistor M1 to its 
original state, VDD when a reset signal, Vrst, is provided to the gate of M1. At t = 
t1, the circuit enters the integration phase. Depending on the integration time 
on the PD, a different iph leading to a corresponding rate of change of Vd, across 
the diode as the capacitance is discharged. At t = t2, the PD voltage is buffered 
to the output voltage node, Vout when the gate of transistor M3 is provided with 
an external logical signal (sel). Hence, the amplitude of Vout is inversely 
proportional to the detected light intensity, as can be seen from traces labelled 
as Vd1 and Vd2 in Figure 4.10b. However, if the PD is saturated which is the trace 
labelled as Vd3, then PD will have completely discharged before t = t2. In order 
to avoid this possibility, the measurement tool had to be designed to fix an 
integration period (t1 – t3) to 100 ms.  
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The second optical sensor in the chip is a SPAD, which is an avalanche 
photodiode that is reversed biased above the breakdown voltage to operate in 
Geiger mode [130]–[132]. High electric field within the active region of the SPAD 
will initiate an avalanche breakdown upon receiving a single photon. This will 
generate a large current pulse to be detected using a passive quenching circuit 
(SPAD connected in series with a load transistor). The reason two different 
optical sensors were used in this work was mainly to extend the dynamic range 
of the light intensity measurement, where high and low intensity light will be 
detected by PD and SPAD respectively. 
 
Figure 4.10 – Single PD pixel of the Multi-Corder chip array. 
Figure 4.11 illustrates the optical micrograph of a single pixel containing its 
three sensors and the complete Multi-Corder chip. Each of these pixels has a 
physical size of 100×100 μm2 and the entire array occupies a total area of 
approximately 1.6×1.6 mm2 in the middle of the chip. As mentioned before, 
microfluidics are required for multiple metabolites detection, thus a continuous 
and smooth liquid flow of metabolites in the microfluidics is essential. However, 
the bond pads of the original ISFET array chip are at all four peripherals of the 
chip (see Figure 4.3b), which does not provide a good inlet and outlet port for 
the microfluidics. Hence, the Multi-Corder chip was designed to only have bond 
pads on opposite sides of the array as shown in Figure 4.11b. This allows a good 
inlet and outlet port for the microfluidics to be made for a continuous liquid 
flow across the array of the chip without any obstruction. In addition, each 
active pixel that is in line with the blank bond pads has a 50 μm gap in between 
b) Operation waveform 
 
a) Circuit diagram 
 
76 
 
to allow microfluidics to be fabricated on top of the gap, without impeding the 
functionalities of the sensors.  
 
Figure 4.11 – Optical micrograph of the Multi-Corder chip. 
4.3.3 On-Chip Readout System 
The on-chip readout system for the Multi-Corder chip is simpler than the one 
from the ISFET array chip. Each of the sensor array has its own corresponding 
addressing system and individual bond pads. Hence, each array can be acquired 
independently. Figure 4.12 illustrates the architecture of the readout system for 
all 16×16 pixels in the array. The ISFET readout system has a 4-bit decoder for 
column addressing and a one from eight multiplexer for row addressing, which 
require a total of 7-bit digital addresses. These digital addresses are supplied to 
the 4-bit decoder to readout one of the 16 columns of the array, which are used 
to activate the transmission gate of the ISFET pixel circuit in the selected 
column (see Section 4.2.3). The row data of the ISFET is divided into eight blocks 
of two analogue outputs which are read using a 3-bit digital address. These 
blocks of two analogue outputs are read out sequentially using a one from eight 
multiplexer. 
As for the PD and SPAD readout system, each one has two 4-bit decoders for 
both row and column addressing. Unlike ISFET, PD only has one analogue signal 
to be readout at a time. For the PD readout system, global shutter readout 
scheme was used. When all the PDs are reset using transistor M1, the 4-bit 
column decoder selects a column and the 4-bit row decoder steps through each 
a) Single pixel 
 
b) Whole chip 
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of the 16 pixels across the column to provide a signal (sel) to the gate of 
transistor M3 (refer to Figure 4.10a). The digital addresses read through all 256 
pixels when all of the PDs are active and discharging, before they are all reset 
again, thus the name global shutter readout scheme. On the other hand, SPAD 
readout system uses a rolling shutter readout scheme [132]. 16 SPAD array 
columns are powered up at a time via a 4-bit decoder. The output pulse from 
each SPAD in the selected column is counted by (16) 16-bit digital pulse 
counters. Each counter gate is opened using an external digital signal (gate) for 
a certain period of time, e.g. 10 ms, and counts the pulses of 16 SPADs from the 
selected column. After the pulse counting, a 4-bit row decoder selects and reads 
out serially from each of the 16 counters. To step through each of the 16-bit 
counters, an external digital signal (read) is used to read from most significant 
bit (MSB) to least significant bit (LSB), until all 16 counters are read. After the 
16 counters of the selected column are readout, another external digital signal 
(clear) is provided to empty all the counters for the next column selection. 
Figure 4.13 shows the digital signals required for the SPAD array readout. The 
whole procedure is run through column-by-column, hence the name rolling 
shutter readout scheme.  
 
Figure 4.12 – A schematic diagram of the addressing and readout architecture of all three 
sensor arrays for 16×16-pixel Multi-Corder chip. 
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Figure 4.13 – SPAD array readout and communication protocol for Multi-Corder chip [132]. 
4.3.4 Off-Chip Instrumentation and Measurement System 
In order to bring metabolome detection from the laboratory to the hands of a 
physician or patient, it is pivotal for the measurement tool to be compact and 
inexpensive. However, the instrumentation and measurement system that was 
constructed for the ISFET array chip was bulky and expensive, and was used 
mainly for laboratory experimentation. Moreover, the number of sensors pixels 
in the Multi-Corder chip is only 256, which is 256 times less than the number of 
pixels in the ISFET array chip. Hence a high-speed acquisition system was not 
required. Therefore, a low cost and miniaturised measurement tool was 
designed and constructed to demonstrate the ability of using the Multi-Corder 
chip to measure the concentration of hydrogen ions or spectrophotometric 
changes in an enzyme assay. The acquisition system was designed to acquire 
analogue signals (voltages) from the ISFET and PD sensors, obtain the digital 
signals from the counters of the SPAD sensors, and provide digital addresses to 
the chip. The system was designed to obtain the data from all three sensors 
independently, working with one sensor array at a time. However, this can be 
modified to acquire two sensor arrays at a time, which is either ISFET and PD or 
ISFET and SPAD, providing ionic and optical information simultaneously. 
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Figure 4.14 illustrates the flow of the instrumentation and measurement system 
for the Multi-Corder chip. The system comprises of a laptop, one ARM mbed 
Integrated Development Environment STM32 Nucleo-F334R8 board 
(STMicroelectronics), a custom PCB (Eurocircuits), and a packaged Multi-Corder 
chip. Similar to the ISFET array testing method, a quasi-reference electrode was 
used to set the floating gate potential for all the ISFET sensors in the array. In 
addition, a light source was required for the testing of spectrophotometric 
enzyme assays on the PD sensor array. An inexpensive and easy way of doing 
that was to use a standard green or blue LED shinning on top of the entire PD 
sensor array. To provide a more accurate measurement, a monochromator was 
used to transmit a narrow band wavelength from the light source and a lens was 
used to focus the light on top of the PD sensor array.  SPAD is a highly sensitive 
optical sensor, thus it had to be operated in the dark. A black cardboard box was 
made to cover the whole measurement setup while realising SPAD-type 
experiments.  
 
Figure 4.14 – System-level description of the measurement setup for the Multi-Corder chip. 
Figure 4.15 shows the picture of the measurement setup. The mbed nucleo 
board (attached on to the PCB) was connected to the laptop via a standard USB 
(Universal Serial Bus) connection. On the PCB, a PGA ZIF 13×13 socket was used 
to house the packaged Multi-Corder chip. Furthermore, the PCB connected the 
two ISFET analogue outputs, one PD analogue output and one SPAD counters 
digital output from the chip to the mbed nucleo board. The PCB was also used to 
connect the 7-bit ISFET, 8-bit PD and 8-bit SPAD digital addresses that were 
provided from the mbed nucleo board to the chip. In addition, the digital signal 
of Vrst for PD and the other three digital signals for the SPAD (clear, gate and 
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read) were provided from the mbed nucleo board to the chip via the PCB.  In 
addition, the PCB also connected a voltage source to all the in-pixel load 
transistor gates (exactly the same as the original ISFET array chip), a 22 V high 
voltage source to bias the SPAD and a 3.3 V power supply to power the chip. 
 
Figure 4.15 – Photograph of the measurement setup for the 16×16-pixel Multi-Corder chip. 
The whole operation of the instrumentation system was controlled by LabVIEW 
using a laptop and the written program in the ARM mbed board. The mbed C++ 
program was written using mbed online compiler, which was downloaded into 
the microcontroller. The communication between the laptop and the ARM mbed 
board was through USB Serial port which uses a standard Serial interface. This is 
a generic protocol that is used by computers and electronic modules to transfer 
data in between each other [133]. It has two unidirectional channels to send and 
receive data through the Serial link. This link is asynchronous where both ends of 
the serial link have to be configured with the same settings such as baud rate, 
the rate of which data is transferred in a communication. Hence, the serial 
connection between the laptop and ARM mbed board was set to a baud rate 
(bits/s) of 115,200 at both ends. Moreover, the data transfer between them was 
designed to use the default 8-bit long data but can also be designed to a 
maximum of 12-bit long data. 
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Similar to the measurement tool for the original ISFET array chip, the digital 
signals for the addressing and readout signals for Multi-Corder chip had to be 
properly synchronised, this is very important to obtain the correct pixel 
measurements. Figure 4.16 is a flowchart showing how the synchronisation of 
the acquisition system works. A character (e.g. “A”) was assigned for each 
sensor array. This character is recognised by the ARM mbed board program as an 
American Standard Code for Information Interchange (ASCII) code in decimal 
format (e.g. 65 for character “A”). This character was sent from the laptop using 
LabVIEW to the ARM mbed board program. When the ARM mbed board program 
receives the ASCII code, the program recognised which sensor array to activate 
and read from. The following steps describe the procedure for the three 
different sensor arrays: 
1. If the ISFET sensor array is selected, the program will scan through 128 of 
7-bit digital addresses to obtain two parallel analogue ISFET signals. These 
analogue signals will be sent through the USB Serial port to the laptop 
sequentially to form a 16×16 frame of data. 
2. If the PD sensor array is selected, the program will send a digital signal 
(reset) to activate the gate of all the transistors M1 (Figure 4.10a) with 
Vrst. Then, the analogue signals from all the 256 sensors are readout using 
the 8-bit digital addresses. These analogue signals will be sent to the 
laptop serially to form a 16×16 frame of data.  
3. If the SPAD sensor array is selected, the program will send the clear, gate 
and read digital signals to the chip, as described in Section 4.3.3. 256 of 
7-bit digital addresses will be scanned through, until all the 16 counters 
for all 16 columns are read as 16-bit digital output signals from SPAD. 
These digital output signals will be sent to the laptop serially to form a 
16×16 frame of data.  
After one frame is obtained, another character is sent from the laptop to the 
ARM mbed board, in order to have a continuous flow of frames as a function of 
time. This summarises the synchronisation technique used to read out all the 
correct pixels. All of the above sensor array data were stored into a standard NI 
TDMS file.  
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Figure 4.16 – Flow chart of the synchronisation architecture for the measurement setup 
used in the Multi-Corder platform.  
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4.3.5 Data Analysis 
The raw data results from the acquisition system had to be extracted and 
analysed for both hydrogen ion concentration and spectrophotometric data. The 
acquired data was arranged into a 16×16 frame for each sensor array. Using the 
numerical functions in LabVIEW, a single pixel or an average of a certain area or 
the full array can be analysed as a function of time. Moreover, the visualisation 
of the 2D images for all the sensor arrays can be viewed across the complete 
duration of the experiment. 
4.4 Summary 
The design and fabrication of both chips, 256×256-pixel ISFET array and Multi-
Corder, were described in detail. The ISFET array and Multi-Corder array designs 
were fabricated using AMS ‘C35B4’ 0.35 μm low voltage and AMS ‘H35B4’ 
0.35 μm high voltage, four metal layer CMOS technology respectively. The 
readout architecture of both chips was discussed in detail, showing the 
interactions with the sensor pixel circuitry. Furthermore, a detail discussion was 
provided on developing a high-speed off-chip instrumentation system (PXI 
platform) to readout the analogue signals from all the sensors on the ISFET array 
chip by providing digital addresses to readout the selected pixels. Moreover, the 
chapter also emphasised on the use of CMOS chips for POC diagnostic 
applications. This led to the development of a low cost and miniaturised 
measurement tool (ARM mbed platform) for the Multi-Corder chip, where a 
detail discussion of the measurement tool was provided. Finally, the data of 
both chips was stored into a NI standard TDMS file and analysed using the NI 
software package LabVIEW. The next step will be to post-process the chips for 
sensitivity enhancement and microfluidics addition. The chips will be packaged 
with a suitable technique to be experimented with enzyme assays in wet 
environment.  
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Chapter 5 : Chip Post-Processing 
5.1 Introduction 
The previous chapter discussed two CMOS sensor array chips and also their 
instrumentation system. This chapter describes the post-processing of the CMOS 
ISFET to improve the sensitivity towards hydrogen and potassium ions. 
Furthermore, this chapter also discusses the microfluidics on top of a CMOS chip 
to provide multiple metabolites measurements. Finally, a discussion on 
packaging techniques that allow a CMOS chip to be used in a wet environment 
without compromising the electrical connections.  
5.2 ISFET Sensitivity 
On return from foundry, the CMOS chips normally cover with a layer of Si3N4 as 
passivation to protect the underlying embedded electronics. As mentioned in 
previous chapters, this passivation layer is in contact with the analyte solution 
and alters the electrical characteristics of the underlying ISFET through the 
metal stack, which can be detected by threshold voltage changes. Hence, the 
passivation layer may comprise of a variety of different materials to facilitate 
the sensitivity towards targeted ion sensitivity. Generally, Ta2O5 [134] is used to 
provide good sensitivity towards hydrogen ion concentration (pH) sensing while 
polyvinyl chloride membrane containing valinomycin [74], [135] provides good 
sensitivity to potassium ion concentration. The following sections will discuss 
about the material, method and characteristics for sensitivity towards both 
hydrogen and potassium ion concentration on a CMOS ISFET.  
5.2.1 Tantalum Pentoxide 
Since Matsuo and Esashi introduction of Ta2O5 as a sensing layer, it has been 
demonstrated that Ta2O5 presents better properties than Si3N4, which is the most 
commonly used pH-sensing layer, as mentioned in Section 2.4.1. These 
properties include better immunity to interference ions (selective to hydrogen 
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ions), higher sensitivity, lower drift, wider pH range and higher chemical 
resistance. Unlike Si3N4, Ta2O5 does not suffer from degradation of pH sensing 
characteristics from surface oxidation. Besides that, Si3N4 is known to show a 
sub-Nernstian response with a sensitivity of 46 mV/pH [60], whereas Ta2O5 has 
been shown to give a Nernstian response similar to glass electrode with a 
sensitivity of 58 mV/pH [134]. Hence, Ta2O5 is an ideal pH sensing layer to be 
used on top of a CMOS ISFET. Figure 5.1 shows the multi-layer metal structure 
CMOS ISFET with Ta2O5 exposed to the analyte solution.  
 
Figure 5.1 – A cross-sectional view of the CMOS ISFET structure with an additional Ta2O5 for 
pH sensitivity improvement. 
5.2.1.1 Micro-Fabrication Process 
In order to selectively deposit a layer of Ta2O5 on top of a CMOS chip, the 
facilities in the James Watt Nanofabrication Centre (JWNC) were used. A recipe 
to deposit Ta2O5 film with desired characteristics for ISFET was investigated in 
the course of this work. Furthermore, suitable processing steps had to be 
developed in order to fabricate on top of a small 4 by 4 mm2 CMOS chip. Next, 
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the deposition steps are explained and followed by the characterisation 
procedures to obtain desired properties of Ta2O5 sensing layer, and also the 
fabrication steps taken to find an optimum recipe to selectively deposit this film 
on top of the chip. 
Ta2O5 Deposition 
For deposition of Ta2O5, the radio frequency (RF) sputtering tool was used. 
Sputtering is a physical thin film deposition technique that ejects target 
material from the surface when the surface is bombarded by sufficient energetic 
particles, normally inert gases such as argon. The target material is placed at 
the cathode while the substrate is placed at the anode. With high positive argon 
ions directed at the highly negative charged target, the target is struck by argon 
ions and the ejected atoms are transferred to the substrate. The atoms are 
condensed and formed a thin film. This technique provides uniform thickness 
and good adhesion of sputtered material across the surface of the substrate 
[136, Ch. 7]. Sputtering deposition technique can be reactive or non-reactive. 
Reactive sputtering is a process where a reactive gas is introduced to the target 
material to deposit compounds such as oxides, nitrides or carbides. While non-
reactive sputtering is to deposit the target material as it is. In addition, the 
sputtering vacuum pressure, RF power and gas flow had to be investigated to 
obtain the desired characteristics for the Ta2O5 sensing layer. 
For a good pH sensing Ta2O5 layer on ISFET, low drift and high sensitivity film is 
pivotal. The work from Chou and Hsiao [137] had demonstrated that the pH 
sensitivity of Ta2O5 varies with surface roughness. In their work, they used RF 
reactive sputtering system to deposit Ta2O5 and found that by changing the 
pressure in the chamber while sputtering had an effect on the surface roughness 
of the film. Hence, this had resulted in different pH sensitivity. Table 5.1 shows 
the effect of sputtering pressure towards surface roughness and pH sensitivity. 
Furthermore, Kwon et al. [138] demonstrated that the pH sensitivity of the 
Ta2O5 film was increased with the number of oxygen sites on the surface of the 
sensing membrane. Using RF reactive sputtering method and heating in O2 
ambient, they had deposited a Ta2O5 film with chemical atomic ratio (Ta:O) of 
1:2.5, which is the ideal stoichiometric Ta2O5 film. With that, they had produced 
a Ta2O5 film with a high sensitivity of 58 – 59 mV/pH over with a wide pH range 
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of pH 2 – 12 and a low long term drift of 0.021 – 0.035 mV/hour. With this in 
mind, the Ta2O5 sputtering used in this work had to be developed to produce 
good surface roughness and chemical composition for good sensing 
characteristics.  
Table 5.1 – Surface roughness and pH sensitivity for different sputtering pressures [137] 
Variables Pressure (mTorr) 
5 15 25 
Deposition rate (Å/min) 30.6 17.5 13.2 
Ra (nm) 0.306 1.853 3.892 
Rmax (nm) 7.334 16.705 24.766 
Rq (nm) 0.621 16.705 24.766 
pH sensitivity (mV/pH) 55.2 48.2 46.8 
 
Using reactive sputtering of Ta2O5 film discussed above, it requires Ta atoms to 
react with oxygen atoms at a proper ratio while having argon gas to bombard the 
target material and form a desired compound on a substrate. To reduce the 
complexity of reactive sputtering, a ceramic target (Ta2O5) with non-reactive 
sputtering was used in this work. According to Wu et al. [139] work, the Ta:O 
ratio of the ceramic target is close to the ideal stoichiometric ratio, thus only a 
small amount of oxygen atoms are required for ceramic target sputtering that is 
essential for the compensation of oxygen atoms lost during deposition process. 
They found that the deposited Ta2O5 film had to be annealed to a temperature 
of 400oC to achieve surface roughness of 0.547 nm and Ta:O ratio of 1:2.5. 
Alternatively, they demonstrated that ceramic target can be deposited in pure 
oxygen atmosphere without any annealing to obtain the desired characteristics.  
Since the RF sputtering tool and chamber in JWNC is different from the work 
described above, investigation had to be established. This includes working 
pressure, gas flow of Ar:O and RF power. The working pressure of almost all the 
JWNC processes used in the sputtering tool was 100 μbar. Therefore, the most 
sensible approach was to sputter Ta2O5 at this pressure to begin with. Later 
atomic force microscopic (AFM) measurement from the final sputtering 
conditions of Ta2O5 film deposition had shown an average surface roughness of 
0.42 nm. This surface roughness agrees well with the earlier work described 
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previously. Hence, no further investigation of working pressures was required. 
Figure 5.2 illustrates the surface profile of the Ta2O5 layer using AFM.  
 
Figure 5.2 – The surface profile of the Ta2O5 film obtained from AFM, where Ra, Rq and Rmax 
are average roughness, RMS roughness and maximum roughness, respectively. 
Since the gas mixture ratio of Ar:O2 is very important to form a good chemical 
composition of Ta:O for pH sensing, different gas mixture ratio was investigated 
using this sputtering tool. Using x-ray photoelectron spectroscopy (XPS) to 
analyse the surface chemistry of the Ta2O5 film, different chemical composition 
of Ta:O corresponded to different gas mixture of Ar:O2 flow rate. Figure 5.3 
shows the XPS spectrums obtained from the Ta2O5 films, which were sputtered 
with three different ratios of Ar:O2. As can be seen in Figure 5.3, by increasing 
the gas mixture ratio of Ar:O2 from 0% to 10% in O2, this affected the Ta:O ratio 
of the surface from 1:1.51 to 1:1.77. These results were as expected from the 
previous work discussed above, thus ideally 100% oxygen sputtering is preferred 
to reach stoichiometric value of 1:2.5 for Ta2O5 film. However, it was noticed 
that as the oxygen content in the chamber increases, the temperature of the 
chamber during sputtering increases as well. High temperature sputtering was 
not good for later patterning process that involves photoresist. Moreover, high 
temperature will also compromise the structure integrity of the aluminium bond 
pads in the CMOS chips. Therefore, the gas mixture ratio of Ar:O2 of 9:1 was 
chosen for this work. Even though the Ta:O ratio was only 1:1.77, a significant 
improvement in ISFET performance was obtained, which will be described later 
in Section 5.2.1.2.  
Lastly, the thickness of the Ta2O5 film was affected by changing the RF power 
and duration of the sputtering. From various literatures, 50 to 120 nm thick layer 
of Ta2O5 was preferred for pH sensing [52], [134], [138]. Hence, the RF power 
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and duration of sputtering was varied to obtain a controllable thickness of 
100 nm, under the sputtering conditions described above. In a nutshell, Table 
5.2 shows the final sputtering conditions used to deposit a Ta2O5 film on a CMOS 
ISFET.  
 
Figure 5.3 – XPS analysis of the chemical composition of the Ta2O5 film surface for various 
gas mixture ratio of Ar:O2. 
Table 5.2 – Sputtering conditions of Ta2O5 film deposition 
RF power 300 W 
Working pressure 100 μbar/75 mTorr 
Gas mixture ratio 9:1 sccm (Ar:O2) 
Chamber and substrate temperature Room temperature 
 
 
 
a) 0% oxygen 
b) 5% oxygen 
c) 10% oxygen 
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Patterning Resist 
The bond pads of the CMOS chip, which are made of aluminium (Al), had to be 
avoided from any Ta2O5 deposition, as they had to be wire bonded onto a chip 
carrier for electrical connections. Therefore, a patterning process had to be 
developed to deposit Ta2O5.  
Two different methods could be used to selectively pattern a layer of Ta2O5. The 
first method consisted of sputtering a layer of Ta2O5 on top of the CMOS chip 
covering the full area, followed by a selective etching to release the Al bond 
pads. However, most of the dry/wet etches that could be used to etch Ta2O5 
would strongly damage the Al bond pads, making the wire bonding almost 
impossible. In addition, a hard mask for the etching had to be investigated (most 
possible a metal mask), which would imply more steps on the fabrication process 
[140].  
The second method consisted of a lift-off process. Lift-off process [141] was 
chosen to be the patterning process as this does not involve any etching process 
that will destroy the aluminium bond pads. Moreover, lift-off process has less 
processing steps compare to etching process, which is a lot more easy and simple 
for patterning. The only disadvantage of using lift-off process is that the 
processing temperature inside the deposition chamber could change the 
properties of the photoresist, as well as affecting the side wall profile of the 
photoresist. This was the reason why the temperature of the sputtering 
conditions had to be low, as mentioned previously. Furthermore, generally for a 
lift-off technique to work properly, a non-conformal deposition such as 
evaporation is preferred, which has poor step coverage. Nevertheless, lift-off 
technique still produced a good patterning Ta2O2 film on top a CMOS chip. 
Figure 5.4 illustrates the lift-off technique for a Ta2O5 film. Photolithography 
was used to define a photoresist pattern on top of the CMOS chip, opening a 
window over the active area of the sensor array. The patterned resist created an 
undercut resist edge profile that will not provide a conformal coating and 
promote lift-off. Then, a Ta2O5 film was deposited all over the CMOS chip, 
covering the photoresist and also the areas where photoresist had been 
removed. Using wet chemical solvent to remove the photoresist underneath the 
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film and take the film as well, leaving the film on top of the CMOS chip with the 
desired pattern. Therefore, a suitable photoresist process had to be chosen to 
provide a good formation of Ta2O5 pattern on top of the CMOS chip.  
 
Figure 5.4 – Schematic diagram of the lift-off technique for Ta2O5 film on top of a CMOS 
chip. 
Negative photoresists are generally the best choice of resists to be used for lift-
off processes. A reproducible undercut can be obtained with negative 
photoresists which is ideal to perform a good lift-off. Besides that, a cross-
linking step of negative photoresists helps to maintain the structure integrity of 
the resist when dealing with high temperature deposition. Hence, a process was 
developed using AZ2070, a negative photoresist with thickness of approximately 
7 μm. The processing steps for depositing Ta2O5 film with AZ2070 [142] are given 
in Table 5.3. However, the lift-off process with AZ2070 was not lifting off after 
the sputtering. Figure 5.5 shows the evaluation of AZ2070, before and after 
92 
 
sputtering. Before sputtering, it had a very significant undercut, while after 
sputtering, the undercut profile was destroyed and the lift-off was not working. 
Hence, a new lift-off process was developed to replace AZ2070 process. 
Table 5.3 – Lift-off process using AZ2070 
Step Details 
Coat 1. Static dispense – covers approximately 80% of the 
surface with AZ2070. 
2. Spin cycle – ramp up from 0 to 4000 rpm at 20000 rpm/s 
and hold for 60 seconds to obtain 7 μm resist layer 
thickness. 
Soft bake Bake at 110oC on a hotplate for 1 minute and 30 seconds. 
Photolithography Expose on a standard mask aligner for 18 seconds. 
Post bake Bake at 110oC on a hotplate for 1 minute. 
Develop 1 minute and 20 seconds in MF-319 developer with 
continuous agitation. 
Rinse and dry Rinse in deionised (DI) water for at least 30 seconds and 
blow dry with a nitrogen gun. 
Metallisation Deposit Ta2O5 with RF non-reactive sputtering. 
Lift-off Immerse the sample in hot acetone after deposition that 
allows the acetone to attack the resist and lift-off the resist 
with Ta2O5. 
 
 
Figure 5.5 – SEM images of the lift-off from AZ2070 before and after deposition of Ta2O5. 
a) Before sputtering b) After sputtering 
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This newly developed lift-off process used S1818 [143], a positive photoresist 
with a thickness of roughly 1.8 μm, together with LOR10A (lift-off resist) [144], a 
resist used to create undercut with a thickness of 1 μm. The first step was to 
spin-coat LOR10A at 6000 rpm for 30 seconds on to the sample. Then, the 
sample was baked on the hotplate at 150oC for 2 minutes. Follow by, spin-
coating of S1818 at 4000 rpm for 30 seconds and baking at 115oC for 3 minutes. 
After the coating process, the sample was found to have large edge beads with 
bubbles at all the corners of the sample. The bubbles will compromise the bond 
pads during sputtering. Hence, a slight alteration to the coating process was 
done to remove the bubbles at the edge beads. This involved changing the speed 
and duration of the spinning of LOR10A. Figure 5.6 illustrates that the alteration 
of the coating process had removed the bubbles at the edge beads of the CMOS 
chip. Table 5.4 shows the working lift-off process for Ta2O5 that was carried out 
throughout this work. 
 
Figure 5.6 – Photo micrograph of the removal of bubbles from the edge bead of the resist 
S1818 and LOR10A. 
With all the sputtering and patterning developed, Ta2O5 film was successfully 
fabricated on both ISFET array chip and Multi-Corder chip, as can be seen from 
Figure 5.7. Since ISFET array chip has only ISFET sensors, the entire array was 
covered with Ta2O5 film leaving only the bond pads exposed. On the other hand, 
Multi-Corder chip has three different sensors, thus the Ta2O5 film was patterned 
and only deposited on top of the ISFET sensors.  
 
 
a) Before resist optimisation b) After resist optimisation 
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Table 5.4 – Lift-off process using S1818 and LOR10A 
Step Details 
Coat 1. Static dispense – covers approximately 80% of the 
surface with LOR10A. 
2. Spin cycle – ramp up from 0 to 9000 rpm at 2000 rpm/s 
and hold for 60 seconds. 
Soft bake Bake at 150oC for 2 minutes on a hotplate. 
Coat 1. Static dispense – covers approximately 80% of the 
surface with S1818. 
2. Spread cycle – ramp up from 0 to 1000 rpm at 250 rpm/s 
and hold for 5 seconds.  
3. Spin cycle – ramp up from 1000 to 4000 rpm at 
2000 rpm/s and hold for 30 seconds. 
4. Edge bead removal cycle – ramp up from 4000 to 9000 
rpm at 20000 rpm/s and hold for 2 seconds. 
Soft bake Bake at 115oC for 3 minutes on a hotplate. 
Photolithography Expose on a standard mask aligner for 6 seconds. 
Develop 2 minute and 30 seconds in MF-319 developer with 
continuous agitation. 
Rinse and dry Rinse in DI water for at least 30 seconds and blow dry with a 
nitrogen gun. 
Ash 40 W and 3 minutes in barrel asher to remove smaller 
residuals.   
Metallisation Deposit Ta2O5 with RF non-reactive sputtering. 
Lift-off Immerse the sample in hot 1165 resist stripper after 
deposition that allows the stripper to attack the resist and 
lift-off the resist with Ta2O5, leaving the desired pattern on 
top of the CMOS chip. 
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Figure 5.7 – Photo micrograph of the patterning of Ta2O5 sensing layer on top of the CMOS 
chips. 
5.2.1.2 Characteristics 
The functionalities and pH response of the Ta2O5 film on top of the CMOS ISFET 
were characterised with the instrumentation system mentioned in Chapter 4 to 
demonstrate the ability and sensitivity to hydrogen ions. This was done with test 
solutions ranging from pH 1 – 14. These solutions were prepared from 1 M 
hydrochloric acid (pH 0) and 1 M sodium hydroxide (pH 14). Both the acid and 
alkali solution were diluted with DI water to make up pH 1 – 6 (0.1 M to 
0.001 mM hydrochloric acid) and pH 8 – 14 (0.001 mM to 1 M sodium hydroxide), 
respectively. The pH sensitivity was tested by introducing different prepared pH 
solution on top of the ISFET sensor array of a packaged chip. The experiments 
were conducted by adding first alkali or acid and followed by a predefined order 
for consistency. Each pH solution was measured on top of the chip for 
approximately 2 minutes to obtain a stable result. The measurements were 
taken as indicated in Figure 5.8. Between each pH measurement, the chip was 
cleaned with DI water and blown dry with nitrogen gun. To ensure correct 
interpretation, the ISFET sensor array was measured with descending and 
ascending order of pH solution.  
As can be seen from Figure 5.9, the sensitivity of the Ta2O5 film on top of the 
CMOS ISFET was about 45 mV/pH and yields a near linear voltage response 
between pH 2 – 12. The pH sensitivity of the Ta2O5 was less than the potential 
pH sensitivity of 58 mV/pH. There are two reasons that could cause the signal 
loss, which are the non-stoichiometric deposited Ta2O5 film from sputtering and 
a) ISFET array chip b) Multi-Corder chip 
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also the attenuation in the voltage-follower circuit in each pixel. Nevertheless, 
this was also termed as an improvement from the pH sensitivity measurement 
previously done in the MST group, using CMOS ISFET with the default Si3N4 
passivation from the foundry, which was only 20 mV/pH [145]. In addition, the 
standard error of the data population from Figure 5.8 can be analysed to give 
2.6 mV. This was calculated using the standard deviation of each pH trace over 
the three independent measurements that were made with the ISFET array chip. 
Then, the limit of detection of the ISFET sensor can be determined from 3 × 
standard error that was obtained and divided by the pH sensitivity [146], which 
is approximately 0.2 pH.  
 
Figure 5.8 – A representation of differential voltage response of pH test measurements. 
Besides pH sensitivity and wide working pH range, the Ta2O5 sensing film has an 
extra advantage over Si3N4 passivation from the foundry [147], which is the long 
term drift. The drift measurement was done by immersing the chip in 
triethanolamine buffered solution at pH 7.4 for a period of up to 6 hours. The 
drift measurements were taken using an average across the whole ISFET sensor 
array. Figure 5.10 shows the constant signal drift from the Ta2O5 sensing layer on 
one chip. Furthermore, two more chips with Ta2O5 sensing layer were also used 
to measure the drift in the same way, in order to investigate the chip-to-chip 
variation. Each chip was measured three times to take account into the 
variability between different experiments, such as the reference electrode 
position, cleanliness of the chip surface, buffer solutions concentration and 
volume. The deposited Ta2O5 sensing layer on all three chips was from three 
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separate batches of sputtering process, thus this will ensure that the film on top 
of all three chips is not identical. As can be seen from Figure 5.11, the drift of 
three different chips from the same wafer run and different sputtering runs are 
3.1 ± 1.1 mV/hour, 0.1 ± 0.1 mV/hour and 16.3 ± 5.9 mV/ hour respectively. The 
drift from three different chips has an average of 6.5 mV/hour with a standard 
deviation of 8.6 mV/hour. The chip-to-chip variation may not completely be 
affected by the separate sputtering runs, as the multi-project wafer run from 
Europractice also had an effect to the variation. This is because each of these 
chips may locate in different areas on the wafer that leads to the chip-to-chip 
variation, which is uncontrollable. Nevertheless, this has still show that Ta2O5 
sensing film can produce a stable enzyme assay measurement, unlike default 
Si3N4 passivation sensing layers from the foundry that suffer from drift issues. In 
addition, the enzyme assay measurements that were done in this work only 
takes 15 minutes to obtain sufficient data, thus the drift was not a major 
concern.  
 
Figure 5.9 – pH sensitivity of Ta2O5 on top of the ISFET sensors. 
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Figure 5.10 – A representation of drift measurement of Ta2O5 film on top of the CMOS ISFET 
sensors from one of the three chips. 
 
Figure 5.11 – The drift measurements from three different chips with different Ta2O5 sensing 
layer. 
5.2.2 Polyoxometalates 
After the introduction of ISFET and the presentation of pH sensitivity similar to a 
glass electrode, Bergveld believed that by introducing impurities to the sensing 
layer on top of the ISFET, would render the device ion selective. Moss et al. [74] 
demonstrated a potassium selective ISFET, using a chemical membrane made of 
valinomycin/plasticizer/poly(vinylchloride), which was solution casted and cured 
99 
 
on top of the Si3N4/SiO2 passivation of the ISFET. However, valinomycin sensing 
membrane is an organic material that is not compatible with current CMOS 
technology, such as finite thermal stability [135] and poor adhesion [148]. 
Therefore, a potassium sensing membrane that is compatible with CMOS process 
is required. To investigate on CMOS compatible potassium selective ISFET 
sensing membranes, MST group, School of Engineering and Cronin group, School 
of Chemistry, from University of Glasgow join forces to make this a reality. 
Polyoxometalates (POMs) [149], [150] are particularly interesting group of 
molecules which possess an unmatched range of physical and chemical 
properties. They consist of early transition-metal atoms (W, Mo, etc.) in their 
highest oxidation states that link together by oxygen bridges to form a cluster of 
well-defined size and shape. Since they are metal oxide based compounds, this 
makes them more compatible to metal oxide based electronics and holds an 
advantage over pure organic compounds. Moreover, they have high thermal 
stability of around 600oC, which makes them an ideal candidate to be used in 
CMOS process. Another great benefit of POMs is their ability to self-assemble on 
surface without any chemical treatments required. Recently, Busche et al. [151] 
demonstrated that POMs are a candidate to act as storage node for MOS flash 
memory.  
One of the POMs structure is particularly attractive to this work as a potassium 
sensing film for ISFET, which is Li17(NH4)21H2[P8W48O184]·85H2O (abbreviated as 
{P8W48} throughout this work). The {P8W48} anion was first reported by Contant 
and Tézé [152] as a mixed lithium/potassium salt. Boyd et al. [153] from School 
of Chemistry at the University of Glasgow later synthesised a {P8W48} anion with 
lithium and ammonium counter ions, which was used in this work. Figure 5.12 
illustrates the structure of the {P8W48} used in this work. 
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Figure 5.12 – Schematic diagram of {P8W48} anion with four lacunary subunits and the 
respective oxygen atom binding sites [153]. 
The {P8W48} anion comprises four {P2W12} lacunary subunits bridged together to 
form a ring, with all the lacunary sites facing the centre of the ring, creating a 
nucleophilic environment. This exposed, nucleophilic, oxygen surface of the 
inner ring allows specific ions with the right size to bind to the inner surface of 
the ring structure, which in this case are potassium ions. Figure 5.13 shows all 
the binding sites for potassium ions. As can be seen from Figure 5.13a, there are 
eight half-occupied binding sites, located at the bridges of each {P2W12} subunits 
and they are marked as red circles. From these eight possible binding sites, 
potassium ions can only bind to either the one above or below the symmetry 
plane of the molecules, as can be noticed in Figure 5.13b. Other potassium 
binding sites are located in between the nucleophilic faces of the {P2W12} 
subunits, which are marked as yellow. These sites are fully-occupied and located 
in the equatorial belt of the molecules, with four terminal oxygen atoms of the 
exposed lacunary sites coordinate with one potassium ion. Hence, in total 
{P8W48} has eight possible binding sites contain in the cavity of the ring, making 
it selective to potassium ions. 
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Figure 5.13 – Cross-sectional view of all the binding sites of the {P8W48} anion [153]. 
5.2.2.1 Process 
The tetrabutylammonium (TBA) salt of the {P8W48} ion was prepared in advance 
by our collaborator, Cronin Group at the School of Chemistry. In order to make 
the surface of ISFET sensitive towards potassium ions, {P8W48} had to be 
functionalised on top of the passivation layer of the ISFET. The surface 
functionalisation process is similar to valinomycin membrane but it is simpler 
and quicker because it does not required a curing step of 24 hours at 50oC. The 
ISFET passivation surface was functionalised with {P8W48} by drop casting. 10 μl 
of 1g/10ml (TBA){P8W48} in acetonitrile was applied with a Gilson pipette and 
left to evaporate for 10 minutes. This led to a formation of a stable and well-
ordered {P8W48} film on top of a CMOS ISFET chip. 
5.2.2.2 Characteristics 
Similar to characterising the Ta2O5 pH sensing capability on top of ISFET, the 
functionalities and pK responses of the {P8W48} film on top of the ISFET were 
measured with the instrumentation system to demonstrate the potassium ions 
sensing capability. The pK measurements were done with test solutions ranging 
from pK 1 – 3. These solutions were prepared from 0.1 M potassium chloride 
(pK 1) and diluted several times to obtain pK 1 – 3 with a step size of pK 0.5. All 
the solutions were kept at pH 7.4 to ensure that any changes to ISFET signals 
would be corresponded to the concentration of potassium ions. Hence, the 
concentrations of the potassium chloride solutions were 100 mM, 31 mM, 10 mM, 
3.1 mM and 1 mM. The different pK solutions were introduced on top of the 
b) Side view a) Top view 
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packaged CMOS ISFET chip in a predefined order for consistency. The 
experiments were conducted by first introducing DI water, which has no 
potassium ions and followed by pK 3 to pK 1 with a step size of pK 0.5. Each of 
the pK solutions was measured for 1 minute to obtain a stable result.   
In order to determine that the {P8W48} film is sensitive to potassium ions, control 
experiments had to be conducted. Moreover, it is very important to validate how 
sensitive Ta2O5 ISFET sensors towards potassium ions, as the sensors will be used 
for enzyme assays in blood serum which contains various ions such as potassium, 
sodium, calcium, magnesium and etc. These ions will be a factor in interfering 
with quantification of metabolites in an enzyme assay that relies on hydrogen 
ions consumption or production. Before any surface functionalisation with a 
{P8W48} film on top of a CMOS ISFET chip, the chip was characterised with the 
whole range of pK solutions, in order to provide as a control measurement. After 
the surface functionalisation, the same pK solutions were introduced again in 
the same way. Figure 5.14 illustrates the pK measurements using a CMOS ISFET 
chip, without and with {P8W48} film from one experiment as an example.  
 
Figure 5.14 – Potassium ion concentration (pK) measurements without and with POMs layer. 
From Figure 5.14, the control measurement (the plot in black) can be plotted as 
voltage difference versus potassium ion concentration, as shown in Figure 5.15. 
As mentioned previously, Ta2O5 film is selective towards hydrogen ions but the 
Ta2O5 film deposited in our cleanroom had a pK sensitivity of approximately 
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5 mV/pK in the range of pK 1.5 to pK 3, which can be observed in Figure 5.15.  
The slight potassium ion sensitivity that is presented by Ta2O5 film may due to 
the fact that the Ta2O5 film is non-stoichiometric as described previously, as 
opposed to the Ta2O5 film in the literature that exhibits almost zero potassium 
ion sensitivity.  Moreover, it can also be seen that the error bars for each 
potassium ion concentrations is quite large, which are approximately in the 
range between 3 mV to 5 mV. These error bars were taken from three separate 
chips in the same wafer run but different Ta2O5 film sputtering runs. With such 
poor pK sensitivity together with the chip-to-chip variation had made each pK 
levels barely distinguishable, hence this level of pK sensitivity is not sufficient to 
be used for potassium sensing and therefore required an extra layer, in this case 
POMs, to boost the pK sensitivity.  
 
Figure 5.15 – Potassium ion concentration (pK) sensitivity on pure Ta2O5 sensing layer. 
It is important to note that pure Ta2O5 sensing layer on top of ISFET sensor can 
be used to perform enzyme assay in blood serum, which will be explained in 
Chapter 6. Even though the potassium sensitivity is very small but it still had to 
be taken into account when doing measurements with enzyme assays in blood 
serum that involve hydrogen ions sensing. In human blood, most of the potassium 
ions contain in red blood cell (approximately 110 mM or above) and blood serum 
only contains about 1 mM or lower in potassium ions [154]. In spite of the low pK 
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sensitivity, the potassium ions concentration still have to be considered as a 
background analyte that will interfere with the enzyme assay results. There are 
a few important points to be taken into consideration when doing enzyme assays 
with blood serum using pure Ta2O5 film. Firstly, all the dilutions of blood serum 
had to be consistent to make sure that all the enzyme assays had the same 
concentration of potassium ions throughout as a background analyte, which can 
be treated as noise. Furthermore, blood serum are normally diluted to perform 
enzyme assays, where the factor of dilution is 1:100 or higher, thus this will 
reduce the potassium ion sensitivity below 1 mM (pK 3) that is 0.01 mM (pK 5) or 
above. Using the data from Figure 5.15, the linear line showing the sensitivity of 
potassium ions can be extrapolated to pK 5 and above, where the voltage 
difference (y-axis) is approximately 20 ± 4 mV or lower. Moreover, the standard 
error from the data population, which is 2.4 mV, had to be taken into account. 
With 3 × standard error and chip-to-chip variation, any potassium ion 
concentration from 0.01 mM and below is nearly at the noise floor of the ISFET 
sensor. Therefore, this made the potassium ion concentration in the blood serum 
almost negligible when doing enzyme assays using ISFET sensors with Ta2O5 
layer.  
In the same way, the pK measurements with a {P8W48} film on top of CMOS ISFET 
chip was repeated, which can be seen in Figure 5.14 as the plot in red. Using the 
same three chips as mentioned before, they were drop casted with POMs from 
three different preparations to take account into both chip-to-chip variation and 
the tolerance of POMs preparations. Using these data, they can be plotted as 
voltage difference versus potassium ion concentrations, as shown in Figure 5.16. 
Using an average linear fitting through the data in Figure 5.16, it can be found 
that the pK sensitivity of ISFET with {P8W48} layer improves to 80 mV/pK in the 
range between pK 1 to pK 3.This pK sensitivity had shown to extend beyond 
Nernstian response, which is named as super-Nernstian. To date, there is still no 
satisfactory explanation for this behaviour. A recent investigation by Wildi et al. 
had shown that super-Nernstian shift will occur if the plane of proton-electron 
transfer event does not coincide with electrode surface [155]. By separating the 
plane of hydrogenation and the OHP, the magnitude of the super-Nernstian shift 
will be affected. In this case, it was believed that the POMs layer is acting as a 
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plane to provoke such an additional voltage shift and provided an increment of 
sensitivity towards potassium ions. 
 
Figure 5.16 – Potassium ion concentration sensitivity using Ta2O5 ISFET sensor with POMs. 
However, the pK sensitivity from Figure 5.16 is the summation of both pure 
Ta2O5 film and {P8W48} layer. Therefore, using a simple equation below will give 
a new sensitivity calculation that is contributed to only {P8W48} layer: 
 ∆𝑉 𝑝𝐾⁄⏟    
𝑛𝑒𝑡 𝑠𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦
= 𝑉 𝑝𝐾⁄
𝑃𝑂𝑀
− 𝑉 𝑝𝐾⁄
𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
5.1 
Hence, the net sensitivity of {P8W48} towards potassium ions was obtained, which 
was calculated to be 75 mV/pK, with a range in between 1 mM (pK 3) to 100 mM 
(pK 1). This had provided a demonstration that a {P8W48} film can be used as an 
alternative to valinomycin membranes as a potassium sensing membrane on top 
of a CMOS ISFET chip. In addition to pK sensitivity, the limit of detection of 
Ta2O5 ISFET with POMs layer was also extracted from the data. Using the trace 
from each pK concentration, a standard error was calculated and it was found to 
be 2.1 mV. Taking 3 × standard error and multiply by the sensitivity, it was 
determined to be 0.1 pK, which means that the Ta2O5 ISFET with {P8W48} layer 
could resolve a step of 0.1 pK. Furthermore, it is also important to note that the 
voltage shift at low concentration of potassium ions between pure Ta2O5 layer 
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and {P8W48} film is almost identical (refer to Figure 5.14). As mentioned 
previously, any low concentration of potassium ions will be reaching the noise 
floor of the ISFET sensor and render them undetectable and negligible. Since the 
physiological level of potassium ions is around 110 mM in red blood cells, thus 
diagnosis of potassium ions level in red-blood-cell level is a better indication 
than commonly used blood serum [154]. Therefore, this will take advantage of 
the increment pK sensitivity that {P8W48} film could provide if the diagnosis of 
potassium ions level is using red blood cells with minimal dilution.  
In addition to demonstrating {P8W48} film is super sensitive to potassium ions 
level, it is also very important to investigate what effect it would give to 
hydrogen ions. The three chips that were used for potassium ions detection were 
cleaned with acetonitrile to dissolve {P8W48} film and tested for hydrogen ions 
sensing for consistency. All these chips were then cleaned with methanol, IPA, DI 
water and finally blown dry with nitrogen gun, to be reused for the subsequent 
experiments. As described previously, solutions with pH 4, pH 3, pH 2.5 and pH 2 
were prepared using HCl titration, where the potassium ions concentration was 
kept constant. Each of the pH solutions were introduced on top of ISFET with 
pure Ta2O5 film in a descending order, then followed by drop casting a layer of 
{P8W48} on top and introduced the same pH solutions in the same order. Each pH 
solution was measured for 1 minute to give a stable result. These pH 
measurements (without and with POMs layer) can be seen in Figure 5.17 as a 
representation from one of the chips.  
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Figure 5.17 – pH measurements on top of ISFET sensors without and with POMs layer from 
one chip. 
From Figure 5.17, the control experiment (plotted in black) can be plotted as 
voltage difference versus pH levels, which can be observed in Figure 5.18. As can 
be noticed, after the treatment of {P8W48} film on top of the ISFET sensors, it 
deteriorated the pH sensitivity of the Ta2O5 film surface. The pH sensitivity of 
Ta2O5 ISFET sensor was approximately 25 mV/pH in the range between pH 2 to 
pH 4. The reason of the low pH sensitivity may be due to the fact that {P8W48} 
changes the surface properties of Ta2O5 to be less oxygen rich, which in turn 
reduces the sensitivity. However, this pH sensitivity was sufficient to evaluate 
the behaviour of ISFET sensor on sensitivity towards hydrogen ions when POMs 
film was added on top of Ta2O5. In the same way, the plot in red from Figure 
5.17 is plotted for voltage difference versus pH levels as well, which is shown in 
Figure 5.19. It can be noted that the pH sensitivity of Ta2O5 ISFET sensor with 
{P8W48} layer on top is around 20 mV/pH in the range between pH 2 to pH 4. 
Using the Equation 5.1, the net sensitivity of the sensor with POMs is -5 mV/pH. 
There was a slight decrement in pH sensitivity when {P8W48} layer was added on 
top of the sensor. From this observation, there are four aspects to be 
considered. First and foremost, {P8W48} layer may prevent some hydrogen ions 
from getting to the plane of hydrogenation and impede the proton-electron 
transfer, which explains the slight pH sensitivity lost after the introduction of 
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POMs film. Second, the fact that the pH sensitivity from CMOS ISFET sensor is 
deteriorating with prolonged usage, which can also be used to explain the 
sensitivity lost after POMs film. Furthermore, the POMs layer did not suppress 
the ISFET sensitivity to hydrogen ions and completely selective to potassium 
ions, thus it is very important to always have a reference of pure Ta2O5 ISFET to 
be used with Equation 5.1 to determine the net change of potassium ions. 
Lastly, since human blood from different individuals ranges from pH 7.35 to pH 
7.45 and the POMs ISFET sensor cannot cancel of pH sensitivity, thus a 
background pH will always be present. Therefore, control is required to be next 
to the POMs layer to be taken as reference, when taking measurement with any 
sample. In conclusion, these experiments had shown that {P8W48} film does not 
give rise to any increment in pH sensitivity or potentially reduce the pH 
sensitivity, at the same time increases the sensitivity towards potassium ions.  
 
Figure 5.18 – pH sensitivity of Ta2O5 ISFET sensor. 
109 
 
 
Figure 5.19 – pH sensitivity of Ta2O5 ISFET sensor with POMs layer. 
Apart from hydrogen ions, there are a lot of other ions to be considered that are 
freely available in human blood, before it can be concluded that POMs layer has 
selectivity towards potassium ions only. One of the most dominant electrolytes 
in human blood is sodium ions, which stands about 85% in human body. The 
physiological concentration of sodium ions in human blood serum is around 
140 mM, whereas the concentration of sodium ions in red blood cells is only 
about 40 mM [156]. With low sodium concentration in red blood cells further 
indicated that red-blood-cell potassium level is the proper approach, due to its 
high in potassium ions and low in interfering sodium ions. However, since blood 
serum measurement is the most common method of inspecting physiology of an 
individual, it would be great if potassium ions sensing and metabolites detection 
can be integrated into one blood serum sample measurement. Therefore, it is 
important to inspect the effect of POMs layer towards high concentration of 
sodium ions as interfering ions. In order to do this, the same pK dilution was 
prepared in a 140 mM NaCl solution as a constant background and maintains all 
the dilutions at pH 7.4. In the same way that was described previously, the 
different pK dilutions were introduced on top of the Ta2O5 ISFET sensors as 
control and POMs coated Ta2O5 ISFET sensors, as can be seen in Figure 5.20. All 
of the measurements were repeated in three different chips from the same 
wafer run with different Ta2O5 sputtering run. 
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Figure 5.20 – pk measurements with the presence of 140 mM NaCl on top of ISFET sensors 
with Ta2O5 film  
By observing the experimental curves from Figure 5.20, it can be deduced that 
high concentration of NaCl interferes and reduces the voltage signal of the ISFET 
sensors significantly for all pK solutions. At low potassium ion concentration, the 
ISFET voltage signal was not detectable. Whereas, at high potassium ion 
concentration, ISFET voltage signal manage to give a slight observable shift.  
Furthermore, the noise level of the ISFET sensors was taken as standard error 
across the data population, which was 1.8 mV. This agrees well with the 
standard error that was extracted from the previous experiments, which means 
that high concentration of NaCl did not increase the noise level of the device. 
Follow by that, data from Figure 5.20 is further plotted as voltage difference 
versus potassium ion concentrations for both control and POMs experiments, as 
shown in Figure 5.21 and Figure 5.22 respectively. From Figure 5.21, it can be 
seen that the potassium ions sensitivity of pure Ta2O5 ISFET sensors was only 
8 mV/pH. This sensitivity is as expected from Ta2O5 surface that was fabricated 
from our cleanroom and it agrees well with previous experiments. However, this 
level of sensitivity can only be observed between pK 1 to pK 2, which is very high 
potassium ions concentration. Due to high NaCl concentration as interfering ions, 
voltage signal from ISFET was quenched. On the other hand, potassium ions 
sensitivity was increased to 15 mV/pH, when a layer of POMs was drop casted on 
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top of Ta2O5 ISFET sensors. However, this sensitivity is only observable in the 
range between pK 1 to pK 2 as well. Furthermore, the pK sensitivity that POMs 
layer offered to ISFET sensors was significantly reduced, in the presence of high 
concentration of NaCl. 
The significant ISFET voltage drop may due to a layer of salt forming on top of 
the surface of the sensor (without or with POMs film), when a high sodium ion 
concentration is present. From these finding, it can be concluded that the 
{P8W48} layer was not sufficient to present the required selectivity and sensitivity 
of potassium ions to be used in blood serum measurements. Further studies into 
the modification of {P8W48} can be investigated to increase the sensitivity and 
selectivity of potassium ions, in order to demonstrate a single platform 
measurement that could extract a lot of physiology information from one type of 
sample. 
 
Figure 5.21 – pK sensitivity in the presence of 140 mM NaCl on top of pure Ta2O5 ISFET 
sensors. 
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Figure 5.22 – pK sensitivity in the presence of 140 mM NaCl for POMs treated Ta2O5 ISFET 
sensors. 
5.3 Microfluidics 
In order to provide multiple metabolites measurements on chip that will lead to 
metabolome, microfluidics offers such capability to do so. Microfluidics is a 
technological system that could manipulate small amount of fluids in channels 
with dimensions of tens of micrometres [157]. It offers a low cost method to 
provide separation of each metabolite measurements on top of a CMOS chip 
without any cross-contamination and high throughput metabolites detection. 
Furthermore, microfluidics is also required to direct the fluids to the location of 
the enzymes to perform enzymatic reaction for metabolites quantification using 
the sensors. In order to fulfil such requirements in this work, the epoxy-based 
photoresist SU-8 was used to fabricate micro-channels on top of the CMOS chips. 
5.3.1 SU-8 
SU-8 is an epoxy-based, negative photoresist with thick and high aspect ratio 
resist structure, which is originally developed by IBM [158]. It is a very popular 
structural material in the field of MEMS [159] and microfluidics [160]. Its most 
distinctive characteristic is the ability to use a conventional spin coater to 
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obtain a film thickness from the range of 750 nm to 450 μm in a single coat. 
Normally SU-8 is exposed with a near ultraviolent (350 – 400 nm) radiation. This 
resist has a very high optical transmission in the ultraviolent region, which is 
very important in obtaining an outstanding high aspect ratio feature and vertical 
sidewall.  
SU-8 is a multifunctional molecule that consists of 8 epoxy groups (the “8” in SU-
8) in a hydrocarbon (ether), together with a photoacid generator (triarylium-
sufonium salts) [161]. During the ultraviolent illumination, the photoacid is 
photochemically generated in the photoresist film. A post exposure bake is then 
used for the cross-linking mechanism in SU-8 and the produced photoacid acts as 
a catalyst for the process. During the cross-linking, the epoxy groups form a 
highly cross-linked three-dimensional network and shrink the film to make it 
denser. In addition, the hydrocarbon compound provided the cross-linked SU-8 a 
high resistance towards many solvents and thermal stability. This makes SU-8 
well-suited for the fabrication of microfluidics in this work, where the material 
has to be chemically stable and resistant, which is non-reactive to the any 
enzymatic reactions.  
In this work, SU-8 3000 series was selected to fabricate microfluidic channels on 
top of a CMOS chip. The 3000 series has been formulated to be the improvement 
from SU-8 and SU-8 2000 series, which has better adhesion and reduced coating 
stress. The key criteria for fabricating microfluidic channels on top of a CMOS 
chip is to have good isolation from each channels to avoid cross-contamination.  
5.3.2 Micro-Fabrication Process 
The SU-8 microfluidic channels fabrication process is shown in Figure 5.23. The 
fabrication of SU-8 microfluidic channels on top of a CMOS chip was according to 
the recommended guidelines from the datasheet [162]. In order to obtain 
maximum process reliability, CMOS chips were cleaned (with acetone, 
isopropanol and DI water) and blown dry with nitrogen gun. For even better 
performance, it is recommended to clean with piranha wet etch (using H2SO4 and 
H2O2) but the aluminium bond pads on the CMOS chips would be damaged by this 
wet etch cleaning. Hence, piranha etching was avoided. After cleaning, the 
surface of the CMOS chip was dehydrated by baking in an oven at 180oC for 5 
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minutes and followed by cleaning with barrel asher supplied with O2 plasma for 5 
minutes at maximum power (Figure 5.23a).  
 
Figure 5.23 – Schematic diagram of SU-8 microfluidic channels fabrication process.  
After O2 ashing, a thick layer of SU-8 3025 was dispensed on to the CMOS chip 
and spin-coated at 2000 rpm for 30 seconds with a ramp up acceleration of 
1000 rpm/s. Before the spin cycle, the CMOS chip went through a spread cycle 
where it was spun at 1000 rpm for 5 seconds with a ramp up acceleration of 
250 rpm/s. Furthermore, before the end of the spin cycle, the CMOS chip was 
spun at 9000 rpm for 2 seconds with a ramp up acceleration of 20000 rpm/s, in 
order to reduce the edge bead size at the corners of the chip. Then the CMOS 
chip was baked on a hotplate at 65oC for one minute and then transferred to 
another hotplate at 95oC to carry out a soft bake for approximately two hours. 
The soft baking time depends on the size of the sample, where the smaller the 
sample, the longer the baking time or vice versa. The lower temperature bake 
before the actual soft bake is to prevent internal stress that can lead to cracked 
features and also to allow the solvent to evaporate in a more controllable way to 
have better resist adhesion. After the soft baking, the sample was transferred 
back to a 65oC hotplate for a minute before removing it and was left to cool 
down at room temperature (Figure 5.23b).  
The SU-8 resist on top of the CMOS chip was exposed with ultraviolent light for 
75 seconds using a standard mask aligner. The long soft baking step is crucial 
a) Substrate cleaning b) SU-8 coating c) UV exposure 
d) Development e) Top lid attachment 
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when the mask and the sample come in contact (Figure 5.23c). If the solvent 
was not properly evaporated, the mask will stick to the resist and make the 
alignment impossible. After the exposure, the CMOS chip was again baked on a 
hotplate at 65oC for one minute, followed by a 95oC bake for 5 minutes and 
finally back to 65oC for another minute. This is the same technique used for the 
soft bake. The CMOS chip was then developed with Microposit EC solvent for 9 to 
10 minutes, depending on the resist thickness and edge beads, with continue 
agitation (Figure 5.23d). Then the CMOS chip was rinsed with isopropanol. When 
the development was done and produced good microfluidic channels, the CMOS 
chip was hard baked in an 180oC oven for two hours. The final hard bake step 
will make the microfluidic channels very robust and extremely difficult to 
remove.  
5.3.3 Evaluation  
The fabricated SU-8 microfluidic channels on top of the CMOS chips were not 
completely seal. This is to allow immobilisation of enzyme in each channel 
before a top lid was used to cover the channels, providing isolation from each 
channel (Figure 5.23e). Figure 5.24 shows the SU-8 microfluidic channels 
fabricated on top of the CMOS chips.  
 
Figure 5.24 – Photo micrograph of SU-8 microfluidic channels on top of the CMOS chips. 
After the packaging and encapsulation of the CMOS chip, the microfluidic 
channels are ready to be tested. To test the isolation of liquids from each 
channel, a surfactant free hydrophilic fluid transport film with transfer adhesive 
tape was used to bond the top lid on top of the SU-8 channels. The transport 
b) Multi-Corder Chip a) ISFET array chip 
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film is optically clear, insoluble in water and non-leaching inert hydrophilic 
coating for capillary fluids transport. Using a pipette, a tiny amount of DI water 
was introduced at one of the open end of the channels and let the fluids to flow 
through the channels. Figure 5.25 illustrates the video images taken using a 
microscope showing the functionalities of the SU-8 channels. As can be seen, the 
top lid and the SU-8 channels have a good seal, which provided a capillary force 
and dragged the liquids into the channels. Moreover, each of the channels had 
no liquids in it until the channels opening were introduced with liquids. Hence, 
this had demonstrated that the SU-8 microfluidic channels on top of a CMOS chip 
can provide good channel isolation and fluids manipulation for the enzymatic 
work, which will be discussed in later Chapters.  
 
Figure 5.25 – Photo micrograph of the fluids flow into the SU-8 microfluidics channel after 
the bonding of a top lid.  
5.4 Packaging 
All the CMOS chips that returned from the foundry and after post-fabrication had 
to be packaged onto a chip carrier to enable access to the bond pads. Moreover, 
all the metabolites and enzymes are in aqueous solution, which requires all the 
electrical connections of the CMOS chip to be well-insulated while leaving the 
surface of the sensors area expose to wet environment. These are the main 
criteria for packaging. The following discussions will explain the chip carrier 
used to house the CMOS chip and also various encapsulation methods to provide 
a waterproof CMOS chip. 
a) Introduction of liquids at the open 
inlet 
b) Liquids flow into the channel 
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5.4.1 Housing 
All the CMOS chips, both ISFET array and Multi-Corder, were packaged in 
Ceramic Pin Grid Array (CPGA) packages from the Company Spectrum 
Semiconductor Materials Inc [163]. They are the largest independent World Wide 
Distributor of packages and lids for IC assembly. The CPGA through-hole mount 
package has a ceramic substrate to enhance thermal heat dissipation. The 
packages offer excellent electrical performance with the gold-plated pins brazed 
in a matrix pattern underneath the package, in order to insert the package into 
a socket. More importantly, the enzymatic reaction is very sensitive towards 
temperature change, thus this package offers a good heat dissipation capability 
to prevent the heat from the CMOS chip to build up and ruin the measurements. 
Since the number of bond pads for ISFET array chip and Multi-Corder chip is 
different, thus two different chip packages were obtained from the company. 
For ISFET array chip, the package contains 144 pins, a cavity of 10.8×10.8 mm, a 
pitch size of 2.54 mm and brazed in a 15×15 matrix. For Multi-Corder chip, the 
package contains 120 pins, a cavity of 8.3×8.3 mm, a pitch size of 2.54 mm and 
brazed in a 13×13 matrix. Figure 5.26a and b shows the top and bottom view of 
the ISFET array chip package, while Figure 5.26c and d shows the top and 
bottom view of the Multi-Corder chip package. As can be seen from Figure 5.26b 
and Figure 5.26d, there is an extra pin in both packages, which allows 
orientation guidance for the placement of the package into a socket. To mount 
the bare CMOS chips on to the chip carrier, EPO-TEK H74 epoxy [164] from Epoxy 
Technology Inc. was used on the back-side of the chip and glued on top of the 
chip carrier. This epoxy has a good thermal conductivity that allows heat to be 
transferred to the chip carrier easily. Then the CMOS chips were wire bonded 
following the specifically designed bonding diagrams. The wire bonding of the 
bond pads to the chip package was done using the Hesse and Knipps 710 
ultrasonic wire bonder, which is located in the School of Physics and Astronomy 
at the University of Glasgow.  
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Figure 5.26 – CPGA chip carrier for both ISFET array and Multi-Corder chips.  
5.4.2 Encapsulation 
In order to ensure an electrically well-insulated and waterproof CMOS chip for 
experiments with aqueous solution, a few methods were used in this work. 
Figure 5.27 shows the different three methods that were explored in this work 
for encapsulation. The following will describe each of the methods. 
 
Figure 5.27 – Three different encapsulation techniques.  
a) ISFET array package top view b) ISFET array package bottom view 
c) Multi-Corder package top view d) Multi-Corder package bottom view 
a) Dam and fill (glob top) b) PDMS c) Manual dam and fill 
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Glob top based dam and fill 
The packaging of the CMOS chips were initially outsourced to a company, Sencio, 
located in Nijmegen, the Netherlands [165]. They are an independent package 
design and assembly company. Using a dam and fill technique, a high viscosity 
fluid was dispense in between the sensor array and the bond pads, creating a 
wall that will prevent the filling material from entering into the dam. Then, a 
filling material with excellent chemical resistance was used to encapsulate the 
wire bonds and bond pads completely. This allows the CMOS chips to function 
without any disruption of the circuit operations. Figure 5.27a shows the 
packaging that was done by the Dutch company. In order for the company to 
provide good encapsulation, the die attachment and wire bonding were also 
done by them. 10 bare CMOS chips were packaged by the Dutch company and it 
turned out that the material they used to create the dam is porous, which allows 
liquids to flow pass the encapsulation and destroy the chips. In addition, the 
services from the company are quite expensive and also they do not handle 
CMOS chips that had already been post-processed. Hence, this method was 
abolished to investigate for a home-made method. 
Polydimethylsiloxane (PDMS) 
PDMS is an elastomeric material that was developed for the applications in 
microfluidics [166]. PDMS has an ability to make reversible van der Waals 
contact (conformal contact) to smooth surfaces. This makes PDMS demountable 
when it is bonded on to a surface. In this work, PDMS was used as a packaging 
material where a PDMS cube was placed on top of the sensor array. This provides 
a protection from any encapsulation material from the sensors area. Then EPO-
TEK 302-3M epoxy [164] was used to encapsulate the bond pads and wire bonds. 
The epoxy was left to cure at room temperature for 24 hours. This long room 
temperature curing time is to eliminate the possibility of the epoxy to flow 
under the PDMS cube, where high temperature causes the viscosity of the epoxy 
to reduce. Finally, the PDMS was peeled off, leaving no markings on the sensors 
area and creating a cavity around the sensor array. This PDMS encapsulation 
technique is the best and simple method that was developed and it was used to 
package most of the CMOS chips throughout this work. Figure 5.27b illustrates 
the CMOS chip packaged with PDMS method.  
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Manual dam and fill 
An alternative method was also used, which is a handmade dam and fill 
encapsulation. This method was mainly used to package CMOS chips that do not 
have smooth surface, such as CMOS chips with SU-8 microfluidic channels. A very 
viscous, short curing time, watertight seal and non-porous material, Aquaria 
transparent silicone sealant from Geocel, was used to create a dam around the 
sensor area. The silicone sealant was applied in between the sensor array and 
the bond pads, which was on top of the SU-8 wall. Then, EPO-TEK 302-3M epoxy 
was used to encapsulate all the wire bonds and bond pads, as described 
previously. Figure 5.27c shows the encapsulation technique that was done 
manually.  
A final step in the packaging of the CMOS chips for wet chemistry experiments is 
to attach a ring surrounding the sensor array, two examples of the fully 
packaged CMOS chips are shown in Figure 5.28. Different sizes of rings were 
catered to different type of experiments. For example, 2D printing experiments 
required a short ring to fit under the printing nozzles, which will prevent the 
print head from crashing onto the ring. It was attached on the CMOS chip 
carriers using EPO-TEK-302-3M. These rings can be a cut Fisherbrand test tube or 
a 3D printed polylactic acid ring. These rings were used to contain all the liquids 
on top of the sensor array and prevent the liquid from leaking out of the chip 
carrier that will go on top of the underlying electronics on the PCB.  
 
Figure 5.28 – Photographs of two chips that are fully packaged and ready for experiments. 
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5.5 Summary 
A few post-processing techniques had been developed on CMOS ISFET to improve 
the sensitivity towards hydrogen and potassium ions. To improve the hydrogen 
ions sensing of CMOS ISFET, a Ta2O5 film was deposited on top of the sensor 
array. While the potassium ions sensing of CMOS ISFET was improved using an 
inorganic film called POMs to demonstrate the capability. Furthermore, 
microfluidic channels were used to segregate the sensor array to provide 
multiple metabolites measurements. This was done with SU-8 photoresist and an 
adhesive top lid, which had good isolation from each channel and well 
directional liquids flow on top of the sensors. Finally, several methods had been 
developed to package the CMOS chip for the use in metabolites experiments. 
This includes glob top based dam and fill, PDMS and manual dam and fill. After 
the post-processing of the CMOS chip, the next step will be to measure 
metabolites on top of the integrated sensor array chip.  
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Chapter 6 : Metabolite Quantification 
on Chip 
6.1 Introduction 
The previous chapter focused on chip post-processes for ultimately quantifying a 
number of metabolites produced by physiologically important enzyme assays. 
This chapter describes the experiments of several enzyme assays to be measured 
using the ISFET array chip including: the discovery of spatial noise reduction 
techniques using an array format; the design of a buffer system to maximise 
sensitivity and responsiveness on the ISFET; spectrophotometric enzyme assays 
are performed to verify the enzyme activity before transferring the assays to 
ISFET or PD devices; the demonstration of ISFET chip’s ability to quantify four 
different metabolites (glucose, pyruvate, urea and triglyceride); and finally a 
description of the enzyme kinetics calculation used to quantify relative 
metabolite levels from the data obtained from ISFET. In addition, this chapter 
will also describe an optical quantification of one metabolite (cholesterol) 
measurement using the PD sensor array on Multi-Corder chip, together with its 
enzyme kinetics calculation.  
6.2 Metabolite Sensing on ISFET 
Both the ISFET array chip and the Multi-Corder chip contain the ISFET sensor, 
together with an enhanced capability from post-processing and a complete 
instrumentation system for each chip. The next step is to demonstrate the 
possibility to measure changes in hydrogen ion concentration as a result of an 
enzymatic reaction. This includes: using the average data from the array of 
sensors to reduce noise, enzyme buffer investigation, quantification of different 
metabolites and a derivation of enzyme kinetics.  
The enzyme assays were mainly done on the ISFET array chip as it was the first 
chip to return from the foundry. In addition, the ISFET sensors on Multi-Corder 
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chip required further post-processing due to a thick passivation layer 
(approximately 7 μm) on top of all the ISFET sensors, which was not specified in 
the foundry’s datasheet. With such a thick passivation layer, the sensitivity of 
the ISFET sensors would be reduced (refer to Section 3.4). Hence, all the data 
that will be presented in the following discussions were from 256×256-pixel 
ISFET array chip. 
6.2.1 Averaging Noise Reduction 
Ensemble averaging is a potent method to improve signals if measurements are 
taken for several times and averaged. Using this method, the signals will 
accumulate while the noise will cancel itself. A criterion for ensemble averaging 
to function correctly is that each measurement has to be repeated with same 
experimental conditions, in order to obtain a consistent signal. An advantage of 
using a sensor array is that it allows a set of identical independent biological or 
chemical reactions to be analysed from a single sensor and also from an average 
of several sensors. Using the ISFET array chip, all the data sets that were 
collected from each sensor pixel were independent from each other. Hence, the 
obtained data from the chip could be taken from just one pixel or from an 
average of 2 to 216 pixels. Using this spatial averaging technique for an array of 
ISFET sensors reduced the mean square (MS) noise of the combined enzyme assay 
signal. Figure 6.1 illustrates a typical signal obtained from the chip for a small 
concentration of glucose as a function of time. As evident, the data obtained 
from one single ISFET sensor, gives an extremely high background noise (data in 
black colour). On the other hand, if the ensemble data obtained from all 216 
ISFET sensors was averaged, there was a significant noise reduction (data in red 
colour). 
In order to understand the characteristic of the spatial averaging effect that 
reduces the noise, the voltage signal from any single sensor pixel in the array 
including its noise component, Vi can be calculated for its MS voltage noise ei
2 
using the equation below: 
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𝑒𝑖
2 =
1
𝑡2 − 𝑡1
∫ 𝑉𝑖
2(𝑡)𝑑𝑡
𝑡2
𝑡1
 6.1 
The voltage signal was taken in the interval from time t1 to t2, which is the 
region in the data where the voltage signal is not changing. When a number of 
independent sensor pixels, N, is taken as an average, the average voltage signal 
can be calculated using: 
 
𝑉𝑁 =
1
𝑁
∑𝑉𝑖(𝑡)
𝑁
𝑖=1
 6.2 
 
Figure 6.1 – The comparison of voltage signals obtained from one typical ISFET sensor and 
the average of all ISFET sensors.  
Hence, the noise for the average voltage signal, VN(t) can be calculated using 
Equation 6.1. Using both Equation 6.1 and 6.2, the MS voltage noise was 
calculated for 1, 5, 25, 125, 625, 3125, 15625 and 65536 number of sensor 
pixels. The obtained results from these calculations were plotted as a function 
of 1 √N⁄ , which is shown in Figure 6.2.  
As can be seen from Figure 6.2, signal averaging from the array reduces the 
noise by a factor of √N and the graph is quite linear. From this analysis, it was 
noticed that a determination on the number of sensor pixels required to perform 
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good measurements for the chosen assay conditions could be made. This is 
crucial when using microfluidic channels, in which several sensor pixels will be 
averaged to obtain a reliable data. 
 
Figure 6.2 – The relationship between the MS noise, ei
2 and 1 √N⁄ , where N is the number of 
sensors. 
Furthermore, it is possible to program a number of sensor pixels used to target 
different metabolite concentrations. If a targeted metabolite concentration is 
too low, more sensor pixels can be used to reduce the noise further so as to 
obtain an observable signal shift. 
Table 6.1 – Physiological range of glucose levels in different body fluids 
Body Fluids 
Glucose Levels (mM) 
References 
Normal Diabetic 
Blood 3.89 – 5.56 7 and higher [167], [168] 
Tears 0.06 – 0.34 0.4 – 1.44 [168] 
Saliva 0.33 – 0.35 0.59 – 0.63 and higher [169] 
Urine 0.1 – 0.5 2.78 – 5.55 [170] 
Sweat 0.28 - 1.11 - [171], [172] 
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Sometimes a metabolite is found at different physiological concentrations in 
different body fluids. Table 6.1 shows an example of the physiological range of 
glucose concentration in different biofluids. Therefore, an array chip offers a 
mean to improve the signal for measuring the metabolite concentration in 
different body fluids.  
6.2.2 Buffer Systems  
It is vital for an enzymatic reaction to proceed at an optimal pH. Enzymes work 
within different optimal pH ranges and this has to be maintained to allow the 
enzymes to remain catalytically active. Enzyme assays routinely employ a buffer 
system to sequester proton fluxes in order to maintain a steady pH. Since the 
ISFET is a device that measures the change in hydrogen ions production or 
consumption, a high concentration buffer system could inherently limit the 
biosensor sensitivity. This is a particular challenging problem when measuring 
enzymes whose reactions produce or consume protons. Therefore, the optimal 
concentration of the buffer employed is vital in maintaining a balance between 
optimal pH and sensitivity of protons detection.  
Before testing the ability of the ISFET chip to detect proton changes from 
enzymatic reactions, the ISFET was used to understand how buffer concentration 
affected the ISFET sensitivity.  A buffer system can be classified into an acid 
buffer or an alkali buffer. An acid buffer commonly consists of a mixture of a 
weak acid (HA) and its conjugated base (A-), which has both acidic and basic 
species to neutralise OH- and H+ respectively, thus maintaining a steady pH. For 
example, if a strong base is added to a buffer, the weak acid will give up its H+ 
to counteract with the OH- to transform into H2O and maintain the pH: 
 𝑂𝐻− + 𝐻𝐴 → 𝐴− + 𝐻2𝑂 6.3 
On the other hand, if a strong acid is added to a buffer, the weak base will react 
with the acid to transform into weak acid (HA) and maintain the pH: 
 𝐻𝐶𝑙 + 𝐴− → 𝐻𝐴 + 𝐶𝑙− 6.4 
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When either the HA or A- has been used up, then the buffer system will lose its 
capability to maintain a steady pH. Hence, the effectiveness of a buffer depends 
on the concentration of HA and A-. 
To test this on the ISFET, 50 mM sodium phosphate buffer, 5 mM of sodium 
phosphate buffer and DI water were tested in a 1 ml volume, together with an 
injection of 1 M HCl acid solution, as shown in Figure 6.3.  
 
Figure 6.3 – Effectiveness of buffering capacity for different solutions. 
The addition of 5 μl of HCl did not exceed the buffering capacity of 50 mM 
sodium phosphate buffer, as a result of the ability of the buffer to sequester the 
excess protons produced by the complete dissociation of HCl in water. The 
buffer was again treated with another 5 μl of HCl and with a continued 
sequestration of the protons. Hence, the rise in signal from ISFET is transient 
before dropping back to the original pH (Figure 6.3a). However at the lower 
5 mM sodium phosphate buffer, an addition of 20 μl of HCl was all that was 
c) DI water 
b) 5 mM sodium phosphate buffer a) 50 mM sodium phosphate buffer 
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required to break the buffering capacity and reduce the pH. Therefore, the 
signal from the ISFET remains at a higher voltage (Figure 6.3b). DI water does 
not have any buffering capacity: an addition of 10 μl of HCl will release more 
protons and drop the pH dramatically. Hence, the signal from the ISFET rises and 
maintains at an even higher level compared to low buffer concentration (Figure 
6.3c). These experiments show that a lower buffer concentration would be less 
effective in sequestering protons, leading to a higher signal from enzyme 
reactions to be measured on ISFET. However, if the pH changes from the enzyme 
reactions go beyond the optimal pH at a lower buffer concentration, then 
enzyme activities would be reduced. Therefore, the enzyme assays had to be 
well developed in a suitable buffer concentration. 
As ISFET detection sensitivity could potentially be augmented at reduced buffer 
concentration, a stepwise approach was taken to understand each enzyme assay. 
Hexokinase was first chosen to illustrate this effect. Before measuring 
hexokinase assay on ISFET, a spectrophotometer was first used to investigate the 
reaction. In order to measure glucose using hexokinase spectrophotometrically, 
a coupled reaction with glucose-6-phosphate-dehydrogenase (G6PDH) enzyme 
was adopted (see Section 3.2.2.2). A product of the reaction, β-NADPH, can be 
measured by spectrophotometry at a defined wavelength (340 nm). The 
reactions are given below: 
 
𝐷 − 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 + 𝐴𝑇𝑃
𝐻𝑒𝑥𝑜𝑘𝑖𝑛𝑎𝑠𝑒
→        𝐷 − 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 − 6 − 𝑃 + 𝐴𝐷𝑃 + 𝐻+ 
𝐷 − 𝐺𝑙𝑢𝑐𝑜𝑠𝑒 − 6 − 𝑃 + 𝛽 − 𝑁𝐴𝐷𝑃
𝐺6𝑃𝐷𝐻
→    6 − 𝑃𝐺 + 𝛽 − 𝑁𝐴𝐷𝑃𝐻 + 𝐻+ 
6.5 
where ATP is adenosine 5’-triphosphate, D-Glucose-6-P is d-glucose-6-phosphate, 
ADP is adenosine 5’-diphosphate, β-NADP is β-nicotinamide adenine dinucleotide 
phosphate and 6-PG is 6-phospho-d-gluconate. 
ATP and β-NADP are essential components for hexokinase assay and both are 
acidic (below pH 5). If the buffering capacity has been exceeded, as for the case 
of low buffer concentration or DI water, the addition of ATP or β-NADP would 
reduce the pH below the optimal pH for hexokinase, rendering the enzyme 
inactive. It was found that this problem was circumvented by adjusting the pH of 
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ATP and β-NADP solutions to physiological pH prior to being used in the 
hexokinase assay. Figure 6.4 shows a spectrophotometric hexokinase assay at 
different buffer concentrations, and ATP and β-NADP at different pHs. As 
evident, a marked improvement in hexokinase activity at low buffer 
concentration was observed when ATP and β-NADP solutions were prepared at 
the optimal pH for hexokinase assay. When the buffer concentration was high, 
the pH of ATP and β-NADP solutions had no effect on the activity, as the higher 
buffer concentration is resistant to pH changes caused by the addition of ATP 
and β-NADP. No change was seen when hexokinase was omitted. Crucially, these 
conditions could be translated to ISFET devices and would greatly enhance its 
sensitivity on the platform. However, a coupled reaction was not required to be 
used on the ISFET for hexokinase assay to produce β-NADPH, which can be 
measured by spectrophotometry. Therefore, only the pH of ATP solution was 
important for hexokinase assay on ISFET.  
 
Figure 6.4 – Spectrophotometric hexokinase assay, using two different buffer 
concentrations with ATP and β-NADP solutions at different pHs. [Spectrophotometric 
measurements were done by Dr. Alasdair MacDonald]. 
Before testing the hexokinase assay on the ISFET, the enzyme reaction was also 
tested using a S220 SevenCompact pH/Ion meter (Mettler-Toledo, USA) to detect 
protons produced by hexokinase reaction, without the G6PDH coupled reaction. 
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Figure 6.5 shows that the pH was decreased when all hexokinase assay 
components were present at optimal buffer concentration.  
 
Figure 6.5 – Results obtained from pH meter with and without all the required components 
for hexokinase reaction. [pH meter measurements were done by Dr. Alasdair MacDonald]. 
These reactions were then performed on a CMOS ISFET chip to see if the 
hexokinase reaction could be recapitulated. In order to demonstrate that a 
lower buffer concentration could maximise the sensitivity of the measurement of 
hexokinase activity, 2.2 mM of triethanolamine buffer was used instead of 
22 mM. Triethanolamine buffer has a wide buffering capacity between pH 5 to 9 
(in the optimal pH range of hexokinase), in conjunction with its low cost, its 
ease of preparation and its compatibility with sodium alginate (will be discussed 
in Section 7.2). All these properties made it a suitable buffer of choice for 
further experiments. This buffer is sufficient to maintain the optimal pH range 
of the hexokinase enzyme (pH 7.5 – 9.0), while still allowing a detectable 
voltage signal from the ISFET sensor. The starting pH of this reaction was 
selected to be 8.5, which is at the higher end of the working pH range of 
hexokinase, allowing for subsequent pH drops to still be within the optimal pH 
range. The pH of the ATP solution had to be adjusted from pH 3.5 to pH 8.5 to 
prevent a pH reduction below the working range of the enzyme. This was done 
by titrating 1 M of sodium hydroxide. Figure 6.6 illustrates the comparison of 
voltage signal obtained from the ISFET sensor with 22 mM and 2.2 mM 
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triethanolamine buffer. Hexokinase activity on the chip was demonstrated by 
using different ATP concentrations and pHs together with a negative control for 
both buffer concentrations. Bovine serum albumin (BSA) was additionally used to 
substitute hexokinase enzyme to show that the voltage observed was hexokinase 
specific. As evident from Figure 6.6, the results of these experiments 
demonstrated that lower buffer concentration gave a higher signal change. 
There was no response from the ISFET when BSA was used instead of hexokinase. 
 
Figure 6.6 – Enzymatic and control experiments on chip with different concentrations and 
pHs for ATP solution, at different buffer strengths.   
6.2.3 Enzyme Assays 
After determining the importance of ensemble averaging and buffer, the next 
step is to show the capability of ISFET to quantify different metabolites using a 
variety of different enzyme assays. To reiterate from Chapter 2 and 3, enzymes 
act as a biological catalysts and can be incorporated with biosensor technologies 
to detect a specific metabolite. The description below details the analysis of 
four different enzymes: hexokinase, lactate dehydrogenase, urease and lipase. 
Their biological significance and metabolite quantification will be discussed.  
6.2.3.1 Hexokinase  
The quantification of glucose concentration in various body fluids has been 
established as a valuable technique to monitor the symptoms of diabetes 
mellitus, a chronic metabolic disorder that is increasing in prevalence to an 
alarming degree [173]. This has placed a heavy burden on the social and medical 
b) 2 mM buffer a) 22 mM buffer 
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resources worldwide. Therefore, various biosensor technologies have been 
developed as an analytical tool to quantify glucose levels. Three enzyme 
reactions are commonly used for glucose measurement: hexokinase, glucose 
oxidase (GOx) and glucose-1-dehydrogenase (GDH) [174]. Commercial glucose 
biosensors are normally based on GOx and GDH to inform patients of their 
glycaemic status because these enzymes are cheap and easily obtainable. 
However, in this work we used hexokinase enzyme as the biological receptor to 
detect glucose levels. This assay was the first to be successfully applied on a 
CMOS platform in the research group and was investigated the most rigorously. 
Hexokinase is the first enzyme in glycolysis that converts glucose to glucose-6-
phopsphate in the presence of ATP. Many clinical laboratories use hexokinase 
spectrophotometry as a reference method for glucose measurement [174], [175].  
Spectrophotometric Measurement 
Before performing the reaction on the ISFET chip, verification of hexokinase 
activity was tested by monitoring β-NADPH production, from the coupled enzyme 
reaction, using a UV-2550 Spectrophotometer (Shimadzu) at 340 nm and 25oC. 
The final concentrations of each reagent in a 1.26 ml volume solution were as 
follows: 20 mM triethanolamine buffer pH 8.5, 219 mM glucose, 7.9 mM MgCl2, 
1.1 mM β-NADP, 0.7 mM ATP, 1.25 Units G6PDH and 0.02 – 5 Units of hexokinase. 
The definition of a Unit of hexokinase activity is the amount of hexokinase 
required to phosphorylate 1 μmole of glucose per minute under standard 
conditions. Addition of different Units of hexokinase in the spectrophotometer 
allowed the determination of optimal amount to be used for subsequent 
experiments on the ISFET chip. By obtaining progress curves at different 
hexokinase concentrations, it was shown that between 0.125 and 5 Units gave a 
good response, with 2.5 Units being used for all subsequent experiments.  
The following experiments were concerned with varying glucose concentration in 
the range of 0 – 220 mM using 2.5 Units hexokinase. This reaction was first 
tested on the spectrophotometer using a coupled enzyme reaction. Figure 6.7 
presents the data obtained from the spectrophotometric hexokinase assay with 
different glucose concentrations. As evident, different glucose concentrations 
corresponded to different light absorbance levels. However, the signal was 
saturated at 0.7 mM glucose concentration, as a result of the depletion of ATP. 
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Nevertheless, this had demonstrated a working hexokinase assay to quantify 
different glucose levels. 
 
Figure 6.7 – The data obtained for different glucose concentrations using 
spectrophotometry. [Spectrophotometric measurements were done by Dr. Alasdair 
MacDonald]. 
ISFET Measurement 
There was no need for a coupled reaction to produce β-NADPH, as the 
production of protons by hexokinase could be readily visualised by a decrease in 
pH. After determining the enzyme reaction conditions for hexokinase using 
spectrophotometry, the hexokinase assay without the coupled reaction was 
verified with a pH meter to see if protons produced by the hexokinase reaction 
resulted in a detectable change in pH (see Figure 6.4). Since ISFET measures 
hydrogen ion (proton) concentration, there is also no need for a coupled 
reaction, hence ISFET was used in replacement of the pH meter to provide a 
direct assay (preferred type of assay, refer to Section 3.2.2.1).  
Hexokinase activity on the chip was tested with glucose concentration varying 
from 0.05 to 231 mM, which encompassed the physiological range of blood 
glucose, from 2.8 mM (hypoglycaemia) to 20 mM (extreme hyperglycaemia). The 
reaction was in a volume of 1.2 ml with final concentrations as follows: 2.2 mM 
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triethanolamine buffer pH 8.5, 8.6 mM MgCl2, varied glucose concentrations, 
4.17 mM ATP and 1 Unit of Hexokinase. A higher concentration of ATP was used 
so that it was stoichiometrically similar to glucose concentration. Furthermore, 
43 μg/ml phenol red was added to the solution to provide a visual pH indicator, 
in order to help determine if the reaction was working properly on the chip 
rather than making a false measurement. To do hexokinase assay on chip, all the 
reagents were added on top of the chip and waited for roughly 3 minutes to get 
a baseline, then the reaction was initiated by adding hexokinase. After adding 
the hexokinase enzyme into the reaction cocktail, the solution was mixed with 
pipette to make sure that diffusion is not limiting the enzyme reaction. In 
addition, a negative control experiment is always a crucial part for biological 
measurements, BSA was used to initiate the reaction rather than hexokinase to 
make sure that the reaction was correct.  
Figure 6.8 illustrates the quantification of glucose levels using ISFET. As can be 
seen in Figure 6.8a, the signal from a single typical ISFET sensor was obtained, 
which gave a rise in voltage signal until a fixed voltage plateau was reached. The 
voltage of the plateau varies as a function of glucose concentrations. Figure 6.8b 
shows the average of five different ISFET sensors. As expected, the noise was 
reduced and enabled the calculation of a standard deviation.  
 
Figure 6.8 – Data obtained from ISFET sensor for different glucose concentrations. 
Since the turnover rate of glucose by hexokinase is constant at the voltage 
plateau and the concentration of glucose is directly related to voltage, hence 
the average of the plateau signal voltage was plotted against log [glucose] for a 
single sensor pixel and an average of five sensor pixels. Figure 6.9 shows that 
b) Average of five sensors a) A typical single sensor 
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there is a straight-line dependency through the central operating region for 
which the conditions of the assay is similar to the physiological range of blood 
glucose. As evident, the plot deviates from the Nernstian fit at both high and 
low end of the glucose concentrations. The assay that was performed in this 
work is not sensitive enough to measure such low glucose concentrations, 
whereas at very high glucose concentrations, the ATP was completely depleted 
after the reaction and led to a saturation of signal. More importantly, the 
sensitive region fell within the physiological range of blood glucose.  
 
Figure 6.9 – The voltage signal from ISFET sensor at the plateau as a function of glucose 
concentration.    
6.2.3.2 Lactate Dehydrogenase 
The next enzyme assay tested on the ISFET chip was lactate dehydrogenase 
(LDH). Pyruvate (pyruvic acid) is the final product of glycolysis and lies at the 
convergence point of multiple different metabolic pathways [176], [177]. A 
deviated amount of pyruvate in blood serum could be associated to several 
diseases, in particular for those who exhibit metabolic acidosis. These 
pathologies include: motor neuron disease, lactic acidosis and others. Hence, 
accurate measurement of pyruvate level could provide a valuable insight into a 
patient’s clinical profile. There are several enzymes that involve in pyruvate 
metabolism and LDH was selected to be the biological recognition element in 
this work. LDH converts pyruvate to lactate by producing β-NADH and consuming 
hydrogen ions, which are measureable by spectrophotometry and the ISFET 
sensor respectively. 
b) Average of five sensors a) A typical single sensor 
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Spectrophotometric Measurement 
Unlike hexokinase assay, LDH activity can be rapidly monitored by measuring the 
consumption of β-NADH using a spectrophotometer, thus the reaction is very 
simple and does not require a coupled reaction. LDH catalyses the following 
reaction: 
 𝑃𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 𝛽 − 𝑁𝐴𝐷𝐻 + 𝐻+
𝐿𝐷𝐻
→  𝐿𝑎𝑐𝑡𝑎𝑡𝑒 + 𝑁𝐴𝐷+ 6.6 
 
Figure 6.10 – Data obtained from spectrophotometry for different Units of LDH. 
[Spectrophotometric measurements were done by Dr. Alasdair MacDonald]. 
As hexokinase gave promising results with triethanolamine buffer, the same 
buffer was also tested with LDH. Ideally, the use of a ‘universal buffer’ would 
allow simultaneous measurements of the activities of a number of different 
enzymes. The final concentrations of each reagent in a 0.99 ml volume solution 
were as follows: 5 mM triethanolamine buffer pH 7.5, 0.12 mM β-NADH, 1 mM 
sodium pyruvate and 0.015 – 15 Units of LDH. A pH of 7.5 was used because it is 
within the optimal pH for LDH enzyme. One Unit of LDH phosphorylates 1 μmole 
of pyruvate to L-lactate per minute at 37oC. Figure 6.10 shows the progress 
curves from spectrophotometer with different Units of LDH. These initial 
titration experiments of different Units of LDH had demonstrated the developed 
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LDH reaction to be used on ISFET chip and showed an optimal rate of reaction of 
0.015 – 0.15 Unit of LDH, in solution. 
ISFET Measurement 
The reduction of pyruvate to lactate will result in the consumption of hydrogen 
ions. Therefore, the reaction functions as a hydrogen ion sink and should 
produce an increase in pH under developed conditions. LDH activity was also 
tested on a pH meter for further validation. A rise in pH was observed only at 
low buffer concentration when all reaction components were present. In 
addition, a higher Unit of LDH was required to obtain a detectable signal in pH 
meter, which was 1.5 Units. Hence, 1.5 Units LDH was used for all ISFET 
measurements. Subsequently, the enzyme reaction was transferred to the ISFET 
sensor to quantify pyruvate, which levels were proportional to hydrogen ion 
consumption. 
The quantification capability of the ISFET sensor was then tested for pyruvate. 
This was done in 0.99 ml with all the required reagents corresponding at the 
final concentration: 5 mM triethanolamine pH 7.5, 1.65 – 6.6 mM β-NADH, 3.5 – 
14 mM sodium pyruvate and 1.5 Units of LDH. Again, 50 μg/ml phenol red was 
added to the solution to visualise the pH change. The LDH assay was done 
similarly to hexokinase with all the reagents added on top of ISFET sensor, 
waiting for approximately 3 minutes before initiating the reaction with LDH. 
Three negative controls were tested by omitting sodium pyruvate, β-NADH and 
LDH from the solution, respectively. Figure 6.11 illustrates the results from the 
ISFET by changing the concentrations in sodium pyruvate and β-NADH. As 
evident, the voltage signal from ISFET decreases as opposed to the hexokinase 
assay, a result of hexokinase assay decreases the pH while LDH assay increases 
the pH of the solution. It is clearly observed from Figure 6.11a that pyruvate 
levels can be quantified with the LDH assay, using 0 mM, 3.5 mM, 7 mM and 
14 mM pyruvate. The highest concentrations of pyruvate gave saturation as a 
result of depletion of 6.6 mM β-NADH, thus the maximum hydrogen ion change 
could only correspond to the concentration of β-NADH. To prove that β-NADH is 
the limiting factor, Figure 6.11b shows that by maintaining sodium pyruvate at 
14 mM while varying β-NADH (0 mM, 1.65 mM, 3.3 mM and 6.6 mM) had an effect 
on final pH/voltage change. All negative controls gave no change in voltage, 
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showing that the signal was a direct result of the LDH reaction. One point to 
note is that the physiological range of pyruvate levels is much lower than the 
one used here. In blood, the range is between 0.08 – 0.16 mM [178], which is 
lower than the lowest concentration used in this assay. Nevertheless, the 
experiments show that pyruvate can be quantified on the ISFET sensor. Further 
work can be done to reduce and investigate the buffer concentration and to 
improve the ISFET pH sensitivity so as to detect physiological concentration of 
pyruvate levels. 
 
Figure 6.11 – Data obtained from ISFET sensors using different pyruvate and β-NADH 
concentrations. 
6.2.3.3 Urease 
The third enzyme assay used was urease, an enzyme which is used to determine 
urea concentration. Urea, CO(NH2)2 is one of the end products of protein 
metabolism and is produced by the liver [179]. By determining human urea 
levels, glomerular filtration rate of kidney and renal function can be analysed 
[180]. Hence, an elevated urea level in serum is important to determine if 
patients suffer from renal dysfunction. In addition, urea production can be 
blocked by liver disease. Therefore, the measurement of urea concentration is 
extremely useful for clinical diagnostic purposes, in terms of diagnosing liver and 
kidney disease. The urease reaction is a straightforward assay that can be 
readily done on the ISFET.  The assay requires only urease and urea in a buffer 
to produce a pH change.  
b) β-NADH measurements 
 
a) Pyruvate measurements 
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Urease does not produce a product that can be measured by spectrophotometry 
directly. The reaction of urease assay is given below: 
 𝐶𝑂(𝑁𝐻2)2 + 3𝐻2𝑂
𝑈𝑟𝑒𝑎𝑠𝑒
→    𝐶𝑂2 + 2𝑁𝐻4
+ + 2𝑂𝐻− 6.7 
The formation of ammonia by hydrolysis of urea (in the form of ammonium 
hydroxide) should result in a detectable rise in pH under suitable buffer 
conditions.  
To verify that urease reaction produces a pH change, a pH meter was used. The 
buffer chosen was 4-morpholineethanesulfonic acid (MES) buffer at pH 6. This 
buffer was selected as urease has an optimal pH range from pH 4 to 9. A pH of 6 
was chosen so that the increase in pH during reaction would still be within the 
optimal pH range of urease, allowing maximum detection. Figure 6.12 illustrates 
the urease assay using a pH meter. As shown, an increase in pH from 6 to 9.2 
was observed at 5 mM MES buffer pH 6 when both 100 mM urea and 1.5 Units of 
urease were present. One Unit of urease will liberate 1 μmole of NH3 from urea 
per minute at 30oC. No change was observed when either urease or urea was 
omitted.  
 
Figure 6.12 – Data obtained from pH meter for urease assay. [pH meter measurements were 
done by Dr. Alasdair MacDonald]. 
140 
 
After validation from the pH meter, the quantification of urea was measured on 
an ISFET chip. This was done in 1007.5 μl volume of solution with the final 
concentrations of each reagent were as follows: 5 mM MES buffer pH 6, 12.5 – 
100 mM urea, 3.75 Units of urease and 50 μg/ml of phenol red. A negative 
control without urea was also measured to show that the pH change was a direct 
result of the enzyme reaction. As with previous assays, a 3 minute baseline was 
recorded before addition of urease. Figure 6.13 shows the quantification of 
different urea levels using this assay. As shown, different urea concentrations 
gave different voltage signals. However, the physiological range of urea in blood 
is 2.9 – 8.9 mM [181]. The lowest concentration that was measured was 12.5 mM, 
so further work to measure physiological range of urea level has to be done to 
investigate the urease assay such as, lowering the starting pH value, reducing 
the buffer concentration or even increasing the pH sensitivity of the ISFET 
sensor. Nevertheless, the capability to quantify urea level using ISFET sensor had 
been demonstrated. 
 
Figure 6.13 – Data obtained from a single ISFET sensor for different urea concentrations. 
6.2.3.4 Lipase 
The final enzyme assay tested on the ISFET chip was lipase. The lipase assay is a 
useful method to measure triglycerides, which are a type of fat (lipid) found in 
the blood. When an excess energy is required, triglycerides are metabolised as 
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an energy source in addition to glucose [182]. Triglycerides are not soluble in 
blood, thus can circulate in the blood with the help of proteins that transport 
the lipids (lipoprotein). Hence, an elevated amount of triglyceride in the blood 
can promote the thickening of artery wall, which increases the risk of stroke, 
heart attack and heart disease (coronary artery disease) [183]. Moreover, 
conditions such as obesity and metabolic syndrome, the latter using a collection 
of markers such as measurement of waist line, high blood pressure, high 
cholesterol and high blood glucose, are linked to elevated triglyceride levels. 
The lipase reaction is another relatively straightforward assay that can be done 
on the ISFET sensor. 
The reaction below shows the reaction catalysed by lipase: 
 
𝑇𝑟𝑖𝑔𝑙𝑦𝑐𝑒𝑟𝑖𝑑𝑒 + 𝐻2𝑂
𝐿𝑖𝑝𝑎𝑠𝑒
→    𝐷𝑖𝑔𝑙𝑦𝑐𝑒𝑟𝑖𝑑𝑒 + 𝐹𝑎𝑡𝑡𝑦 𝑎𝑐𝑖𝑑 6.8 
The formation of fatty acid by hydrolysis of triglyceride should result in a 
detectable lowering of pH under suitable reaction conditions. To test this assay, 
the reaction with a lipase substrate (trioleoyl glycerol) was first developed. The 
final concentrations of each reagent were as follows: 1.25 mM triethanolamine 
pH 8.5, 1.8 mM lipase substrate, 400 mM sodium chloride, 5 mM calcium 
chloride, 50 μg/ml phenol red and 80 Units of lipase in solution. One Unit of 
lipase will hydrolyse one microequivalent of fatty acid from a triglyceride per 
hour at pH 7.7 and 37oC. As was done with previous assays, the reaction was 
initiated by addition of lipase. A pH meter was initially used to test the assay 
and found a decrease of one pH unit in the presence of lipase, and no observable 
change when either lipase or trioleoyl glycerol was omitted. This assay was next 
transferred to an ISFET chip. Figure 6.14 shows the ISFET voltage signal obtained 
from a lipase assay. As can be seen, 1.8 mM trioleoyl glycerol gave a response 
from the ISFET sensor while no response was observed when lipase or lipase 
substrate was omitted, recapitulating pH meter results. Healthy individuals 
should have around 1.7 mM triglyceride in the blood, which corresponds to the 
measurement obtainable from the ISFET. Even though, time had limited a 
number of different triglyceride levels to be measured, the assay suggested that 
higher levels of triglyceride could be detected by the ISFET sensor. 
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Figure 6.14 – Data obtained from ISFET sensors for lipase assay to detect triglyceride.  
6.2.4 Enzyme Kinetics 
As discussed in detail in Section 3.2.1, enzyme kinetics is an important field to 
understand the fundamentals of the catalytic mechanism of an enzyme. Since 
the hexokinase assay had been most rigorously tested on the ISFET, the plots 
from both spectrophotometer and ISFET were used to calculate the Michaelis-
Menten constant of hexokinase enzyme for comparison. The Michaelis-Menten 
constant can be extracted from the initial rate of enzyme progress curves from 
different substrate concentrations. Usually an enzyme progress curve will have a 
rapidly rising linear signal before it slows down as substrate is being consumed. 
The progress curve from spectrophotometer and ISFET measures absorbance of 
product (β-NADPH) or production of hydrogen ions versus time, respectively. As 
time increases, more β-NADPH or hydrogen ions are formed in hexokinase assay, 
resulting in an increase in absorbance or ISFET voltage respectively, and then 
the absorbance or ISFET voltage plateaus are reached as the substrate is 
exhausted. The initial velocity at different substrate concentrations (i.e. by 
doing a number of progress curves) are then used to plot a graph of substrate 
concentration versus initial velocity. This gives a hyperbolic curve. At high 
substrate concentration, the enzyme is saturated and so the initial velocity 
remains constant, which is termed as the maximal velocity. At substrate 
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concentration where the initial velocity is half the maximal of velocity, it is 
defined as the Michaelis-Menten constant, Km (see Section 3.2.1 for more 
details). Therefore, the initial velocity of each of the progress curve was taken 
and plotted against the substrate (glucose) concentrations. By using the 
software, GraFit, which has a built-in Michaelis-Menten algorithm, the value of 
Km was calculated for both spectrophotometric and ISFET assays. By measuring 
the velocity during the first 60 seconds of the reaction, the reaction rate 
(absorbance for spectrophotometer or voltage for ISFET) was calculated for each 
substrate concentration. Using a linear fit at the slope of each concentration 
from the data obtained from spectrophotometric assay (refer to Section 6.2.3.1, 
Figure 6.7), the velocity of the first 60 seconds was then obtained and the Km 
value was calculated to be 0.85 mM using GraFit.  
With the data obtained from the ISFET for the hexokinase assay (refer to Section 
6.2.3.1, Figure 6.8), the initial velocity (first 60 seconds) at each concentration 
was also plotted as a function of glucose concentration using GraFit to calculate 
the Km. The reaction rate versus glucose concentration plot was then further 
plotted into Lineweaver-Burk double reciprocal plot for each concentration. 
Figure 6.15 shows the Lineweaver-Burk double reciprocal plots of 1/(dV/dt) 
versus 1/[glucose] for both typical single sensor pixel and average of five sensor 
pixels signals. As shown, the points fitted onto a line with the intercept 
1/[glucose] axis being as 1/Km using the equation below: 
 1
𝑣
=
𝐾𝑚
𝑣𝑚𝑎𝑥
1
[𝑆]
+
1
𝑣𝑚𝑎𝑥
 6.9 
Using this method, the value of Km was calculated to be 0.58 ± 0.36 mM for the 
average of five sensor pixels for hexokinase assay on ISFET sensor. This Km 
corresponded well with the one obtained from spectrophotometric assay for 
hexokinase. This had proven that CMOS ISFET with hexokinase as biological 
receptor has the capability to be used as a biosensor to monitor the symptoms of 
diabetes mellitus, with an accuracy that is comparable to a large-scale 
laboratory based spectrophotometer.  
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Figure 6.15 – Lineweaver-Burk double reciprocal plot for Km value using the data obtained 
using ISFET.  
6.3 Metabolite Sensing on PD 
The Multi-Corder chip consisted of three different sensors, two optical sensors 
(PD and SPAD) and an electrochemical sensor (ISFET). 50 chips were delivered by 
the foundry, but only the PD and SPAD sensors could be used for testing as the 
ISFET sensors had some technical issues. A thick passivation layer on top of the 
ISFET reduced its sensitivity significantly. The Multi-Corder chip was also 
designed to allow microfluidic channels to be fabricated with ease for multiple 
metabolite quantification. In order to demonstrate that multiple metabolites 
could be tested on a single chip using microfluidic channels, one of the optical 
sensors had to be tested with at least one enzyme assay. Since some enzymatic 
reactions produce a colorimetric product, an optical sensor could be used to 
detect enzyme activity using a Multi-Corder chip. Therefore, PD was chosen to 
test cholesterol oxidase activity and to detect its corresponding metabolite, 
cholesterol. The following sections will explain how the cholesterol oxidase 
assay works in cholesterol solution and in serum, and finally the determination 
of the Michaelis-Menten constant from cholesterol oxidase will be described. 
6.3.1 Cholesterol Oxidase and Cholesterol Esterase Assay 
Cholesterol is a sterol lipid and is an essential constituent of animal cell 
membranes [184]. It is mainly produced by the liver and is also found in foods 
such as meat, milk, eggs and so on. As with triglyceride, cholesterol is insoluble 
b) Average of 5 sensors a) A typical single sensor 
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in blood, and is transported through the blood stream as a lipoprotein. There are 
three common lipoproteins: low-density lipoproteins (LDL), high-density 
lipoproteins (HDL) and very low-density lipoproteins (VLDL). Medical studies have 
shown that an elevated level of LDL cholesterol (“bad” cholesterol) could lead 
to a higher risk of coronary artery blockage, whereas an increased level of HDL 
cholesterol (“good” cholesterol) could lower the risk.  
Even though cells require cholesterol for a number of metabolic processes and 
functions, an excess can lead to a thickening of arteries wall with a build-up of 
plaque deposits, a condition known as atherosclerosis (similar to elevated level 
of triglyceride). A blood clot can be formed on an exposed area when a piece of 
plaque breaks off from the surface. This will decrease blood flow and oxygen 
supply to other organs, leading to coronary heart diseases (heart attack or 
angina) [185], stroke or other  cardiovascular diseases. These diseases pose a 
threat to society and a heavy burden towards healthcare resources in UK and 
worldwide. It is estimated that cardiovascular disease caused 160,000 deaths in 
2011, which is the UK’s biggest killer [186]. Normally, the best way to detect 
cholesterol is by a blood test. Normal serum cholesterol should be 5 mM or lower 
for a healthy individual.  
Cholesterol oxidase is the most commonly used enzyme for cholesterol 
quantification in biosensors, and was thus used in this work. Only approximately 
20% of cholesterol in serum is in ‘free’ form, while the remaining takes the form 
of cholesteryl esters [187]. To accurately determine total cholesterol in serum, 
the esterified form of cholesterol has to be hydrolysed to free cholesterol by 
addition of cholesterol esterase. Hence, in order to measure total cholesterol in 
human serum, two enzymes (cholesterol oxidase and cholesterol esterase) had 
to be applied together, in addition to a third enzyme (peroxidase) that yields an 
optical product to be measured by the spectrophotometer and the PD.  
6.3.1.1 Spectrophotometric Measurement 
Neither cholesterol esterase nor cholesterol oxidase produces a product that is 
measureable optically. Therefore, the enzymatic activity was evaluated using a 
coupled colorimetric assay to quantify the concentration of cholesterol in human 
serum, specifically human male AB plasma, USA origin, sterile-filtered and 
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sourced from Sigma Aldrich. The concentration range of cholesterol stated by 
Sigma Aldrich was 2800 – 5400 μM and it was later quantified by the NHS to be 
3500 μM. The reaction involved three enzymatic steps. In the first step, the 
enzyme cholesterol esterase was used to hydrolyse cholesteryl esters to free 
cholesterol: 
 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑦𝑙 𝑒𝑠𝑡𝑒𝑟 + 𝐻2𝑂
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 𝐸𝑠𝑡𝑒𝑟𝑎𝑠𝑒
→               𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 + 𝐹𝑎𝑡𝑡𝑦 𝑎𝑐𝑖𝑑 6.10 
The second step involved the addition of cholesterol oxidase, an oxidoreductase, 
which uses molecular oxygen as the electron acceptor and reduces it to 
hydrogen peroxide. In this reaction, the free cholesterol in the serum with the 
addition of free cholesterol produced by the esterase reaction, giving the ‘total 
cholesterol’ that could be quantified: 
 
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 + 𝑂2
𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 𝑂𝑥𝑖𝑑𝑎𝑠𝑒
→               4 − 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑛 − 3 − 𝑜𝑛𝑒 + 𝐻2𝑂2 6.11 
However, cholesterol oxidase enzymatic reaction does not produce a 
measureable optical product for either spectrophotometry or PD. Thus, a 
coupled enzyme assay had to be used: 
 
𝑜 − 𝐷𝑖𝑎𝑛𝑖𝑠𝑖𝑑𝑖𝑛𝑒(𝑟𝑒𝑑𝑢𝑐𝑒𝑑) + 2𝐻2𝑂2
𝑃𝑒𝑟𝑜𝑥𝑖𝑑𝑎𝑠𝑒
→        𝑜
− 𝐷𝑖𝑎𝑛𝑖𝑠𝑖𝑑𝑖𝑛𝑒(𝑜𝑥𝑖𝑑𝑖𝑠𝑒𝑑) + 2𝐻2𝑂 
6.12 
In the presence of peroxidase, hydrogen peroxide produced in Equation 6.11 is 
used to oxidise o-Dianisidine to a coloured product, which progressively changes 
into a deep orange colour. This change in colour depends on the concentration 
of hydrogen peroxide, which is itself proportional to the cholesterol 
concentration. Hence, the total amount of cholesterol in serum was quantified 
by measuring the absorbance at 500 nm wavelength of the oxidised o-
Dianisidine. The reason for choosing 500 nm wavelength to perform the 
measurement will be explained later in the discussion. 
The enzymatic activity of cholesterol oxidase was initially evaluated using a 
spectrophotometer. Initially, cholesterol oxidase activity was evaluated using 
cholesterol supplied in solution (refer to Equation 6.11 and 6.12). The 
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absorbance of oxidised o-Dianisidine was monitored at 500 nm and 25oC with a 
UV-2550 Spectrophotometer. The following final concentrations of each reagent 
in a 1 ml volume solution were used: 42 mM triethanolamine pH 7.5, 0.32 mM o-
Dianisidine, 429 μM cholesterol in 0.33% Triton X-100, 3.3 Units of peroxidase 
and 0.067 - 0.67 Units of cholesterol oxidase. The definition of a Unit of 
cholesterol oxidase activity is the amount of cholesterol oxidase required to 
convert 1 μmole of cholesterol to 4-cholesten-3-one per minute at pH 7.5 and 
25oC. The reaction was initiated with cholesterol oxidase. It was observed that 
0.33 Units of cholesterol oxidase gave suitable kinetics, which was then used for 
all the subsequent experiments. The next experiment involved varying the 
concentration of cholesterol from 0 μM to 214 μM. Figure 6.16 illustrates the 
quantification of cholesterol in solution obtained from the spectrophotometer. 
As evident, as the concentration of cholesterol was higher, more o-Dianisidine 
was oxidised and formed a darker orange colour, resulting in more absorption at 
500 nm wavelength (refer to Equation 6.11 and 6.12). By obtaining progress 
curves at different concentrations, it was shown that different concentrations of 
cholesterol corresponded to different endpoint absorbance. This had 
demonstrated a cholesterol oxidase assay that can quantify free cholesterol in 
solution.  
 
Figure 6.16 – Data obtained from the spectrophotometer for different cholesterol 
concentrations in solution. [Spectrophotometric measurements were done by Dr. Alasdair 
MacDonald]. 
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The next step involved the evaluation of human serum using the developed 
cholesterol oxidase reaction conditions, together with the cholesterol esterase 
step to release free cholesterol from its esterified form (refer to Equation 6.8). 
To do this, an additional 15 minutes pre-incubation step at 37oC with cholesterol 
esterase was required. The temperature 37oC is the standard condition required 
for cholesterol esterase, thus it was used instead of 25oC. The reaction mixture 
was at the following final concentrations for each reagent: 34.6 mM 
triethanolamine pH 7.5, 4.7 mM of taurocholic acid sodium salt hydrate, 5.9 mM 
sodium cholate hydrate, 25 mM sodium chloride, 0.14 Units of cholesterol 
esterase and diluted serum with final concentrations of cholesterol at 118 μM, 
236 μM and 471 μM. Following the pre-incubation step, 0.32 mM o-Dianisidine 
and 3 Units of peroxidase were added, followed by initiation with 0.3 Units 
cholesterol oxidase. Figure 6.17 illustrates the results obtained from the 
spectrophotometer with serum cholesterol and cholesterol supplied in solution. 
The cholesterol in serum was diluted into 118 μM, 236 μM and 471 μM and was 
compared with cholesterol solution made up at 107 μM, 214 μM and 429 μM. As 
shown in Figure 6.17, when the cholesterol in serum was diluted to 236 μM or 
lower, the results corresponded quite well with the cholesterol supplied in 
solution. However, at higher concentration of cholesterol in serum, the result 
started to deviate from the result obtained from the cholesterol supplied in 
solution. This may be because of inhibitors present in the serum that may 
interfere with the reaction, or could be because at higher concentration the 
absorbance of the o-Dianisidine had reached saturation. Nevertheless, the 
results had demonstrated that by pre-treatment of human serum with 
cholesterol esterase, total amount of free cholesterol in serum could be 
determined. 
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Figure 6.17 – Data obtained from the spectrophotometer for the comparison of cholesterol 
levels in serum and solution. [Spectrophotometric measurements were done by Dr. Alasdair 
MacDonald]. 
6.3.1.2 PD Measurement 
In order to measure light absorbance of o-Dianisidine using PD, a light source 
was required. Since POC diagnostics aim to provide medical devices that can be 
available to a physician during medical investigation or patient for bedside 
treatment, biosensor technologies have to be low cost and amenable to 
miniaturisation. Therefore, a small and cheap off-the-shelf green light emitting 
diode (LED) was chosen as the light source. Figure 6.18 shows the experimental 
setup of a green LED with CMOS PD to measure light absorbance from an enzyme 
assay. For consistency, the optical light path between the LED and the chip was 
maintained at 5 cm for all experiments. Furthermore, the light path in the 
solution was also maintained the same by keeping the volume of the enzyme 
solution and also the size of the culture ring on top of the chip carrier (see 
Section 5.4.2) constant for all experiments. However, before commencing 
measurements of cholesterol levels on PD, the relationship between the optical 
characteristics of PD and the colorimetric product had to be determined and 
compared with commercially available green LED.  
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Figure 6.18 – Schematic diagram of the working principle of a colorimetric enzyme assay 
using PD on the Multi-Corder chip with LED illumination. 
To evaluate the optical characteristics of the PD, a TMc300 monochromated light 
source (Benthem Instruments) was used and swept between 350 nm and 1000 nm 
in a dark environment. The output voltage of the light source was maintained at 
11.5 V for every single wavelength. As can be seen in Figure 6.19, the spectral 
response produced from the PD (plot in black) has a maximum peak at 600 nm. 
This has shown that CMOS PD has varied sensitivity toward different wavelength 
of visible light. The next step was to investigate the spectrum of oxidised o-
Dianisidine during cholesterol assay as a time course. A cholesterol reaction mix 
was prepared following the protocol as described above. Using a glass slide 
sample and attached with a cut test tube, all the reagents except the 
cholesterol oxidase was added and well mixed on top of the glass sample. A 
transmission measurement of the reaction mixture on top of the glass slide was 
performed using a TFProbe MSP300 spectrometer (Ångstrom Sun Technologies). 
The spectrometer was scanned between 350 nm and 1000 nm to obtain the 
absorbance spectrum of o-Dianisidine as a function of time. Using automated 
software, the spectrometer was obtaining the spectral response every five 
seconds. As can be seen in Figure 6.19, the first five traces of the o-Dianisidine 
maintained unchanged, which has zero adsorption at any wavelength. As soon as 
the cholesterol was added into the reaction cocktail and mixed it with a pipette 
for several times, the adsorption of the oxidised o-Dianisidine increases 
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monotonically with time until it reaches saturation. The oxidised o-Dianisidine 
absorbance spectrum was observed to have an absorption peak at 460 nm.  
From both PD spectral response and oxidised o-Dianisidine absorbance spectrum 
when it comes to saturation, it can be seen that there is an overlap between 
these two traces, which is around 500 nm. Consequently based on this 
information, a green LED that has a peak spectrum close to 500 nm was chosen. 
Subsequently, a TFProbe MicroSpectrometer was used to measure the spectrum 
of the green LED to confirm its spectrum. As evident, the LED spectrum has a 
wavelength peak around 500 nm, which can be seen to coincide quite well at the 
overlap between the sensitivity of the PD and the absorbance spectrum of 
oxidised o-Dianisidine for the enzyme assay. Figure 6.19 illustrates the 
spectrums of o-Dianisidine, PD response and green LED, which are all plotted 
together. 
 
Figure 6.19 – The spectral response of the photodiode, the oxidised o-Dianisidine as a 
function of time during a cholesterol assay and a green LED.  
In addition to optical evaluation, electrical evaluation of the photodiode array 
was also performed. As mentioned before, an increased in amount of ISFET 
sensors to be averaged is capable of reducing white noise and improve the 
output signal of the device. In the same way, the Multi-Corder chip also has an 
array of PD sensors, of which there are 256 sensors in total. The averaging 
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technique that was used in the ISFET array chip to reduce noise could be applied 
using the Multi-Corder chip as well. This could potentially be used to reduce 
noise as a function of √N, where N is the number of sensors. Figure 6.20 
illustrates the data obtained from the PD using one single sensor and an average 
of all sensors for a low concentration of cholesterol. As evident, the signal 
obtained from one single sensor had a high level of noise which masked the 
signal, whereas the noise from an average of 256 sensors was much lower. 
Therefore, all the subsequent experiments were done and analysed using an 
average of the PD sensors with the same metabolite measurements. 
 
Figure 6.20 – The comparison of the absorbance levels obtained from the CMOS PD as 
voltage signal for one single sensor and an average of 256 sensors. 
Using all the required reaction components and conditions that had been 
investigated using spectrophotometry, the reaction was tested on the Multi-
Corder chip using the PD as the detector. The reagents were added to the chip 
in the same order as described above, with the serum being diluted to give four 
different cholesterol concentrations. This was followed by a pre-treatment with 
cholesterol esterase and then transferal of the reaction mix on top of PD with 
the addition of peroxidase and o-Dianisidine. The measurement was left for a 
base line of approximately 2 minutes before initiation with cholesterol oxidase. 
The serum supplied by Sigma Aldrich was evaluated by NHS to determine 
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cholesterol concentration and found to be 3500 μM. Hence, the final cholesterol 
concentrations in the diluted serum were 29 μM, 58 μM, 115 μM and 230 μM.  
The initial measurement was done with the PD using a monochromated light 
source at 505 nm, with a linewidth of 5 nm. The reason of doing this was to 
replicate the exact same configuration of the spectrophotometer, which 
contains a charged coupled device (CCD) as a detector, diffraction gratings to 
obtain a monochromated light and a white light source. The intensity of the light 
source was adjusted, so that the voltage level from the PD was not too high to 
be saturated by the monochromated light or too low to be undetectable by the 
PD. This PD voltage level was chosen to be 1.8 V. The intensity of the light 
source was kept constant (11.5 V) throughout all the experiments for 
consistency. Three measurements for each cholesterol concentration were 
performed to check consistency and to extract the standard deviation of the 
measurements. A no-cholesterol oxidase negative control was also included.  
The results obtained from the PD with a monochromated light source can be 
observed in Figure 6.21a. Subsequently, a green LED was used to replace the 
monochromated light source. The light intensity from the green LED was also 
adjusted to the same intensity level to give the same voltage signal on the PD as 
the monochromated light source, which was 1.8 V. The same cholesterol 
concentrations and negative control experiments were repeated. All the 
experiments were also repeated for three times for consistency and accuracy. 
Figure 6.21b illustrates the data obtained from PD with green LED illumination. 
In addition, the Figure 6.21 was further plotted into plateau PD voltage as a 
function of cholesterol concentration, since the reaction of cholesterol oxidase 
has come to saturation and remained constant at the voltage plateau, as shown 
in Figure 6.23 for both light sources. Hence, this plateau signal voltage is 
indirectly related to the concentration of cholesterol. As can be observed in 
Figure 6.22, both light sources could resolve a similar plateau PD voltage for the 
same cholesterol concentration and they have a straight-line dependency 
between 29 μM and 116 μM. Both plots deviate from the linear fitting at high 
concentration of cholesterol. This may due to the o-Dianisidine colour has come 
to a saturation point, where it can no longer change to a darker orange colour. 
Using the linear slope for both the plots, the sensitivity of the device was 
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determined to be 2.1 mV/μM and 2.2 mV/μM for both LED and monochromated 
light source, respectively.  
 
Figure 6.21 – Data obtained from the PD using Multi-Corder chip for different cholesterol 
serum dilutions.  
 
Figure 6.22 – The PD voltage plateau as a function of different cholesterol serum dilutions. 
However, by observing the data from Figure 6.21, it was come to realise that the 
slope of the reaction is faster for the case of the monochromated light source 
compared to the slope of the reaction from the green LED and 
spectrophotometer, but the plateau from both was almost identical. The reason 
for this artefact was believed to due to the increment of temperature for the 
enzyme assay, as higher temperature increases enzyme reaction. Using an 
infrared camera, light spot of the LED and the monochromated light source 
shone on top of the PD array chip was evaluated. It was found that LED light spot 
has a temperature of 24.3oC while monochromated light source spot has a 
temperature of 29.2oC. Furthermore, the temperature condition of the 
a) Monochromated light source b) LED 
 
a) Monochromated light source b) LED 
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spectrophotometer was at 25oC. Hence, the monochromated light source that is 
available in our laboratory could produce a light spot that ultimately affects 
temperature, leading to a false reading. This has to be taken into account in the 
future experiments when doing enzyme assay that is sensitive to temperature 
changes. Regardless of this observation, monochromated light source 
measurement was not the main goal. The aim is to demonstrate the capability of 
using the above triple enzyme procedure to quantify the cholesterol levels in 
human serum using an inexpensive green LED and CMOS PD platform. From the 
experiments, it has shown that the inexpensive and miniaturised platform could 
replicate the measurements produced by a bench top spectrophotometer. 
Furthermore, the lowest concentration of cholesterol that was measured using 
this device configuration with LED light source is 150 times lower compare to the 
physiological range of cholesterol level in human serum, proving that this device 
has the capability for greater sensitivity applications. Moreover, using the data 
from Figure 6.22b, the limit of detection of the device can be calculated, by 
taking three times of the standard deviation of the blank control curve and 
divide by the sensitivity of the device [146], which equates to approximately 
13 μM. Hence, a handheld diagnostic device based on this technology is proven 
to be feasible. This could ultimately be a miniaturised version of a 
spectrophotometer.  
6.3.2 Enzyme Kinetics 
As shown for ISFET enzyme kinetics, extracting the Michaelis-Menten constant 
could be calculated from the initial rate of a series of enzyme progress curves at 
different cholesterol concentrations with respect to time. Using the data 
obtained from the spectrophotometer, the PD with monochromated light source 
and the PD with LED illumination, a value of Km for cholesterol oxidase was 
calculated and compared for each measurement technique. Hence, the 
extrapolated gradient during the first 60 seconds of the reaction was taken as 
the initial reaction rate, at different cholesterol concentration. Using GraphPad 
Prism, which has a built-in Michaelis-Menten algorithm, the initial velocity was 
plotted against each cholesterol concentration, using the data obtained from the 
spectrophotometer and PD sensors. Each of the plots was also plotted onto 
Lineweaver-Burk double reciprocal plot. The 1/Km value can be obtained by 
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taking the interception of the line at the 1/[cholesterol] axis. Using this method, 
the Km value for the spectrophotometer, the PD with monochromated light 
source and the PD with LED illumination, was obtained to be 40 ± 7 μM, 263 ± 95 
μM and 80 ± 12 μM, respectively. Figure 6.23 shows all the initial velocity versus 
cholesterol concentration plots with its respectively Lineweaver-Burk double 
reciprocal plot for each measurement technique. The Km value obtained from 
the spectrophotometer and the PD with LED illumination correlates well with 
each other. However, the PD with monochromated light source gave a higher Km 
value, which may due to the sensitivity of colour change from o-Dianisidine 
towards such a narrowband light source. Nevertheless, this had further 
demonstrated that a low cost LED CMOS PD sensor array can be used as a POC 
diagnostic tool, with comparable results with conventional bench top 
spectrophotometer.  
 
Figure 6.23 – Data obtained from GraphPad Prism for Km value extraction from all the 
individual techniques. [Results were analysed by Dr. ChunXiao Hu] 
a) Spectrophotometer 
 
c) LED 
 
b) Monochromated light source 
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6.4 Summary 
An example of a very minute amount of glucose was used to demonstrate that an 
array format can reduce the signal noise obtained from ISFET sensors. In 
addition, a buffer system was developed to improve the sensitivity of ISFET. This 
was then followed by the demonstration of ISFET sensors with the capability to 
quantify four different metabolites, those being glucose, pyruvate, urea and 
triglyceride.  Each of these metabolites is linked to a number of different 
diseases. Moreover, the Michaelis-Menten constant was calculated using the data 
obtained from ISFET sensors for glucose and agreed very well with a 
conventional spectrophotometric method. Finally, the PD sensor array on the 
Multi-Corder chip was used to demonstrate cholesterol quantification in human 
serum. The quantification and Michaelis-Menten constant obtained from the PD 
sensor array was compared with spectrophotometric technique as well, and all 
the data agreed with each other. Since the CMOS chips had been demonstrated 
with the capability to quantify different metabolites, the next step will be 
integrating the CMOS sensor array with microfluidics and enzyme immobilisation 
techniques to demonstrate multiple metabolites measurement simultaneously, 
using one single chip.  
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Chapter 7 : Enzyme Immobilisation 
with Microfluidics 
Integration for Metabolite 
Sensing on Chip 
7.1 Introduction 
The previous chapter focused on the development of enzyme assays to quantify 
different metabolites on a CMOS ISFET and PD. This chapter describes the 
enzyme immobilisation technique used on top of a CMOS chip and also 
demonstrates working microfluidic channels fabricated on top of a CMOS chip. 
Finally, the complete system is then used to measure a metabolite with a 
specific enzyme assay.  
7.2 Enzyme Immobilisation 
As discussed in Section 2.3, a 2D microarray is important to allow simultaneous 
metabolite measurements on chip. Immobilisation of the enzyme onto the solid 
surface of the CMOS chip is a critical step. The matrix support used in 
immobilisation should be affordable, stable, chemically inert, reusable and 
should not interfere with enzyme activity. In the first instance, the bead arrays 
immobilisation technique used in an Ion Torrent chip was replicated in this work. 
Initially, sepharose beads (45 - 165 μm in diameter) were first used to 
immobilise the enzyme, in conjunction with an etching step on the surface of 
the CMOS chip to form a microwell to accommodate an enzyme bead. However, 
it was found that the immobilisation protocol was very complicated and 
involving numerous steps. Moreover, it was also realised that the surface 
topography on top of the ISFET array chip has a few trenches (1 μm wide and 
400 nm deep) for each sensor pixel, which could act as microwells to 
accommodate enzyme beads. The trenches formed from the topography of the 
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chip can be seen in Figure 7.1a. It was therefore thought to take advantage of 
these trenches to eliminate the need to etch the surface of the CMOS chip to 
create microwells. Regardless, measurements were made using hexokinase 
sepharose beads with glucose as illustrated in Figure 7.1b but the results were 
difficult to interpret. This was then followed by the use of silica mesoporous 
nanobeads (200 nm in diameter) that are small enough to be placed into the 
microwells formed from the topography of the chip. However, it was found that 
the enzyme beads did not produce an observable signal from the ISFET. 
Furthermore, after the enzyme beads were used to fill up the surface 
topography of the ISFET chip, the chip was also not responding to any hydrogen 
ion concentration changes. The reason may be due to the overcrowding of the 
nanobeads on top of the surface of the chip, creating a hydrophobic 
environment. This could stop any hydrogen ions from penetrating through the 
nanobeads layer and interact with the sensing layer on top of the ISFET gate to 
produce a voltage signal. Due to all the complications faced from microwell 
bead array, this idea was therefore abandoned.  
 
Figure 7.1 – AFM image showing trenches of a single ISFET pixel for nanobeads 
accommodation and also the data obtained from ISFET using sepharose bead hexokinase. 
At a later stage, alginate gel immobilisation of enzymes using a 2D inkjet 
printing technique was used, as described in Section 2.3.1. Alginate, derived 
from brown algae, is a complex carbohydrate (polysaccharide) that polymerises 
in the presence of divalent cations such as calcium ions [188], [189]. Alginate is 
cheap to source and droplets can be easily prepared by dropping a defined 
volume of sodium alginate/enzyme solution into a CaCl2 solution. In this process, 
sodium ions are displaced by calcium ions, rapidly forming a polymerised gel. 
Generally 10 μl droplets are added to CaCl2 solution to form a single bead with a 
a) AFM image of a single ISFET pixel 
 
b) Data obtained from an ISFET 
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defined number of enzyme units entrapped. Although easy to prepare, there are 
a number of caveats that must be addressed, most notably the possibility of 
enzyme leaching and the preclusion of the substrate into the gel. These 
conditions can be controlled by varying the gel percentage of the alginate. 
Alginate beads are stable and compatible with triethanolamine buffer, making 
them an attractive method for immobilisation.  
In order to test the efficacy of enzymes entrapped in alginate before using the 
2D inkjet printer, lactate dehydrogenase (LDH) and hexokinase were used to 
form alginate beads to be measured using the ISFET array chip. To do this, 1.5% 
sodium alginate solution was made up in the triethanolamine buffer and then 
mixed with a defined amount of enzyme to give a 1% final concentration of 
sodium alginate. The final amounts of enzyme in 1% sodium alginate were as 
follows: 0.05 U/μl LDH and 0.2 U/μl hexokinase. Sequentially, 10 μl drops of 
enzyme-alginate mix were then dropped from a height of approximately 5 cm 
into a vial of 0.2 M CaCl2, upon which beads of enzyme entrapped in calcium 
alginate were rapidly formed. Beads were washed in triethanolamine buffer 
prior to assay.  For each reaction, 5 Units of LDH and 10 Units of hexokinase 
were used respectively. Slightly different from the experiments explained in 
Chapter 6, the reaction was initiated with sodium pyruvate for the LDH assay 
and ATP solution for the hexokinase assay, rather than using the enzyme as 
initiation, since the enzyme was already immobilised in alginate beads. In 
addition, negative control beads were also made up without any enzyme 
entrapped in it, consisting of only buffer solution in alginate solution. Figure 7.2 
illustrates the results obtained from an ISFET array chip for both a LDH and a 
hexokinase assay. As can be seen from Figure 7.2a, when there were LDH beads 
in the solution, the pH increased and decreased the voltage signal of ISFET, 
whereas when blank beads were used, there was no change in voltage signal 
from the ISFET. Similar to the LDH assay, Figure 7.2b shows that when there 
were hexokinase beads in the solution, the ISFET will detect a change in the 
voltage signal while the voltage signal stays unchanged if only blank beads were 
used. This demonstrated that the hexokinase or LDH in this concentration of 
alginate solution was sufficient to entrap the enzyme and also produce a 
measureable signal for the ISFET sensor. 
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Figure 7.2 – Data obtained from ISFET for LDH and hexokinase alginate beads assay.  
Instead of using a pipette to put down the droplet of enzyme alginate solution 
and form a bead in CaCl2, a Jetlab II 2D inkjet printer was used, as shown in 
Figure 7.3. The 2D printer was used to print the CaCl2 and then print the 
alginate containing enzyme to form a well-defined gel on top of the surface. As 
shown, the 2D printer is a very sophisticated tool which consists of a printing 
stage, a fluid reservoir, two cameras (vertical and horizontal), an air 
compressor, a vacuum pump and a dispenser print head [190]. The printing 
stage, controlled by a computer, can move in horizontal x and y directions. The 
fluid reservoir is used to contain the printing fluid with a maximum capacity of 
around 1.5 ml. The vertical camera is used to observe the printed droplets, 
whereas the horizontal camera is used to inspect the droplet formation at the 
tip of the print head. An air compressor is used as a pressure source (compressed 
air) to supply to the reservoir, in order to push the liquid through the tube that 
is connected to the dispenser print head. The air compressor is set to give a 
pressure of 4 bar. A control panel on the printer is used to change the pressure 
in between 0 to 400 in arbitrary units. The vacuum pump is required as a mean 
to switch between vacuum and pressure to the reservoir, in order to get the 
optimal pressure for printing. A control panel is also used to change the vacuum 
pressure in the range of 0 to -400 in arbitrary units. The optimal pressure 
required for printing (normally ranging from -14 to 20 in arbitrary units) is when 
the fluid is idled at the tip of the print head.  
a) LDH assay 
 
b) Hexokinase assay 
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Figure 7.3 – A photograph showing the Jetlab II 2D inkjet printer [190]. 
The most important component of the 2D printer is the dispenser print head, 
which is made of glass. It consists of a ring-shaped piezoelectric actuator that is 
bonded to the glass capillary tube, which is connected to a fluid supply 
(reservoir) at one end, and an opening (30 – 60 μm) at the other end to dispense 
the fluid. By applying voltage to the actuator, the cross-section of the glass tube 
is reduced or increased, causing pressure variations of the fluid in the glass 
tube. These pressure variations are propagated in the glass capillary towards the 
opening of the glass tube. If a sudden change happens in the cross-section of the 
opening of the glass capillary tube, a droplet will be formed. In order to print 
multiple droplets, normally a sinusoidal voltage waveform is applied to the 
actuator.  
In order to control the dispenser print head, the computer is used to drive the 
actuator with a waveform, as shown in Figure 7.4. The driving actuator 
parameters are trise = initial rise time, tdwell = time at high voltage V1 (dwell 
voltage), tfall = transition time from high voltage to low voltage, techo = time at 
low voltage V2 (echo voltage), and tfrise = final rise time. The voltage V0 (idle 
voltage) generally is set to zero, while V1 and V2 have the same amplitude but 
with opposite phase. Normally, the rise and fall time is short, which is around 2 – 
3 μs. The dwell time is typically in the range of 15 to 35 μs, and the echo time is 
normally twice the dwell time. The first half of the waveform (solid line) is used 
to form a droplet and dispense it, whereas the second half of the waveform 
(dotted line) is used to produce a clean break-off of the droplet from the tip of 
the print head. The droplet size is proportional to the dwell time tdwell and 
voltages V1 and V2. Hence, in order to print a desired droplet size (normally 
ranging from 50 pl to 200 pl), all these parameters have to be well controlled. 
163 
 
 
Figure 7.4 – The driving waveform for the piezoelectric actuator at the print head. 
The process of printing was straightforward. First, 1.5 ml of the enzyme alginate 
solution or any fluid was filled into the reservoir connected to the printer. It was 
then followed by an investigation step to produce a desired droplet size. This 
was done by varying the actuator driving parameters (voltages and timings) and 
the required idle pressure (air compressor and vacuum pump), in order to form a 
nice droplet at the tip of the print head. One important thing to note was that 
the amount of solution that was required to be loaded into the reservoir must be 
greater or equal to 0.5 ml in volume, in order to obtain a good pressure for a 
decent droplet formation. The reason is because of the connection of the tube 
between the air compressor and the reservoir does not go all the way down to 
the bottom of the reservoir. When the desired droplet size and smooth printing 
are obtained, the solution can be readily printed onto the surface of the sample. 
Using this printer technique, multiple droplets can be printed in an array format 
on the surface of the chip in each microfluidic channels, leading to multiple 
enzyme assays. As can be seen from Figure 7.5a, an array of droplets with well-
defined size and pitch size was successfully printed, demonstrating the 
technique’s capability. Furthermore, the process of gelation of enzyme 
entrapped in alginate was also successfully printed on a silicon nitride coated 
substrate, demonstrating a good adhesion to the surface, this can be seen from 
Figure 7.5b. The droplet can be removed with ultra-sonication in a phosphate 
buffer solution.  
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The viscosity of the alginate solution, however, can increase the difficulty to 
perform a successful printing. The printer can only print fluids with a viscosity 
lower than 40 cP. The “thick” nature of the alginate solution clogged the printer 
nozzle very often, which required several hours of refinement to print a decent 
droplet. Therefore, a 1% final concentration of alginate enzyme solution (4 – 12 
cP) was selected in order to create a successful printing and also to be able to 
entrap the enzyme. In addition, after the droplet was refined for a specific 
enzyme alginate solution, it had to be printed immediately before the alginate 
solution would accumulate and clog the printer nozzle. 
 
Figure 7.5 – Optical microphotograph showing the printing of an array of droplets, and 
enzyme alginate gel printed on a silicon nitride coated substrate. 
The printed alginate enzyme gel on the surface of the chip was tested and 
validated to make sure that the enzyme was still active after going through the 
printing procedure and also to make sure that it was detectable using the ISFET 
array chip. To do this, a small droplet of CaCl2 solution was pipetted on top of 
the CMOS chip, enough to cover the whole surface of the sensor array. 
Refinement of both the CaCl2 and enzyme alginate solution to be simultaneously 
printed normally takes a long time, thus CaCl2 solution was pipetted to test the 
enzyme alginate immobilisation. The same enzyme alginate solution used to 
form the enzyme beads was used to print. The same amount of enzyme was 
printed in one go to reach the same concentration that was obtained using the 
enzyme alginate beads. After the printing, the excess CaCl2 solution was cleaned 
with triethanolamine buffer and immediately all the substrate required for the 
enzyme assay was added to the chip except the initiation solution. As before, 
a) Array printing b) Enzyme alginate printing 
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the chip acquired a baseline of approximately 3 minutes and was followed by the 
initiation solution to trigger the enzyme assay. 
As can be seen from Figure 7.6a, the printed droplet enzyme alginate gel was 
very big, covering the whole surface of the chip to produce the number of Units 
of enzyme similar to that obtained from enzyme alginate bead. This experiment 
was performed to determine if the printed enzyme was still active after the 
printing process, thus the droplet size was not a concern. However, a more 
concentrated enzyme alginate solution was later prepared for subsequent 
experiments to reduce the number of droplets required to print, with the 
downside that it is very expensive to prepare a highly concentrated enzyme 
alginate solution in 1.5 ml. Since there were no microfluidic channels on top of 
the chip, there was no segregation of the chip into multiple compartments to 
present multiple enzyme assays, all the sensors in the array therefore read the 
same assay. From Figure 7.6b, it can be seen that hexokinase was selected to be 
printed on top of the CMOS ISFET chip and the activity of hexokinase with 
glucose concentration of 23.1 mM was measured. It can be noticed that the 
signal obtained from the hexokinase assay from two separate prints was very 
alike, proving the repeatability of the printing process.  A negative control with 
a triethanolamine buffer alginate solution was printed on the surface of the 
CMOS chip to form a blank gel. No signal was observed from the chip for the 
enzyme assays with the blank gel. Another negative control was done by 
removing glucose from the reaction with the result, as expected, of no change in 
ISFET response. These negative controls demonstrated that the assay was a 
direct result of the hexokinase reaction. Hence, this had proven that alginate gel 
immobilisation of enzymes using a 2D inkjet printing is a viable technique to 
perform enzyme assays. 
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Figure 7.6 – Optical micrograph showing enzyme alginate gel printed on top of a CMOS chip 
and the data obtained from ISFET for enzyme alginate gel and control experiments.  
7.3 Microfluidics  
After demonstrating that the 2D inkjet printer can be used to immobilise 
enzymes on the surface of a CMOS chip, leading to a detection of substrate that 
is specific to the enzyme, the segregation of the chip into different 
compartments for multiple enzyme assays had to be validated. As discussed in 
Section 5.3, the microfluidic channels were fabricated using SU-8 negative 
photoresist on top of a CMOS chip. The CMOS chip was then wire bonded and 
encapsulated with epoxy, without compromising the channels, and finally the 
channels were covered with an adhesive film for complete isolation. In Section 
5.3.3, the microfluidic channels were evaluated using an optical microscope to 
ensure that the liquid could flow into the channels without any obstruction and 
also verify the channels are well isolated from each other. However, this 
evaluation was done on a silicon substrate that has a different topography from 
a CMOS chip. In this section, the microfluidics will be evaluated again but using 
the sensor array in the CMOS chip as a “camera” and also having the SU-8 
microfluidic channels on top of the sensor array. 
As mentioned before in Section 4.3, the ISFET array chip has bond pads on each 
side of the chip, which does not leave any room for inlet and outlet ports for 
liquid to be injected or ejected. However, SU-8 microfluidic channels were still 
fabricated onto the ISFET array chip to be inspected. Since the resolution of the 
ISFET array chip (11.2 μm – the sensor pixel pitch size) is smaller compared to 
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the Multi-Corder chip (100 μm pitch size), the fluid flow in the channels can be 
observed using ISFET array chip. To be reminded of how the chip will look like 
after packaging and encapsulation, this is shown in Figure 7.7. The encapsulation 
epoxy formed a square cavity on top of the sensor array and there was no space 
to introduce the liquid. Several attempts had to be tried to inject some buffer 
solution at one end of the chip to allow the liquid to flow in. This was observed 
to be a major flaw due to the inconsistent flow of liquid into the channels. In 
spite of that, the buffer solution started to flow into the SU-8 channels after 
several attempts, proving that the SU-8 channels with the adhesive film is a 
viable technique to be used on a CMOS chip to separate the enzymes into 
different spatial locations, enabling simultaneous measurements of enzyme 
assays without cross-contamination. Using the high resolution ISFET array chip, 
images of the fluid flow in the SU-8 channels were taken, as shown in Figure 7.8.  
 
Figure 7.7 – Optical image of the 256×256-pixel ISFET array chip with packaging and 
encapsulation. 
a) Side view b) Top view 
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Figure 7.8 – 2D imaging of proton distributions over the 256×256-pixel ISFET array chip to 
visualise the fluid flow event across the SU-8 microfluidic channels. 
 
a) 39.3 s 
 
b) 39.4 s 
 
c) 39.5 s 
 
d) 40 s 
 
e) 41.4 s 
 
f) 43.2 s 
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7.4 Integration and Characterisation 
Section 7.2 demonstrates that alginate enzyme immobilisation with 2D inkjet is a 
viable technique to perform enzyme assays, and Section 7.3 shows that SU-8 
microfluidic channels on a CMOS chip provide good segregation and isolation. 
Hence, the final step is to integrate the immobilisation technique with 
microfluidics to perform multiple enzyme assays simultaneously, on one single 
chip. To integrate microfluidics and the immobilisation of the alginate enzyme 
gel, the adhesive film (top lid) was left out in the beginning to allow printing. 
After the printing, the top lid was immediately introduced on top of the 
channels, providing isolation. Since the ISFET array chip does not have any 
openings to introduce liquid with ease, the Multi-Corder chip was used because 
it only has two sides with bond pads and wire bonds. As can be seen from Figure 
7.9, the encapsulation and packaging of the chip left two openings to allow 
liquid to be introduced easily into the channels. However, as mentioned in 
Section 6.3, the ISFET sensor did not work in the Multi-Corder chip, thus the PD 
sensor was used as the sensor to detect cholesterol oxidase assay, with 
microfluidics and alginate enzyme immobilisation. Since the ISFET sensor can be 
used to detect enzyme assays immobilised in alginate gel, it was believed that 
PD could also be used for enzyme assays entrapped in alginate gel. In addition, a 
cholesterol assay in solution had also been validated using the PD sensor 
(presented in Section 6.3), thus there were no reason to believe that it should 
not work in alginate. 
In Section 6.3, a PD was used to demonstrate cholesterol quantification. 
Therefore, in this experiment, cholesterol oxidase with alginate solution was 
printed in the channel, followed by the introduction of CaCl2 on top of the Multi-
Corder chip for the gel formation. Then, the chip was gently cleaned with 
triethanolmine buffer to remove any excess CaCl2 solution. This was then 
followed by the introduction of the adhesive film as the top lid of the SU-8 
channels. The chip was inserted into the experimental setup and all the required 
reagents were introduced at one end of the SU-8 channels without any delay. 
The capillary force from the channels drags the reagents towards the sensor 
array, triggering the cholesterol oxidase assay. It is important to note that the 
top lid and reagents were introduced without delay (after the printing), in order 
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to preserve the enzyme activity. As the gel droplet was very small, evaporation 
may occur and hamper the enzyme activity.  
 
Figure 7.9 – Optical image of Multi-Corder chip with packaging and encapsulation. 
 
Figure 7.10 – 3D representative image of the SU-8 channels obtained from PD sensor array, 
with channel 1 to 4 is labelled as black, red, blue and cyan, respectively.  
In Figure 7.10, the CMOS PD array was used to take a 3D representative image of 
the SU-8 channels fabricated on top of the chip. As can be seen, the PD signal is 
lower when the LED light is shining through the SU-8 resist wall on top of the 
a) Side view b) Top view 
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sensors, whereas the PD signal is higher when the LED light is shining straight on 
top of the sensor. It can be clearly observed that, there are three walls made up 
of SU-8 resist and four channels. A shadowing effect was occurring on top of the 
channels depending on how the LED light was shone on top of the PD. Some 
channels may have stronger PD signal than others due to this shadowing. 
Therefore, every time the enzyme assay was taken, a reference data was 
obtained in order to differentiate the change of PD signal. To better understand 
the following results, each of the channels was labelled from one to four with 
different colours, which were black, red, blue and cyan, respectively. 
As can be seen from Figure 7.11a, 10k droplets and 5k droplets (ranging from 
100 to 400 pl/droplet) of cholesterol oxidase alginate solution (0.0067 Units/μl) 
were printed on channel 1 and channel 2, respectively. Channels 3 and 4 were 
left blank to act as a negative control. A difference in magnitude of PD signal 
was observed when channels 1 and 2 were printed with different concentrations 
of cholesterol oxidase. In addition, channels 3 and 4 did not give rise to any 
signal, as was expected. A second experiment was performed in a reverse order 
to better interpret the results. This time, channel 1 was left blank as the 
negative control, whereas channels 2, 3 and 4 were printed with cholesterol 
oxidase alginate solution with 500 droplets, 1k droplets and 10k droplets, 
respectively. As can be seen from Figure 7.11b, the 10k droplets in channel 4 
gave a signal change, with a similar response to the first experiment. At the 
same time, channel 1 gave no signal from the PD, which was expected from a 
negative control. However, channels 2 and 3 gave a small signal, which was 
barely distinguishable from the negative control. A lot more repeatable 
experiments have to be done to fully understand the working mechanism of the 
integration of microfluidics with alginate enzyme gel immobilisation on top of a 
CMOS chip to quantify metabolites. An optimised level of enzyme droplets to be 
printed has to be obtained and follow by doing measurements with different 
metabolites concentration in different channels to obtain variable electrical 
signals. By understanding having control experiments in one channel and varying 
different metabolites in other channels with the same printed enzyme, we can 
proceed to have more than one enzyme assay. Nevertheless, these preliminary 
experiments had demonstrated an important first step in understanding the 
integration of microfluidics and enzyme alginate gel immobilisation on a single 
172 
 
chip to run multiple enzyme assays for different metabolites quantification, 
leading towards a personal metabolome machine.  
 
Figure 7.11 – Data obtained from PD sensor array with SU-8 channels for different 
cholesterol oxidase concentrations and control experiments. Channels 1 to 4 are labelled as 
black, red, blue and cyan, respectively. 
7.5 Summary 
In this chapter, a complete metabolome measurement system was realised by 
enzyme immobilisation and integrating microfluidic channels on top of a 16×16-
pixel Multi-Corder chip. For enzyme immobilisation, alginate gel was used to 
entrap the enzyme and a state-of-the-art 2D inkjet printer was used to 
immobilise the enzyme alginate gel on the surface of the CMOS chip. SU-8 
microfluidic channels were fabricated on top of a CMOS chip to image the flow 
of liquid, in order to prove good isolation of the channels. A cholesterol assay 
was then carried out with the immobilisation technique and microfluidic 
channels to demonstrate negative and positive control experiments, which were 
measured simultaneously. In the next and final chapter, a summary of the 
conclusions from the research will be given along with some future work.  
 
b) Second attempt 
 
a) First attempt 
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Chapter 8 : Conclusion 
8.1 Introduction 
The previous chapter described how to integrate SU-8 microfluidic channels and 
entrapped alginate enzyme gel using a 2D inkjet printer into a complete system, 
in order to demonstrate metabolite detection and a control measurement 
simultaneously. This system has the potential to be used as a multi-enzyme 
platform for detection of different metabolites. This chapter concludes the 
research work and provides some potential suggestions for future work. 
8.2 Final Analysis 
Metabolites are the tiny molecules of life. Healthy metabolite levels are 
fundamental to our wellbeing and the collection of all these molecules makes up 
the metabolome. In the same way that pioneering technologies unravelled the 
personal genome for less than a thousand dollars and in just one day, it is also 
necessary to develop a technology to provide everyone their own metabolome. 
This technology will ultimately revolutionise diagnostics and delivery of precision 
healthcare worldwide. The purpose of this study focussed on developing an 
integrated CMOS sensor array technology as a single platform, while integrating 
microfluidics and bio-functionalisation techniques, to produce a portable multi-
metabolite detection machine. The main achievements of this work are reported 
as follows: 
 Two CMOS sensor array chips, a 256×256-pixel ISFET array chip and a 
16×16-pixel Multi-Corder chip were fully understood. A high-speed 
instrumentation system was developed for the ISFET array chip. As the 
work progressed, a miniaturised version of the instrumentation system 
was developed for Multi-Corder chip, with the idea of making it portable 
and compatible with a portable electronic device such as a laptop. 
 A lot of the work involves chemical and biological experiments, which 
have to be introduced in an aqueous solution. Therefore, a biocompatible, 
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robust and water-tight packaging technique was developed to encapsulate 
all the electrical connections from the aqueous environment. 
 A fabrication process was developed using room temperature sputtering 
and a lift-off technique to deposit Ta2O5 film on top of a CMOS ISFET to 
improve sensitivity to hydrogen ion concentration, drift and robustness of 
the sensor performance.  
 Several enzyme assays were investigated, measured and analysed using an 
ISFET array chip for hydrogen ion measurement and using PD array on the 
Muti-Corder chip for colorimetric light absorbance detection.  
 SU-8 microfluidic channels were fabricated on top of the CMOS chips and 
the isolation of each channel and fluid flow in the channels demonstrated.  
 Different enzyme immobilisation techniques were explored. The suitable 
technique was to entrap the enzyme in alginate and print it onto the 
surface of the CMOS chip using a 2D inkjet printer. This immobilisation 
technique had been demonstrated to be able to use on top of the CMOS 
chips and the enzyme assay signals were able to be detected by the CMOS 
sensor. 
 A complete system was constructed by integrating SU-8 microfluidic 
channels and alginate enzyme entrapment using 2D inkjet printer on a 
CMOS platform. A first demonstration of a single enzyme assay and control 
experiments simultaneously performed on a single CMOS chip was 
presented. Further work still required to demonstrate multi-metabolite 
measurement on a single CMOS chip.  
The following sections will summarise the major findings of the complete system 
and some significant problems that were encountered along the course of the 
research work. 
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8.2.1 Instrumentation Systems 
The 256×256-pixel ISFET array chip was designed by Dr. Balazs Nemeth and 
provided to me. The sensor pixel design and readout architecture of the 
256×256-pixel ISFET array chip was understood to begin with. Since the array 
size of the chip is very big, it was decided to construct a high-speed 
instrumentation system. It comprises a desktop computer, four PXI-Express-6538 
X series acquisition cards in a PXI-Express-1073 chassis (National Instruments), a 
PCB and a fully packaged ISFET array chip. The whole system was controlled by a 
software package, LabVIEW, to acquire 64 analogue outputs from the chip and to 
provide 10-bit digital addresses to the chip. It has the capability to read one 
sensor pixel at a maximum speed of 2 μs/pixel. Hence, the maximum readout 
speed for the entire array (all 65,536 pixels) is 2.048 milliseconds for one frame, 
equating to approximately 500 frames per second. Using LabVIEW, 2D and 3D 
representation imaging can be obtained, as well as single pixel analysis. 
Two thirds of the way through the research work, a second chip was designed by 
Dr. Mohammed Al-Rawhani, which was the 16×16-pixel Multi-Corder chip. Similar 
to ISFET array chip, the design and readout architecture of the chip was 
understood. This chip contains three different sensors, which are ISFET, PD and 
SPAD. The number of pixels on this chip is only 256, thus a high-speed 
acquisition system was not required. Moreover, the idea of creating a portable 
device and low cost diagnostic tool was in mind. Therefore, a low cost and 
miniaturised instrumentation system was constructed. This system comprised a 
laptop, one ARM mbed Integrated Development Environment STM32 Nucleo-
F334R8 board (STMicroelectronics), a PCB, and a packaged Multi-Corder chip. 
LabVIEW was again used to control the whole system and to do 2D imaging and 
analysis of the data. Each of the sensors in the array could be addressed 
independently, thus any sensor can be selected using LabVIEW.  
8.2.2 Post-Processing of CMOS Chips 
The beginning of the research work concentrated solely on the ISFET, thus a lot 
of the post-processing of the CMOS chips was developed based on it. The first 
task was to improve the sensor performance on the ISFET array chip. Ta2O5 has 
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always been known to be an excellent material for pH sensing. Therefore, using 
a sputtering tool in JWNC, a room temperature sputtering process was 
developed to deposit Ta2O5 on chip. Various trials were performed followed by 
characterisation using AFM and XPS to determine the best approach to deposit 
Ta2O5, which is compatible for CMOS processing. Furthermore, a patterning 
method on top of the CMOS chip was also required. Since Ta2O5 is a difficult 
material to dry or wet etch, a lift-off process was chosen. Several photoresists 
were trialled to establish the most suitable lift-off process when sputtering 
Ta2O5. The best combination proved to be a LOR10A and S1818 bi-layer. After 
successful deposition of Ta2O5 on top of the ISFET sensor, the sensor 
performance was characterised with the instrumentation system. It was found 
that the pH sensitivity was 45 mV/pH, which is very close to Nernstian response 
of 58 mV/pH. In addition, the average drift of the sensor from chip-to-chip was 
around 6.5 ± 8.6 mV/hour and the working pH range was pH 2 – 12. Another 
material, polyoxometalates (POMs) was deposited by drop casting on top of the 
ISFET to improve its performance towards potassium sensing. Using POMs on an 
ISFET, a net potassium sensitivity of 75 mV/pK was obtained, with a linear range 
between pK 1.5 to 3. Moreover, the POMs ISFET had a pH sensitivity of -
5 mV/pH, proving that POMs layer is selective towards potassium ions and not 
hydrogen ions. In addition, sodium ions as interfering background ions were 
investigated and found to reduce the POMs ISFET pK sensitivity to 15 mV/pK. 
Hence, POMs layer has to be investigated further to produce better sensitivity 
and selectivity.  
Since the project required simultaneous quantification of different metabolites 
on a single chip, fabrication of microfluidic channels to segregate the sensor 
array was vital. Using SU-8 photoresist, microfluidic channels were developed. In 
addition, these channels had to have good channel isolation, a surfactant free 
hydrophilic fluid transport film was used to bond on top of the channels. The 
channels were then evaluated with an optical microscope and found to have 
good isolation and allow smooth liquid flow. The last processing step for the 
CMOS chips was packaging. Since all the biological and chemical experiments 
were done in aqueous solution, a good encapsulation technique to protect the 
electrical connections was developed using a PDMS method and a manual dam 
and fill method.  
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8.2.3 Enzyme Assays on Chip 
Most of the research work was conducted with the ISFET array chip, thus many 
of the enzyme assays were performed using it. Using an array of sensors greatly 
reduces the noise as a function of √N, where N is the number of sensors used for 
averaging. This averaging spatial noise reduction was also found to obey 
Gaussian statistics. The work was then progressed to investigate different 
enzyme assays on the ISFET. This proved to be a major challenge since enzyme 
assays have to be measured in a buffer system to keep them in the optimised pH 
range, while the ISFET is a sensor that measures pH. To overcome this, the 
strength of the buffer system of each enzyme assay had to be altered, in order 
to work on the ISFET. Four different enzyme assays, hexokinase, lactate 
dehydrogenase, urease and lipase, were performed on the ISFET and showed 
quantification capability. In addition, enzyme kinetics calculations were 
performed using a hexokinase assay data to further demonstrate the capability 
of the device.  
On receiving the Multi-Corder chip from the foundry, the ISFET sensor was not 
working correctly due to a 7 μm thick passivation on top of ISFET that impeded 
its operation. Therefore, one of the optical sensors had to be evaluated with an 
enzyme assay to achieve multi-enzyme platform quantification. The chosen 
sensor to be used was a PD. A colorimetric assay was demonstrated using 
cholesterol oxidase on a CMOS PD, with a green LED as a light source, to quantify 
cholesterol concentrations. It was then further demonstrated that this approach 
can be used to quantify cholesterol levels in pure human blood serum. 
Furthermore, the metabolite quantification results and enzyme kinetics obtained 
from this method were comparable to that obtained from a bench top 
spectrophotometer. This demonstrated a low cost and miniaturised version of 
spectrophotometer as a portable diagnostic device. 
8.2.4 Integration of Microfluidics and Enzyme Immobilisation for 
Metabolite Detection on Chip 
Last but not least, an enzyme immobilisation technique had to be developed to 
allow multiple metabolites to be quantified in a single chip format. A few 
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approaches for enzyme immobilisation were investigated. In the end, an alginate 
enzyme immobilisation was selected for the course of this study. The alginate 
enzyme entrapment technique was initially tested to demonstrate its capability. 
The work progressed onto using a 2D inkjet printer to deliver the alginate 
enzyme gel onto the desired location on the top surface of the CMOS chip. After 
showing that enzyme entrapped in alginate gel together with 2D inkjet printing 
was a viable immobilisation technique, the whole complete system was 
constructed, by integrating microfluidic channels as well. The complete system 
was then used to perform an enzyme assay with different enzyme concentrations 
in each channel together with control experiments simultaneously, proving that 
the system could be potentially used as a multiple metabolite quantification 
platform.  
8.3 Future Work 
The emphasis of this research work was placed on demonstrating a complete 
working system for multiple metabolite measurements. However, the system 
was not tested to its full potential. Moreover, there are still a lot of factors to 
be considered for every single component, in order to develop a future personal 
metabolome machine. Consequently, it is now possible to identify a few key 
criteria to improve on this technology. 
8.3.1 Handheld Diagnostic Device 
The instrumentation system that was constructed for the Multi-Corder chip has 
the capability to be further miniaturised to a complete handheld diagnostic 
device which can be connected to a mobile phone. Currently, the CMOS chip is 
powered by an Agilent power supply while a USB cable is connected to a laptop 
controlled by LabVIEW to power the mbed. The reason why ubiquitous USB 
connectors are such a popular interconnect for electronic devices is due to their 
battery free and plug-and-play capability. However, not all mobile phones offer 
USB as propriety power and analogue interfaces. Recently, the ubiquitous audio 
jack has been proven to be able to use for this functionality [191]. This can 
eliminate the need for a power supply and a laptop or a PC. As an alternative 
the electronic platform can be powered using a lithium battery while utilising 
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the standardised Bluetooth wireless communication to transfer data between 
mobile phone and the electronic system. Figure 8.1 shows how the multicorder 
chip is interfaced with the mobile phone in the future. 
 
Figure 8.1 – The future of the Multi-Corder project – a handheld personal metabolome 
machine. 
Secondly, the introduction of liquid to the device currently uses a pipette, which 
is not user friendly. Ideally, consumers will just need to prick their fingers and 
use a simple accessory to transfer the blood to the biosensor. A lot of the 
existing technology uses cyanoacrylate paper for home test kits to transfer blood 
into the biosensor [192], [193], which could be a good addition to the electronic 
platform that was developed in this study. Finally, the long term stability of 
alginate enzyme gel is very poor, which is not ideal to be used as a commercial 
product. There is also a lot of existing technology based on sol-gel film in dry 
format [194], which is used in commercialised glucose biosensors. They provide 
long term stability where the biosensor can be mass-produced and kept in store 
for a long period of time before it is actually being used. In a nutshell, in order 
to realise a handheld diagnostic device to produce a personal metabolome 
machine, all of these features have to be significantly improved. Figure 8.2 
shows how the Multi-Corder platform would look like in the future. 
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Figure 8.2– Schematic of a CMOS device with microfluidic channels for quantification of 
multiple metabolites of any body fluids. 
8.3.2 Antibodies with Plasmonics Integration 
Many of the currently available commercial biosensors exploit enzyme assays for 
the detection of specific metabolites. However, there are several serious 
limitations for using enzymes to quantify metabolites. For an enzyme reaction to 
function properly, the temperature, pH and other environmental factors have to 
be taken into consideration. Moreover, every single enzyme works in different 
conditions, which makes developing a multi-enzyme platform extremely difficult 
to match up one hundred or even thousands different enzymes. Furthermore, an 
enzyme reaction normally requires more than one substrate, where ideally a 
multiplexing platform would just require metabolite and a probing biomolecule 
to detect an output product change. Finally, the greatest weakness of enzymes 
is that they are very prone to various different kinds of inhibitors, for example a 
lot of drugs are inhibitors that stop enzyme reactions from occurring.  
Recently, Hoshi et al. [195] had used a specific metabolite specific antibody to 
quantify metabolite trytophan for acute viral myocarditis in mice. Hence, a 
proposed suggestion to overcome enzymes’ limitations is to use specialised 
antibodies that could accept specific metabolites into their binding ground. 
Antibodies are more robust structures than enzymes; they do not require a lot of 
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special conditions to be active. Furthermore, antibodies are very specific to only 
one specific target. Up until 7 to 10 years ago, antibodies were expensive and 
difficult to obtain, now they are a lot of antibodies that are widely available and 
are easily purchased. Hence, antibodies could be an alternative probing 
biomolecule to enzymes. However, antibodies and their specific antigen reaction 
do not release any biological product that is easily detected. Normally, an 
antibody and antigen reaction could use ELISA (enzyme-linked immunosorbent 
assay) detection to produce a colour change and quantify the antigen. This 
reaction requires a first antibody to bind to the antigen and a second antibody 
(containing an enzyme that could produce a colour product) to bind to the 
remaining binding sites of antigen to produce colour change, similar to a 
“sandwich”. This approach will not work for antibodies and metabolites reaction 
because metabolites are a factor of 100 times smaller than an antigen, which do 
not provide a vast amount of binding sites for a second antibody. 
More recently, Shakoor et al. [196] had developed a monolithic integration of 
nanophotonics structure on CMOS PD and demonstrated the capability to 
perform label-free immunoassay. Therefore, in order to detect this metabolite-
antibody reaction, it is proposed to use localised plasmonics based on gold 
nanodisks, as can be seen in Figure 8.3. Since these nanodisks measure a shift in 
wavelength, which has no need of any detectable products from the biological 
reaction, thus this fits the bill perfectly. These gold nanodisks can be used to 
bind antibodies by exploiting straightforward thiol chemistry. Therefore, the 
quantification of metabolites will depend on how much wavelength shift. This 
can also be further integrated onto the CMOS PD platform to quantify the 
intensity of light based on the wavelength shift. As a concluding comment, 
specialised antibodies integrated on plasmonics and CMOS PD could be the future 
towards multiplexing platform for personal metabolome machine.  
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Figure 8.3 – Schematic showing the integration of plasmonic structures on top of a CMOS 
chip. 
8.4 Summary 
This research work has successfully achieved the main objective of developing 
an integrated CMOS sensor array with corresponding electronics platform that 
has the potential to be used to detect multiple metabolites simultaneously. This 
chapter has summarised the major findings and difficulties faced during the 
course of this study. Also, several suggestions to improve the current electronic 
and biological systems were given. 
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Appendix A : Graphical Programming 
Code 
A.1 256×256-Pixel ISFET Array Platform 
The software used for the instrumentation system to obtain analogue signals and 
provide digital addresses to the ISFET array chip, as well as data analysis, was 
based on the LabVIEW system-design platform and development environment, 
which is a visual programming language from National Instruments.  
 
Figure A.1 – LabVIEW program used to send digital addresses to the memory and self-
regenerate. 
 
Figure A.2 – LabVIEW program used to acquire analogue signals which is synchronised 
with digital addresses. A partial of the analogue data was presented in real time and all the 
analogue data was logged into a TDMS file. 
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Figure A.3 – LabVIEW program for data analysis of a single pixel and an average of the 
entire array. The same program was also used for 2D and 3D imaging with slight alteration. 
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Figure A.4 – LabVIEW program to extract standard deviation and mean of the analogue 
signals. 
 
Figure A.5 – LabVIEW program for flattening of ISFET signal to cancel the drift. 
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A.2 16×16-Pixel Multi-Corder Array Platform 
The same software LabVIEW was also used for instrumentation system to control 
Multi-Corder chip, in order to for the laptop to communicate with the 
microcontroller, mbed on the PCB and also data analysis. 
 
Figure A.6 – LabVIEW program to synchronise and obtain analogue signals for ISFET array 
on Multi-Corder chip. This program was also used to show real time 2D image and single 
pixel data, while storing as a TDMS file. 
 
Figure A.7 – LabVIEW program for PD array of Multi-Corder with the same functionalities 
like ISFET array. 
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Figure A.8 – LabVIEW program for SPAD array of Multi-Corder with the same functionalities 
like ISFET and PD array. 
 
Figure A.9 – LabVIEW program for data analysis and 2D imaging, this is an example of PD 
array on Multi-Corder chip. 
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Appendix B : Source Code 
The following C++ program enables the mbed platform to acquire signals and to 
provide digital addresses to the Multi-Corder chip. 
#include "mbed.h" 
PortOut ISFETcol(PortA, 0x03c0); //PA_6,7,8,9 
PortOut ISFETrow(PortA, 0x1c00); //PA_10,11,12 
PortOut PDcol(PortB, 0x0f00); //PB_8,9,10,11 
PortOut PDrow(PortB, 0x00f0); //PB_4,5,6,7 
PortOut SPADcol(PortC, 0x03c0); // PC_6,7,8,9 
PortOut SPADrow(PortB, 0xf000); //PB_12,13,14,15 
 
AnalogIn isfeta(PA_0); 
AnalogIn isfetb(PA_1); 
AnalogIn PD(PB_0); 
DigitalOut PDrst(PD_2);  
DigitalOut clear(PC_10);  
DigitalOut gate(PC_11);                                      
DigitalOut read(PC_12);                                      
DigitalIn SPADout(PA_15); 
 
Serial pc(USBTX, USBRX); 
 
int main() 
{ 
    int i,j,k; 
    int isfetav, isfetbv, PDv, SPAD; 
    pc.baud(115200); 
    int a; 
    uint32_t counter = 0; 
    a=0; 
    while(1) { 
        a = pc.getc(); 
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        if (a==66) { //B 
            a = 0; 
            PDrst = 0; 
            wait(0.001); 
            PDrst = 1; 
            wait(0.0005); 
            PDrst = 0; 
            wait(0.040); 
            for (i=0; i<16; i++) { 
                for(j=0; j<16; j++) { 
                    wait(0.00001); 
                    PDcol.write(i<<8);  
                    PDrow.write(j<<4); 
                    wait(0.00001); 
                    PDv = PD.read_u16(); 
                    pc.putc(PDv>>8); 
                    wait(0.00001); 
                } 
            } 
        }else  if (a==69) { //E 
            a = 0; 
            PDrst = 0; 
            wait(0.001); 
            PDrst = 1; 
            wait(0.0005); 
            PDrst = 0; 
            wait(0.040); 
  for (i=0; i<16; i++) { 
                for(j=0; j<16; j++) { 
                    wait(0.00001); 
                    PDcol.write(i<<8); 
                    PDrow.write(j<<4); 
                    wait(0.00001); 
                    PDv = PD.read_u16(); 
                    pc.putc(PDv>>8); 
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                    pc.putc(PDv&0xff); 
                    wait(0.00001); 
                } 
            } 
        } else if (a==65) { //A 
            a = 0; 
            for (i=0; i<16; i++) { 
                for(j=0; j<8; j++) { 
                    wait(0.00001); 
                    ISFETcol.write(i<<6); 
                    ISFETrow.write(j<<10); 
                    wait(0.00001); 
                    isfetav = isfeta.read_u16(); 
                    pc.putc(isfetav>>8); 
                    isfetbv = isfetb.read_u16(); 
                    pc.putc(isfetbv>>8); 
                    wait(0.00001); 
                } 
            } 
        } else if (a==67) { //C 
            a = 0; 
            for(i=0; i<16; i++) { 
                SPADcol.write(i<<6); 
                clear = 1; 
                gate = 0; 
                read = 1; 
                wait(0.000001); 
                clear = 0; 
                wait(0.000001); 
                clear = 1; 
                gate = 1; 
                wait(0.01); 
                gate = 0; 
                for(j=0; j<16; j++) { 
                    SPADrow.write(j<<12); 
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                    for(k=0; k<18; k++) { 
                        read = 0; 
                        wait(0.000001); 
                        read = 1; 
                        wait(0.000001); 
                        SPAD = SPADout.read(); 
                        if (k==0 && SPAD == 1) { 
                            counter++; 
                        } else if(SPAD == 1) { 
                            counter = counter << 1; 
                            counter++; 
                        } else { 
                            counter = counter << 1; 
                        } 
                    } 
                    pc.printf("%i", counter); 
                    counter = 0; 
                    wait(0.0001); 
                } 
            } 
            wait(0.1); 
        } else { 
            ISFETcol.write(0); 
            ISFETrow.write(0); 
            PDcol.write(0); 
            PDrow.write(0); 
            SPADcol.write(0); 
            SPADrow.write(0); 
            PDrst = 0; 
            clear = 0; 
            gate = 0; 
        } 
        a = 0; 
    } 
} 
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